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1.1 Historical perspective 
Porcine reproductive and respiratory syndrome (PRRS) is one of the most important 
diseases of swine (Neumann et al. 2005). The annual cost of the disease has been 
estimated at $664M in the USA alone (Holtkamp, 2011), representing over one-third 
of the total losses in swine industry attributed to infectious diseases (Lewis et al. 
2007). The syndrome appeared almost simultaneously in Western Europe and North 
America in the late 1980s and has since spread to become endemic in the major 
swine-producing nations of Europe, Asia and the Americas (Keffaber, 1989, 
Wensvoort et al. 1991, Calvert et al. 2007). Genetic analysis by Forsberg (2001) and 
Stadejek (2008) led to the hypothesis that the virus was already circulating in Eastern 
Europe for a much longer time. At the beginning of the PRRS outbreaks, the 
European genotype was restricted to Europe, while the American genotype was 
restricted to the US and Asia (Andreyev et al. 1997, Shibata et al. 1996). However, 
the North American genotype was introduced in Europe due to reversion of a 
VR2332-derived vaccine strain (Bøtner et al. 1997, van Vugt et al. 2001); and in 
2000, a European type virus entered Canada (Dewey et al. 2000). Nowadays, both 
genotypes co-circulate in all continents (Lunney et al. 2010, Ropp et al., 2004). Two 
distinct genotypes of the porcine reproductive and respiratory syndrome virus 
(PRRSV) designated ‘European’ (type 1), with Lelystad virus (LV) as prototype 
European PRRSV strain; and ‘North American’ (type 2), with VR-2332 as prototype 
American strain have been described (Forsberg, 2005, Hanada et al. 2005). 
Phylogenetic analysis revealed approximately 40% genomic difference at the 
nucleotide level, which suggests that both genotypes have evolved independently 
prior to their almost simultaneous appearance in commercial swine herds (Andreyev 
et al. 1997, Gagnon and Dea, 1998). PRRSV appears to be continuously evolving 
resulting in the emergence of new variants (Rowland et al. 1999; Chang et al. 2002, 
Goldberg et al. 2003). As a direct consequence of the high degree of genetic 
variability within each genotype, the type 1 genotype has been proposed to be 
subdivided into different subtypes; a Pan-European subtype 1 and East European 
subtypes 2 and 3 (Goldberg et al. 2003, Stadejek et al. 2008, Shi et al. 2010). 
The disease is characterised by reproductive failure in sows and gilts and respiratory 
problems in pigs of all ages (Wensvoort et al. 1991, Collins et al. 1992). Different 
PRRSV isolates display a high antigenic and pathogenic variability. Their virulence 
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ranges from moderately to highly pathogenic, like the recently emerging type 2 
isolates described in China and Vietnam (Tian et al. 2007, Feng et al. 2007, Zhou et 
al. 2008, Hu et al. 2012); and the type 1 subtype 3 isolate PRRSV (Lena) originating 
from Belarus (Karniychuk et al. 2010). 
1.2 Taxonomy 
PRRSV belongs to the genus Arterivirus, which is classified within the family of the 
Arteriviridae. This family together with the Coronaviridae (genus Coronavirus and 
Torovirus) and the Roniviridae (genus Okavirus) form the order Nidovirales (Sidell 
and Snijder, 2008). The classification was based on genome organisation and the 
relatedness of the nonstructural proteins used in RNA replication and transcription 
(Costers et al. 2008). The name “Nidovirales” is derived from ‘nidus’ and refers to 
the “nested” set of 3’ co-terminal subgenomic-length mRNAs that are generated for 
translation of PRRSV proteins (Snijder and Meulenberg, 1998). 
Besides PRRSV, the Arteriviridae contain three other members: equine arteritis virus 
(EAV) infecting horses and donkeys, lactate dehydrogenase-elevating virus (LDV) 
infecting mice, and simian haemorrhagic fever virus (SHFV) infecting several genera 
of African and Asian monkeys. Even though all four viruses form a distinct 
phylogenetic group and share a common replication strategy, PRRSV, LDV and 
SHFV are genetically more closely related to one another than they are to EAV 
(Sidell and Snijder, 2008). 
1.3 Virion and genomic structure 
By cryo-electron microscopy, the virions appear as round to egg-shaped particles 
ranging in diameter from 50 to 70 nm, with a median value of 54 nm (Figure 2A). 
They consist of an icosahedral nucleocapsid core encapsidating an RNA genome and 
surrounded by a smooth spherical envelope (Spilman et al. 2009). The virus consists 
of three major structural proteins, which together represent approximately 90-95% of 
the structural protein content: the nucleocapsid protein N, the nonglycosylated 
membrane protein M, and the glycosylated membrane protein GP5 (Mardassi et al. 
1996, Meulenberg et al. 1995, Snijder and Meulenberg, 1998) (Figure 2B). The N 
protein is incorporated in virions mainly as a disulphide-linked dimer. The M and 
GP5 proteins are incorporated in virions mainly as a disulphide-linked heterodimer or 
Introduction	  
 
 10 
as a disulphide-linked multimer. The M and N proteins are also present as single 
proteins in purified virions (Vanderheijden et al. 2003). Also, minor structural GP2a, 
E - envelope (GP2b), GP3, and GP4 proteins are suggested to be present as 
heteromultimeric complexes in the envelope (Wissink et al. 2005, Delputte et al. 
2002, Van Nieuwstadt et al. 1996). PRRSV is a positive-sense single stranded RNA 
virus with a genomic length of 15.1 kb for the European strains and 15.4kb for the 
North American strains (Allende et al. 1999, Nelsen et al. 1999). The genome 
contains at least 9 partially overlapping open reading frames (ORFs) (Lee and Yoo, 
2005). ORF1a and ORF1b constitute about 80% of the genome and encode the virus 
replication machinery including the RNA-dependent RNA polymerase. ORFs 2-7 are 
located in the 3′ terminal region of the genome and encode structural proteins 
(Meulenberg et al. 1995, Meulenberg and Petersen, 1996) (Figure 2C). ORF7 
encodes the nucleocapsid protein N, ORF6 the non-glycosylated membrane protein 
M, ORF5 the major envelope glycoprotein GP5 and ORFs 2-4 the minor envelope 
glycoproteins GP2, GP3 and GP4, respectively (Meulenberg et al. 1995). Within 
ORF2, a second ORF is present that expresses the non-glycosylated protein E (Wu et 
al. 2001). Besides the coding regions, the genome contains a 5’ non-coding region of 
189 (American genotype) to 221 (European genotype) nucleotides (nt) which carries 
a cap at its 5’ end, and a 3’ non-coding region of 114 (European genotype) to 150 nt 
(North American genotype), to which a poly-A tail is attached (Meulenberg et al. 
1997; Allende et al. 1999). Two RNA structures, a slippery sequence (7 nt) located 
upstream of the ORF1a stop codon and a pseudo-knot structure downstream of this 
sequence are considered to play a role in the ribosomal frame-shifting during 
translation of ORF1ab (Meulenberg et al. 2000; Allende et al. 1999). 
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Figure 1. A. - Arterivirus structure. Cryo-electron microscopy of a representative 
PRRSV particle in vitreous ice. Putative spike protein complex and striations 
possibly corresponding to the transmembrane domains of envelope proteins are 
indicated. B. - Schematic representation of the structure of an arterivirus particle. C. -
Arterivirus genome organization. The replicase ORFs 1a and 1b are followed by the 
genes encoding the minor and major envelope proteins and the N protein. GP-
glycoprotein; M-membrane; E-envelope; N-nucleocapsid. Red arrowheads: sites 
cleaved by the nsp4 SP (S); blue arrowheads: sites cleaved by PLP domains (P) in the 
nsp1/nsp2 region. Three ORF1a-encoded (putative) transmembrane domains (TM) 
and four highly conserved ORF1b-encoded domains are depicted: RNA-dependent 
RNA polymerase (R), (putative) multinuclear zinc-binding domain (Z), RNA 
helicase (H), and NendoU endoribonuclease domain (N). Image adapted from Snijder 
et al. 2013. 
 
 
 
 
 
&
Introduction	  
 
 12 
1.4 Heterogeneity  
Both type 1 and type 2 PRRS viruses revealed great genetic and antigenic diversity 
after extensive sampling over the years and sequencing of ORF5 and ORF7 (Meng et 
al. 1995; Kapur et al. 1996; Stadejek et al. 2008). Since the first European PRRSV 
strain was isolated in Lelystad, the Netherlands it was regarded as the prototype type 
1 PRRSV (Lelystad-LV) (Wensvoort et al. 1991). Different type 1 clusters have been 
identified, by analyzing ORF3, ORF4, ORF5, ORF6 and ORF7 sequnces of PRRSV 
strains in Great Britain, Italy, Denmark and Hungary (Frossard et al. 2013). Eastern 
European isolates showed a high divergence compared to Western Europe isolates. 
Three subtypes were identified based on their ORF5 and ORF7 sequences with the 
latter ORF recommended as a more stable indicator for subtyping due to size 
polymorphism (Stadejek et al. 2008). It is also important to point out that until now 
the current phylogenetic clustering has no predictive value concerning the virulence 
and the immunogenicity of the isolates, and an alternative prediction model is needed. 
In South-Eastern Asia (Thailand, Vietnam, China) several subtype 1 viruses were 
genetically related to two types of live-attenuated vaccine strains based on their 
ORF5 sequences, an event that was quite surprising since type 1 MLV vaccines were 
not officially registered in these countries (Thanawongnuwech et al. 2004). After 
multiple introductions of type 1 subtype 1 PRRSVs in countries outside Europe, it 
was possible to further divide this subtype into 12 clades, which confirmed the 
appearance of viruses from the same country in different clades (Shi et al. 2010b) 
(Figure 1). 
Type 2 PRRSV isolates were divided into nine lineages based on their ORF5 
sequences (Shi et al. 2010b). The greatest diversity was shown in type 2 viruses 
isolated in North America as they are distributed in seven out of nine lineages. 
Lineage 3 and 4 only include Asian isolated viruses. Within the seven lineages 
constituting the North American viruses, Asian and European isolated viruses are 
also represented. This lineage also harbors the Ingelvac MLV vaccine, which is the 
preferred vaccine against Type 2 PRRSV in most European countries (Stadejek et al. 
2013). Type 2 PRRSV isolates in Europe are not diverse since so far the majority of 
type 2 PRRSV circulating in the European pig herds were vaccine-like (Stadejek et al. 
2013).  
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Figure 2. Genetic tree of type 1 PRRSV based on a complete collection of ORF5 
sequences from GenBank. The phylogenetic tree was constructed in MrBayes v3.2 
(Ronquist et al. 2012). The figure was adapted from Shi et al. 2010b. 
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1.5 PRRSV replication and infection  
1.5.1 Cell tropism 
Like other Arteriviruses, PRRSV has a very restricted host cell specificity. In vivo, 
the virus shows a marked tropism for cells of the monocyte/macrophage lineage 
(Plagemann and Moennig, 1992; Snijder and Meulenberg, 1998). Of particular 
importance in this context is a sub-population of differentiated macrophages, which 
can be identified by expression of CD163 and sialoadhesin (Sn) cell surface markers 
(Duan et al. 1997b, Vanderheijden et al. 2003, Van Gorp et al. 2008).  
In vitro, it was shown that PRRSV is able to propagate in primary cell cultures of 
porcine alveolar macrophages (PAM). Cultivated peripheral blood monocytes, 
monocyte-derived dendritic cells (Mo-DCs), bone marrow-derived dendritic cells 
(BM-DCs), the African green monkey kidney cell-line MA-104 and its derivatives 
(MARC-145, CL-2621) have equally been used to cultivate the virus (Kim et al. 1993, 
Voicu et al. 1994, Duan et al. 1997a).  
1.5.2 Entry mediators and replication cycle 
A number of key cellular mediators have been implicated in the entry process of 
PRRSV. The infectious process starts with an unstable binding of the virus with 
sugars on the cell surface. The viral envelope matrix (M) protein on itself or as a 
complex with GP5, functions as a heparin-binding protein interacting with the 
heparan sulphate moieties on cellular glycoproteins anchored in the plasma 
membrane. These weak virus-sugar interactions allow the virus to glide through the 
roof of foliage of the ‘sugar forest’ until it finds its real receptor, sialoadhesin on 
macrophages for both European and American strains (Vanderheijden et al. 2001, 
Delputte et al. 2002). This receptor mediates only viral attachment, as blocking of 
heparin sulfate did not prevent virus internalization. Sialoadhesin (Sn; CD169; 
Siglec-1), a 210 Kd membrane glycoprotein in the Siglec family of sialic acid-
binding immunoglobulin-like lectins, has been identified as a receptor that mediates 
both attachment and internalization of European and American strains 
(Vanderheijden et al. 2003, Delputte et al. 2004, 2005). This was demonstrated by the 
ability of a Sn-specific monoclonal antibody (mAb) (41D3) to completely block 
PRRSV infection and the fact that naturally non permissive cells to PRRSV infection 
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acquired the ability to internalize the virus upon transfection with the Sn gene. Sialic 
acids on the GP5/M complex bind to this lectin, thus activating an internalisation by a 
microfilament-dependent process through small clathrin-like coated vesicles 
(Nauwynck et al. 1999, Vanderheijden et al. 2003, van Breedam et al. 2010). The 
virus then ends up in early endocytic vesicles where a drop in the pH, an aspartic 
protease cathepsin E, and an unidentified trypsin-like serine protease are involved in 
proper virus uncoating. (Duan et al. 1997b, 1998, Kreutz and Ackermann, 1996, 
Misinzo et al. 2008). 
However, transfecting of cells with Sn did not result in virus uncoating, genome 
release or production of infectious virus, demonstrating that an additional function(s) 
or protein(s) was essential for the disassembly of the virus (Duan et al. 1998, 
Delputte et al. 2005, Vanderheijden et al. 2003). The macrophage scavenger receptor 
CD163 belonging to the scavenger receptor cysteine-rich (SRCR) superfamily was 
identified as the missing link (Calvert et al. 2007, van Gorp et al. 2008). It has been 
shown to interact with the virus via envelope proteins GP2a and GP4 (Das et al. 2010).  
1.6 Pathogenesis 
Pigs of all ages are susceptible to PRRSV infection. Natural infection of pigs by 
PRRSV occurs mainly via inhalation, ingestion or sexual intercourse. The virus 
spreading within herds is via close contact between carrier and susceptible pigs 
through nose-to-nose contact, or by contact with urine and faeces. Viral spread 
between herds has mainly been attributed to intensive animal movement practices 
such as the introduction of infected animals and contaminated fomites (boots and 
clothes, transport vehicles, equipment) (Zimmermann, 2006, Albina et al. 1997, 
Pesente et al. 2006). Airborne transmission by aerosols in a distance of roughly 9 km 
has also been reported to be another important means of spread, and is influenced by 
the pathogenicity of the different isolates (Kristensen et al. 2004, Otake et al. 2002). 
It is thought to be enhanced by low temperatures, high humidity, and low wind speed 
as experienced during winter (Komijn et al. 1991). Spread via semen is another well-
established potential transmission route (Christopher-Hennings et al. 1995). Other 
indirect mechanical routes of transmission such as via slurry and arthropod vectors 
have been reported (Cho and Dee, 2006, Dee et al. 2004a, Zimmermann et al. 2006, 
Otake et al. 2003, 2004). Experimental infection has been achieved following 
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intranasal, intratracheal, oronasal, intramuscular, intrauterine, intravenous or 
intraperitoneal inoculations (Albina et al. 1997, Christianson et al. 1992, Collins et al. 
1992, Van Reeth et al. 1999, Swenson et al. 1994, Yoon et al. 1999, Nodelijk et al. 
2003).  
One of the prime characteristics of PRRS viral pathogenesis is the specific tropism 
for differentiated cells of the monocyte/macrophage lineage (Wensvoort et al. 1991; 
Snijder and Meulenberg, 1998). The susceptibility of these cells varies from one 
tissue to another. For instance, macrophages in lungs, tonsils, lymph nodes and 
spleen were found to be permissive to PRRSV infection (Duan et al. 1997a,b, 
Thanawongnuwech et al. 1997, Beyer et al. 2000, Labarque, 2002); whereas, virus 
infection was not detected in macrophages of kidneys, liver, heart and peritoneum, 
nor in peripheral blood monocytic and bone marrow cells (Duan et al. 1997a,b).  
Upon virus uptake by the host, primary viral replication occurs in macrophages of the 
respiratory tract and in draining lymphoid tissues, and subsequently arrives in the 
blood (Duan et al. 1997a, Rossow et al. 1995, Beyer et al. 2000). Viremia can be 
detected by virus isolation and subsequent IPMA staining as early as 12 hpi to 3 dpi 
and can last up to 42 dpi in weaned and grower piglets and up to 14 dpi in sows and 
boars (Halbur et al. 1996, Karniychuk et al. 2010). The replication pattern of PRRSV 
is characterized by an acute phase with peak viremia (average titers: 103-4 TCID50/ml) 
during the first 2 to 3 weeks of infection, followed by a subacute phase with low 
viraemia (average titers: 100.5-1.5 TCID50/ml) lasting till 5-8 weeks of infection. The 
viremia is not cell-associated, with a pattern and duration largely dependent on the 
age of the animals and the viral strain involved (Bilodeau et al. 1994, Paton and Drew, 
1995, Yoon et al. 1993). During viremia, the virus is distributed to various body 
organs such as the lungs, lymph nodes, Peyer’s patches of the ileum, spleen, liver, 
heart and muscles (Duan et al. 1997a, Lawson et al. 1997, Rossow, 1998). As early as 
3 dpi, it is possible to detect the virus in nasal swabs, tonsillar scrappings, 
bronchoalveolar lavage (BAL), lungs, retropharyngeal lymph nodes, bronchial and 
thoracic aortic lymph nodes, and spleen (Duan et al. 1997a, Labarque et al. 2000, 
Karniychuk et al. 2010). 
In boars, the virus infects the reproductive tract, and can be detected in the gonads 
and shed in the semen (Swenson et al. 1994, Christopher-Hennings et al. 1995a,b). In 
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pregnant sows, PRRSV replicates in the endometrium prior to crossing the placenta 
barrier causing fetal infection. This is often seen during the third trimester of 
gestation, and rarely much earlier (Mateusen et al. 2007, Karniychuk et al. 2013). The 
exact mechanism is still unknown. A possible role of Sn+CD163+ macrophages acting 
as vehicles in the maternal-fetal cell-transmigration process; as well as pathological 
changes affecting the placenta permeability have been suggested (Prieto and Castro, 
2000, Christianson et al. 1993, Mengeling et al. 1994, Karniychuk et al. 2009; 
Karniychuk 2013).  
Finally, a non-viremic persistent phase may occur, which can last up to 5 months, and 
is characterized by a continuous low-level replication mainly in the lungs and 
lymphoid tissues (tonsils, lymph nodes, spleen) (Allende et al. 2000, Labarque et al. 
2000, Beyer et al. 2000, Wills et al., 2000).  
1.7 Clinical picture 
PRRSV is characterized by reproductive failure in pregnant sows and gilts, and 
respiratory distress in pigs of all ages, particularly in nursing pigs. However, these 
clinical presentations vary considerably between herds, and are influenced by the 
virulence of the different isolates, the age of the animals, the immune status of the 
herd, and the concurrent infections (Halbur et al. 1996, Goldberg et al. 2000, Xu et al. 
2010).  
Profound genetic and virulence differences characterize the different PRRSV isolates, 
both in the field and under controlled experimental settings. Postulated reasons for 
such observed variances dwell on variations in the replication kinetics amongst 
strains, effects of inflammatory immune responses and viral clearance by the host 
(Epperson and Holler, 1997, Yu et al. 2012, Martinez-Lobo et al. 2011, Brockmeier 
et al. 2012, Morgan et al. 2012, Shang et al. 2013). Several experimental infection 
studies, as well as the recent disease outbreaks in China and Vietnam evidently show 
that some strains are more virulent compared to others (Tian et al., 2007, Zhou et al. 
2008, Feng et al. 2007, Li et al. 2012, Han et al. 2012, Karniychuk et al. 2010, Guo et 
al. 2012). In a recent study with wild type and vaccine type 1 strains it was shown 
that the virulence of different PRRSV strains correlates with their transmission 
efficiency, as vaccine strains significantly reduced virus transmission (Pileri et al. 
2015). It is generally accepted that both type 1 and type 2 isolates can cause 
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reproductive disorders, whereas, up till now only type 2 and highly pathogenic type 1 
strains have been shown to cause severe respiratory disorders.  
In swine farms displaying respiratory disease features, single PRRSV infections are 
often rare. PRRSV is more often isolated in combination with bacteria like 
Actinobacillus pleuropneumoniae, Streptococcus suis, Haemophilus parasuis, 
Arcanobacterium pyogenes, Pasteurella multocida, Salmonella cholerasuis, 
Escherichia coli, Mycoplasma hyopneumoniae and Mycoplasma hyorhinis. Some 
common respiratory viruses such as swine influenza viruses and porcine respiratory 
coronaviruses are often isolated as well, and it has been shown that PRRSV is able to 
increase the susceptibility of pigs to secondary bacteria and other viral infections 
(Hopper et al. 1992, Done and Paton, 1995, Van Reeth et al. 1996, Solano et al. 1997, 
Brockmeier et al. 2000, Thanawongnuwech et al. 2004, Fraile et al. 2009, Qiao et al. 
2011, Díaz et al. 2012). Thus, these findings support the claim that PRRSV 
inevidently contributes to the porcine respiratory disease complex (PRDC) 
(Opriessnig et al. 2011).  
PRRS in sow herds is characterized by anorexia, lethargy, infertility, late fetal 
mummification, late-term abortions, early farrowing, stillbirths and the birth of weak 
piglets that usually die shortly after birth due to respiratory distress and secondary 
bacterial infections (Ohlinger et al. 1991, Wensvoort et al. 1991, Hill et al. 1996). In 
addition, PRRSV-infected boars exhibit also a temporary decrease in sperm quality 
and viral shedding via sperm, which is a result of the virus detection in the testes 
(Prieto et al. 2005). 
In weaned and fattening pigs, acute PRRS initially manifests as anorexia, lethargy, 
prolonged fever, cutaneous hyperaemia or cyanosis of extremities (“blue ears”), 
dyspnea, tachypnea, rough hair coat, failure to thrive, and an increase in mortality 
due to secondary infections (Dee and Joo, 1994, Li et al. 2007, Zhou et al. 2008) 
(Figure 3). Older pigs may show milder respiratory signs. Nevertheless, PRRS in 
finishing pigs, boars, gilts and sows is often found to be subclinical in nature (Done 
and Paton, 1995, Stevenson et al. 1993, Zimmerman et al. 2006)  
The majority of clinical signs described for field PRRSV infections have been 
reproduced with experimental PRRSV infections. Clear respiratory signs could be 
observed upon inoculation with highly pathogenic PRRSV isolates (HP-PRRSV) 
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such as Lena (European type 1, subtype 3), and HUN4, SD-JN, SY0608, HEB1 and 
HUB2 (American type 2). The clinical information regarding the type 1 subtype 3 
Lena strain is very important since in the last decade other type 1 subtype 2, 3 and 4 
strains have emerged, but the available data concerning their virulence is very scarce. 
Coughing, sneezing and dyspnea could be seen starting from 3 dpi, alongside a 
gradually increasing anorexia and depression lasting till death or till 2 to 3 weeks pi. 
Prolonged fever (40.5-42°C), starting at 1 to 3 dpi and lasting till death or till about 
14 to 18 dpi, was a much more common finding with these infections  (Karniychuk et 
al. 2010, Guo et al., 2012, Weesendorp et al. 2012, Han et al. 2012). In a few 
instances, subcutaneous peri-ocular edema and polyarthritis was reported. 
Experimental inoculations with low virulent strains such as the European subtype 1 
(Lelystad and 07V063) viral strains and other American isolates (SDI, CH-1a, HB-1 
and HB-2) generally resulted in much milder clinical presentations with often full 
recovery in most infected animals (Halbur et al. 1995, Mengeling et al. 1996, 
Karniychuk et al. 2010). Conclusively, infections involving the various viral isolates 
generally showed more severe respiratory signs for the HP-PRRSV strains compared 
to their low virulent counterparts (Rossow et al. 1994, Halbur et al. 1995, Loemba et 
al. 1996, Tian et al. 2007, Tong et al. 2007). However, the final outcome of a PRRSV 
infection under natural field conditions appears not to be determined solely by the 
effects of a single isolate, but likely, a combination of several factors. 
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Figure 3. Clinical signs typical of infection with highly pathogenic PRRSV. (a) 
Infected piglet shivering with high fever. (b) Characteristic purple/blue colouring of 
the ears. (c) Adult sow that has succumbed to porcine high-fever disease. In most 
cases, infection in pregnant sows leads to abortion, but occasionally also to death of 
the sow. (d) Aborted fetuses as a result of infection. (e) Kidney from an infected pig 
showing numerous blood spots (red arrows), found in 20–30 % of the cases. (f) 
Severe lesions and haemorrhages (red arrows) in lungs are unique to highly 
pathogenic PRRSV infection. (a, e, f). Adapted from Snijder et al. 2013. 
1.8 PRRSV immune response 
Type 1 IFN, including IFNα and IFNβ are the major players in the innate immunity, 
and are essential for the subsequent development of an effective adaptive immune 
response (Borgethi, 2005, Haller et al. 2006). They have been reported to interfere 
with viral replication in encephalomyocarditis virus, vesicular stomatitis virus and 
herpes simplex virus infected cells by induction of apoptosis, and in uninfected 
neighbouring cells by stimulating these cells to express antiviral proteins (Tanaka et 
al. 1998, Samuel, 2001). In vitro, IFNα and IFNβ, as well as IFNγ have been reported 
to control PRRSV replication in pulmonary alveolar macrophages (PAM). In vivo it 
was shown that PRRSV infected pigs produce no or very low concentrations of these 
cytokines in their respiratory tract (Buddaert et al. 1998, Bautista and Molitor, 1999, 
Loving et al. 2007).  
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Besides the downregulation of the IFN system, PRRSV has been reported to 
adversely affect the expression levels of other cytokines, such as TNF α/β, IL-1, IL-6, 
IL-10, and IL-12. However, the majority of publications show contradictory data. 
Some investigators have reported a downregulation of TNF-α expression levels 
(either mRNA or proteins) in PRRSV-infected PAM and BAL fluids from PRRSV 
infected animals (Van Reeth et al. 1999, Chiou et al. 2000, Lopez-Fuertes et al. 2000, 
Labarque et al. 2003a, Thanawongnuwech et al. 2001, Van Gucht et al. 2003). In 
contrast, others claimed that TNF-α is actually induced upon PRRSV infection (Choi 
et al. 2002, Aasted et al. 2002, Ait-Ali et al. 2007, Miguel et al. 2010). Chen et al. 
(2010) may give an answer to these conflicting findings. They demonstrated that 
changes and deletions in the nsp2 of the virus corresponding to one of the most 
variable regions of the viral genome might actually be responsible for the ultimately 
observed regulatory pattern for TNFα. Regarding IL-8, most studies have reported an 
increased expression during PRRSV infections (Thanawongnuwech et al. 2001, 
Aasted et al. 2002), whereas for IL-6 reports have argued for (Liu et al. 2009, Peng et 
al. 2009, Barranco et al. 2012) and against (Diaz et al. 2005) an increase in 
production. IL-10 is a pleiotropic cytokine with regulatory properties that is thought 
to play an important role in PRRSV immunopathogenesis. For instance, it has been 
demonstrated to enhance the viral infection process through the upregulation of 
CD163 expression in CD14+ monocytes (Patton et al. 2009). However, most papers 
suggest this cytokine is an important element in PRRS (Darwich et al. 2010). 
A delayed onset of IFNγ-secreting cells (IFNγ-SC) is seen as 2 to 3 weeks pi, steadily 
increasing afterwards, and reaching a steady state only after several months pi (Meier 
et al. 2003, Xiao et al. 2003, Diaz et al. 2005). The mechanisms governing such 
aberrant and erratic patterns are still unclear. IFNγ inducing epitopes and responses 
have been described for the major viral proteins N, M, GP5 and GP4 of which 
epitopes in N seem to be immunodominant (Kwang et al. 1999, Vashisht et al. 2008, 
Diaz et al. 2009). Nevertheless, Jeong et al. (2010) has reported IFNγ responses 
triggered by M rather than N. Regarding the cells responsible for these IFNγ 
responses, Meier et al. (2003) reported a predominant role for CD4+CD8+ cells 
compared to CD4-CD8+ cells, whereas Xiao et al. (2003) and Rodriguez-Carreño et al. 
(2002) instead proposed a dominant role for CD4-CD8+ T-lymphocytes. 
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Most infected pigs generally show seroconversion at approximately 5 to 9 dpi. These 
anti-PRRSV antibodies are mostly of the IgM class measured by an indirect 
fluorescent antibody method (IFA), which peak at about 9 to 14 dpi, and then 
disappear to undetectable levels at about 21 dpi (Loemba et al. 1996, Joo et al. 1997, 
Labarque et al. 2000, Diaz et al. 2005, Mulupuri et al. 2008). IgG antibodies have 
been detected by ELISA as early as 7 to 10 dpi, peak at 2 to 4 weeks pi, remain 
constant for months, and then decline to low levels at about 300 dpi (Nelson et al. 
1994, Zimmerman et al. 2006, Diaz et al. 2005). Early antibody responses are 
believed to be directed against epitopes in the nucleocapsid (N), nsp1 and the nsp2 
proteins (very immunogenic proteins); and much later against the M and GP5 
envelope proteins (Nelson et al. 1994, Yoon et al. 1995, de Lima et al. 2006, 
Oleksiewicz et al. 2001, Johnson et al. 2007). However, early PRRSV-specific 
antibodies are not neutralising both in vitro and in vivo (Yoon et al. 1994, Labarque 
et al. 2000, Lopez and Osorio, 2004). Several papers have suggested a possible role 
of these early non-neutralising antibodies in the potentiation of the viral replication 
process by a phenomenon known as antibody-dependent enhancement of infection 
(ADE). This phenomenon is described as an enhanced internalisation of the virus in 
the macrophages as a result of opsonisation by the non- neutralising antibodies (Choi 
et al. 1992, Christianson et al. 1993, Yoon et al. 1997, Cancel-Tirado et al. 2004, 
Welch et al. 2004). 
Neutralising antibodies most often appear from 4 or 5 week pi, or even later. Their 
levels peak between 5 to 11 weeks pi, and afterwards, they slowly decline to low 
levels (Diaz et al. 2005, Yoon et al. 1995, Meier et al. 2003, Lopez and Osorio, 2004, 
Delputte et al. 2004). Generally, variations in the onset of neutralising antibodies are 
often dependent on the viral strain used, type and modifications of the viral 
neutralisation tests or both (Diaz et al. 2005, Kim et al. 2007, Takikawa et al. 1996, 
Yoon et al. 1995). In any case, titres of neutralising antibodies against PRRSV are 
usually low (below 1:32 and 1:64) in pigs inoculated with wild type viruses (Diaz et 
al. 2005, Meier et al. 2003, Loemba et al. 1996). Finally, passive transfer of PRRSV-
specific neutralising antibodies protected pregnant sows against the virus-induced 
reproductive form of the infection, as well as provided sterilizing immunity in both 
sows and offspring (Osorio et al. 2002). 
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1.9 PRRSV vaccines 
Vaccination is one of the most effective tools to control PRRS through reduction of 
clinical signs, despite the fact that it does not prevent infection. Currently, modified-
live virus (MLV) and killed-virus (KV) vaccines are commercially available. 
Research on PRRSV vaccines has so far focused on their immunogenicity, efficacy 
and safety aspects (Charerntantanakul, 2012). It is recommended for vaccines to 
contain the specific genomic type(s) in order to reduce viral replication.  
PRRS MLV (modified-live virus vaccines) derived from both the North American 
and European genotypes have been licensed for use in regions where the original 
wild type strains are circulating. Analogous to infection with the wild type PRRSV, 
MLV vaccines preferentially stimulate the production of neutralising antibodies, and 
a delayed and weak host IFN-γ response (Meier et al. 2003, Bassaganya-Riera et al. 
2004, Zuckermann et al. 2007). PRRSV neutralizing antibodies seem to appear at the 
same moment as observed during infection, and are often characterised by very low 
titres (approximately 23 to 25) (Darwich et al. 2010). Regarding the protective 
efficacy of MLV vaccines, it is accepted that they are able to protect pigs against 
PRRSV-mediated reproductive and respiratory diseases. PRRSV MLV vaccines 
confer protection; with a resultant reduction in the severity of clinical signs in gilts, 
sows, and piglets born to vaccinated sows against homologous reinfection with 
PRRSV. However, their efficacy against heterologous reinfection appears to be much 
more variable (Scortti et al. 2006, Rowland, 2010, Alexopoulos et al., 2005, Pejsak 
and Markowska, 2006, Cano et al. 2007a, 2007b). Finally, another major concern of 
PRRS MLV vaccines resides in the possibility of reversion to virulence through 
genetic mutation of the vaccine virus and/or recombination with field virulent 
PRRSV (Murtaugh et al. 2010). This often predisposes to clinical disease, with the 
possibility of viral shedding (Thanawongnuwech and Suradhat, 2010).  
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PRRS KV (killed-virus vaccines) unlike the MLV vaccines, are licensed for use in 
EU countries and other parts of the world, but not in the US (Charerntantanakul, 
2012). In general, KV vaccines are poorly immunogenic, inducing barely detectable 
(or none at all) post-challenge PRRSV neutralising antibodies (Plana-Duran et al. 
1997, Zuckermann et al. 2007, Kim et al. 2011), as well as CMI responses (Piras et al. 
2005). Consequently, they confer ineffective protection even against homologous 
challenge (Scortti et al. 2007, Zuckermann et al. 2007). Nevertheless, the 
administration of PRRSV KV vaccines to PRRSV-infected pigs has been shown to 
increase antibody and CMI responses against infection. These enhanced immune 
responses can be detected 2 weeks after the second shot of vaccination, and correlate 
with protection (Kim et al. 2011). In PRRSV-positive farms, KV vaccines have been 
reported to improve reproductive performance and health status of piglets born to 
vaccinated sows (Papatsiros et al. 2006). With regards to safety, PRRS KV vaccines 
are considered safe, with no existing reports of any negative impact on pig health 
(Charerntantanakul, 2012). 
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2. The use of mucosa explants for studying pathogen infection of the respiratory 
tract  
2.1 Historical perspective of ex vivo models 
Experiments in animals should be limited as much as possible due to ethical reasons. 
In 1959, the 3R principals (reduction, refinement, replacement) concerning the 
reduction of the number of experimental animals, the refinement of the experiments 
to minimize pain and distress, and the replacement of experimental animals by using 
ex vivo models, were set up by Russel and Burch in 1959. In vivo work with large 
animals is difficult, as purchase and maintenance costs are high and suitable 
experimental animals are often difficult to obtain. Thus, there is a constant search for 
in vitro models that minimize the number of in vivo experiments and the use of 
experimental animals. The most valuable explant models are those with a three-
dimensional (3D) structure, which can mimic best the natural environment. In 3D 
explant systems the architecture of the microenvironment and the cell-cell contact are 
preserved resembling the natural in vivo condition (Anderson and Jenkinson, 1998). 
Variation between animals is minimized as tissues can be obtained from the same 
animal. Explant models have proven to be beneficial for the study of the interaction 
of bacterial or viral pathogens with the respiratory mucosa of different species such 
as pigs, horses, cows, chickens and humans (Butler and Ellaway, 1972, Fanucchi et 
al. 1999, Glorieux et al. 2007, Steukers et al. 2011, Vandekerckhove et al. 2009, 
Vairo et al. 2012, Tugizov et al. 2012). In order to maintain the natural condition, the 
nasal mucosa is set at the air-liquid interface (Middleton et al. 2003).  
2.2 General characteristics of the respiratory mucosa 
The respiratory tract is divided anatomically into two distinct parts, the upper and the 
lower respiratory tract, which are separated by the pharynx. The upper respiratory 
tract comprises the nasal cavity and the nasopharynx. The respiratory mucosa lines 
the nasal cavities, the nasopharynx, larynx, trachea and bronchial tree, representing 
the first line of defense against pathogens (Reynolds et al. 1991). The lower 
respiratory tract begins with the larynx and then continues into the thorax as the 
trachea, bronchi and lungs. Cartilage or bone provide a supporting skeleton for the 
wall of the airways and prevent the collapse of these airways during respiration. Air 
enters the respiratory tract through nostrils and a pair of nasal cavities (cavum nasi) 
situated in the external nose (nasus externus). The respiratory mucosa consists of 
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consecutive barriers in order to prevent the entry of respiratory pathogens. The 
luminal surface epithelium is the first barrier, which is supported by the extracellular 
matrix of the basement membrane (BM). The BM separates the epithelium from the 
underlying lamina propria (Pabst et al. 1996). 
2.3 Histology of the upper respiratory mucosae 
2.3.1 Respiratory epithelium 
The respiratory epithelium lines the surface of the upper and the lower respiratory 
tracts. In this thesis, research is focused in the respiratory mucosa of the nasal 
cavities. The two nasal cavities are divided by the septum, and the inner surfaces of 
the cavities are increased by the perturbations of the turbinates or the conchae. The 
nasal mucosa can be divided into the cutaneous (pars cutanea), the respiratory (pars 
respiratoria), and the olfactory area (pars olfactoria). The largest part of the nasal 
cavity is covered by the pars respiratoria (Dyce et al., 1987). The mucosa of the 
nasal cavities is covered with pseudostratified ciliated columnar epithelium 
containing ciliated cells, basal cells, goblet cells and brush cells, lymphoreticular 
tissue aggregates, loose myeloid cells, and combined tuboalveolar glands (Figure 4). 
All epithelial cells are in contact with and supported by the basement membrane and 
although they represent a single layer of cells, their nuclei are not aligned on the same 
level (Eurell et al., 2006).  
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Figure 4. Haematoxylin-eosin photograph of the different tissue compartments and 
cell types present in the nasal mucosa. Adapted from School of Medicine, Illinois, 
USA. 
2.3.2 Composition of respiratory epithelium 
2.3.2.1 Ciliated cells 
Ciliated cells are the main cell type of the ciliated pseudostratified columnar 
epithelium. The surface of each of the cells is equipped with approximately 200 to 
300 ciliae and their beat frequency is 300 to 600 per minute (Plopper and Adams, 
1993). Ciliary columnar cells are about 20 µm in height and 7 µm in width, and they 
are narrower towards the base. Their shape is columnar in the proximal part of the 
respiratory tract and becomes cuboidal with shorter ciliae in the caudal part (Breeze 
et al. 1976, Reynolds, 1991). They have a wide apical side and a narrow basal side 
directed towards the BM. 
2.3.2.2 Brush cells  
Brush cells or tuft cells are a population of epithelial cells, which is scattered 
throughout the respiratory epithelium. Their characteristic morphologic feature 
originates from the brush of relatively long, rigid and thick microvilli on their apical 
cell surface. The function of brush cells is not fully elucidated but it is believed that 
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they act as chemosensory cells with secretory and absorption properties (Sato et al. 
2007). 
2.3.2.3 Goblet cells 
Goblet cells are the primary secretory cells in the respiratory epithelium and their 
name originates from their “wine goblet” shape. They are scattered among epithelial 
cells with an average ratio of 1 to 5, but they increase in number in the case of 
chronic inflammation. They do not possess cilia and they contain membrane-bound 
granules containing mucin, which is secreted straight into the lumen of the 
respiratory tract to form the mucus layer (Reynolds, 1991). Mucus is important for 
the maintenance of epithelial moisture and the filtering of inhaled air by trapping 
inhaled particles and pathogens (Davis and Dickey, 2008). The discharge of the 
mucus is very rapid in response to a wide variety of stimuli (Rogers, 2002). Mucus 
mobility is controlled by the synchronized beating of surface cilia (Harkema et al. 
2006). Although this cell type was thought to differentiate into functional ciliated 
epithelial cells, another study showed that they lack telomerase activity (Haij et al. 
2007). 
2.3.2.4 Basal cells 
Basal cells are the only cell type of the respiratory epithelium that is directly attached 
to the basement membrane by hemidesmosomes and to adjacent columnar cells by 
desmosomes. Their wide basal side covers the basement membrane. They are 
considered as resident epithelial progenitor cells as they can fully replace epithelial 
cells, through mitosis, migration and differentiation. By flattening out and covering 
the BM, basal cells can act as a defense mechanism when neighboring columnar cells 
are lost (Evans et al. 2001). 
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2.3.3 Cell-cell and cell-matrix adhesions 
There are three types of cell-junctions: tight junctions, anchoring junctions and gap 
(or communicating) junctions. Specialized cell junctions are abundantly present at the 
level of cell-cell and cell-matrix contact (Ebnet, 2008).  
2.3.3.1 Tight junctions 
Tight junctions separate the apical from the basolateral cell surface domains and 
establish cell polarity (Alberts, 2002) (Figure 5). Tight junctions are formed by 
integral transmembrane protein families (claudins, occludin, junctional adhesion 
molecules), and by many peripheral membrane proteins (Kojima et al. 2013). They 
are the most apically located of the intercellular adhesion complexes, and inhibit 
liquids to flow through the paracellular space. Recent evidence suggests that tight 
junctions also participate in signal transduction mechanisms that regulate epithelial 
cell proliferation, gene expression, differentiation, and morphogenesis (Matter, 
2014). Epithelial cells can alter their tight junctions to permit an increased flow of 
liquids through breaches in the junctional barriers (Van Itallie and Anderson, 2006). 
Tight junctions prevent invasion of inhaled environmental agents such as allergens 
and pathogens through the respiratory epithelium. Viral infection and allergic rhinitis 
may cause, dynamic changes of tight junctions (Kojima et al. 2013).  
2.3.3.2 Anchoring junctions 
Anchoring junctions are responsible for anchoring one cell to another by the 
mechanical attachment between neighboring cytoskeletons, thus they coordinate cell 
movement and cell polarity (Niessen et al. 2007, Co 
sta et al. 2013). Anchoring junctions can be categorized in adherens junctions (or 
zonula adherens) and desmosomes (or macula adherens). Cell-cell adhesion is 
supported with adherens junctions, by forming a continuous adhesion belt just below 
the tight junctions (Gumbiner, 1996). The two basic adhesive units within adherens 
junctions are the nectin-afadin complex and the cadherin-catenin complex (Niessen, 
2007).  
Desmosomes provide mechanical stability and due to their highly adhesive ability 
they connect intermediate filaments of neighboring cells forming a structural 
framework of great strength and resistance against mechanical stress (Alberts et al., 
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2002). Transmembrane desmosomal cadherins are the structural proteins of 
desmosomes (Brooke et al. 2012).  
Finally, hemidesmosomes function as active signaling between the epithelial cells 
and the connective tissue, by directly linking the cytoskeleton to the extracellular 
matrix (Litjens et al. 2006).  
2.3.3.3 Gap junctions 
Gap junctions (or communicating junctions) function as a channel that brings the 
cytoplasm of two neighboring cells in contact. This channel is created by the 
formation of two connexons, each one formatted by six connexin subunits. Connexin 
is the main structural protein of gap junctions (Giepmans, 2004). These channels 
enable passive diffusion of ions, water, metabolites and small molecules to pass 
directly from cell to cell and they participate in cell synchronization, growth, 
differentiation and migration (Giepmans, 2004). 
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Figure 5. Schematic representation of the cell-cell and cell-matrix junctions in 
respiratory epithelium. Detailed locations of the different proteins forming the tight 
junctions (upper left), gap junctions (upper right) and anchoring junctions (center) are 
illustrated. Adapted from the department of Biology, Memorial University of 
Newfoundland.  
2.3.4 Extracellular matrix 
The basement membrane and the lamina propria are the two structural entities, which 
form the extracellular matrix (ECM) of the respiratory mucosa. They consist of 
collagens, proteoglycans and glycoproteins, which give the support to the respiratory 
epithelium and act on cell metabolism and polarization of epithelial cells (Alberts et 
al. 2002). 
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2.3.4.1 Basement membrane 
The basement membrane (BM) is a thin, sheet-like structure of 50 to 100 nm that is 
found underneath epithelial cells, supporting and separating them from the 
underlying stroma in different tissues (Kalluri, 2003). The structure of the BM 
consists of fibers, which participate in regulation of biological activities such as cell 
growth, differentiation and migration, during tissue development and repair 
(Aumailley and Gayraud, 1998). Immune and other cell types may traffic across the 
BM during morphogenesis and immune surveillance (Rowe and Weiss, 2008), by 
breaching the BM barrier using proteolytic enzymes (Kalluri, 2003). Transmission 
electron microscopy showed that the BM is the fusion of two structures: the lamina 
densa (or lamina basalis) and the lamina reticularis (Ham and Cormack, 1979). 
Another region of about 40 nm called the lamina lucida acts as attachment region 
between the epithelium and the lamina densa. This region contains the extracellular 
portion of cell adhesion molecules such as integrins, whereas the lamina densa 
consists of connective tissue networks made up of type IV collagen, adhesive 
glycoproteins (laminin and fibronectin), proteoglycan (perlecan) and entactin. Type 
IV collagen is a non-fibrous polymer and is the major constituent of the lamina 
densa, representing the backbone of the BM, which provides mechanical strength and 
stability. As it was seen by transmission electron microscopy, the lamina reticularis 
belongs to the connective tissue and the major component is the numerous collagen 
III fibers (Alberts et al., 2002). Other collagens like type I, V, VI and VII are also 
present. Collagen VII is the main structural component of anchoring fibrils, linking 
the lamina densa to the underlying lamina reticularis (Evans et al., 2000). 
2.3.4.2 Lamina propria 
The lamina propria of the respiratory mucosa consists of a complex three-
dimensional network of collagen, elastin fibers (fibrous proteins) and proteoglycans. 
This network is located underneath the basement membrane and harbors local cells 
(fibroblasts), mucus producing glands, blood and lymphatic vessels and nerve 
endings (Alberts et al. 2002).  
The most abundant proteins in the ECM are collagens. The main type of collagen 
proteins are I, II, III, V and VI, which form fibers. Their most important task is to 
give structural support to resident cells (van der Rest and Garrone, 1991). 
Proteoglycans are heavily glycosylated glycoproteins. They form a highly hydrated 
gel, which creates a physicochemical environment for free diffusion of nutrients and 
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chemical messengers (LeBleu et al. 2007). In addition, proteoglycans can bind 
secreted signal molecules and enzymes like fibroblast growth factor 2 (FGF-2), 
vascular endothelial growth factor (VEGF), proteolytic enzymes and protease 
inhibitors, and regulate signaling activity (Alberts et al. 2002). 
Fibronectins are large multidomain glycoproteins connected with collagen fibers due 
to their adhesive properties. They act as a connection between cells and their 
extracellular matrices by binding collagen and cell surface integrins. Thus, they 
reorganize the cytoskeleton of the cell allowing migration through the ECM 
(Henderson et al. 2011). They also display a wound healing function, by binding to 
platelets during blood clotting and facilitating cell movement to the affected area 
(Plopper, 2007). Finally, fibroblasts secrete the precursors of all the components of 
the extracellular matrix and thus, they maintain the structural integrity of connective 
tissues.  
2.3.5 Mucosal immune cells 
The mucosa lining the respiratory tract is highly susceptible to colonization and 
invasion by many pathogens. The specific defence of the respiratory tract comprises 
of lymphoid tissue cells present in the mucosal lamina propria and adjacent regional 
lymph nodes. The lymphoid tissue of the respiratory mucosa is separated in two 
morphologically and functionally distinct parts, the organised and the non-organized 
lymphoid tissues (Liebler-Tenorio and Pabst 2006). The organized mucosa-
associated lymphoid tissue (MALT) is a site of immune response induction and forms 
lymph node-like aggregates in certain parts of the airways. MALT structures are 
strategically located at different sites to allow efficient antigen sampling from 
mucosal surfaces, and are subdivided in the respiratory tract according to their 
anatomical localization, into nose-associated lymphoid tissue (NALT), Waldeyer’s 
ring, larynx-associated lymphoid tissue (LTALT) and, bronchus-associated lymphoid 
tissue (BALT) (Liebler-Tenorio and Pabst 2006). This organised lymphoid tissue is 
specialised in the recognition and processing of antigens, and in the primary 
activation of B-lymphocytes. The non-organized lymphoid tissue acts as an effector 
composed of a high number of cells that are distributed in the lamina propria and 
epithelia of mucosae (Wright, 2011). The different immune cell types that are present 
within respiratory mucosa will be briefly described. 
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2.3.5.1 Lymphoid cells 
Non-organised lymphoid tissue of the respiratory tract mucosa is composed of 
diffusely scattered lymphocytes and rather small clusters of lymphocytes. Plasma 
cells, B-lymphocytes and T-lymphocytes (mainly CD4+) prevail in these non-
organised clusters (Pabst 1996). The ratio of these cells depends on antigenic 
pressure or on the pathological process in the airways (Puci et al. 1982). 
Intraepithelial lymphocytes (IEL) were found in the epithelial layer of respiratory 
tract mucosa (Fournier et al. 1989). In humans, these lymphocytes carried the αβ T-
cell receptor (αβTCR). The presence of IEL was described in the intestinal epithelium 
of pigs and it is assumed that the population of these cells is also present in the 
respiratory tract. In new-born piglets, IEL do not possess the surface antigens CD2, 
CD4 and CD8. They begin to express surface antigen CD2 and CD8 from week 7 
(Whary et al. 1995). IEL is thought to participate in mucosal immunoregulation (Erle 
and Pabst 2000). 
The antibodies in the respiratory mucosa of pigs, comprise predominantly of locally 
synthesized IgA and IgG antibodies, and to a lesser extent IgM antibodies. Special B-
lymphocytes scattered throughout the lamina propria of respiratory tract mucosa 
differentiate into IgA-producing plasmatic cells (Bradley et al. 1976a, Morgan et al. 
1980). IgA dimers bind to transport receptors on the plasma membrane of epithelial 
cells, and the complex of transport receptor and IgA, undergoes endocytosis and is 
transferred by transcytosis to the opposite side (lumen) of the cell where the 
membrane of the vesicle fuses with the other cell membrane. Up to 97% of all IgA 
antibodies present in the airways of pigs penetrate through the mucosal surfaces in 
this way (Morgan et al. 1980). Colostrum antibodies penetrate through the nasal and 
bronchial mucosa in newborn piglets (Bradley et al. 1976a, Nechvatalova et al. 
2011). Finally, isotype specific IgA and IgG antibodies have been detected in serum, 
nasal and lung lavage fluids of swine following aerosol immunization with 
Actinobacillus pleuropneumoniae isotype 1 (Bosse et al. 1992). 
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2.3.5.2 Myeloid cells 
Besides the above mentioned cell types, macrophages and to a lesser extent 
granulocytes and mast cells are present in this lymphoid tissue. Macrophages play a 
major role in the immune system of animals and are separated into two categories, 
resident tissue macrophages and inflammatory macrophages (Gordon and Taylor, 
2005). Resident tissue macrophages are resident phagocytic cells that populate every 
lymphoid and non-lymphoid tissue (Hashimoto et al. 2011). They have the ability to 
produce growth factors and cytokines, clear cellular debris and apoptotic cells via 
phagocytosis, and are involved in haematopoiesis (Gordon and Taylor, 2005). 
Depending on the stimuli, they follow either the classical M1 (inflammatory 
macrophages) activation pathway or the alternative M2 (wound healing 
macrophages) pathway. Innate activation and deactivation are also possible 
conditions for regulatory macrophages (Gordon and Taylor, 2005, Mosser and 
Edwards, 2008). In pigs, resident macrophages in the lungs and the lymph nodes 
express high amounts of sialoadhesin, whereas resident macrophages in the thymus, 
liver, and spleen show weak expression of sialoadhesin (Duan et al. 1997, 
Vanderheijden et al. 2003, Karniychuk et al. 2009). Dendritic cells (DC) are a distinct 
cell population involved in the immune activities of mucosae (Sertl et al. 1986, Holt 
et al. 1989). They differentiate from monocytes and they are both present in the 
mucosal epithelium and lamina propria. They connect innate and adaptive immunity 
by migrating to the draining lymph nodes after recognition of pathogens via pattern 
recognition receptors (PRRs) (Soloff et al. 2010). The phenotypic characteristics of 
myeloid dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs) have been 
described in mouse, human and pigs. Both DC populations can be discriminated 
based on CD11c and CD123 expression, respectively, and have been described in 
swine (Summerfield and McCullough, 2009). In the nasal mucosa, the most 
extensively studied dendritic cell is the Langerhans cell (LC), as this one found in 
both the epithelial cell layer and in the lamina propria (Fokkens et al. 1991). 
Immature LCs are well equipped for antigen binding and processing, but weak in 
stimulating resting T cells (Romani and Schuler, 1992). These cells are situated on 
the basement membrane of epithelium where they form a dense interconnected net 
that increases in density after birth (von Garnier and Nicod, 2009). They are capable 
of mannose receptor-mediated antigen endocytosis and subsequent antigen 
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presentation. It seems that they play a key role in the induction of an immune 
response by the respiratory tract mucosa, particularly in animal species without 
organized lymphoid tissue (Reynolds, 1991). Airway mucosal DCs continuously 
sample incoming airborne antigens by extending their dendrites through the intact 
epithelial layer into the airway lumen (von Garnier and Nicod, 2009). Their 
participation in mucosal immune response regulation and in immune response control 
towards Th1 or Th2 is significant (Holt, 2000). Another myeloid cell population that 
is present at all levels of the respiratory tract is the mast cell. Up to 94% of this cell 
population is located within the connective tissue of the lamina propria, while only 
small numbers are present in the surface epithelium. They participate in innate 
immune responses and with their granules rich in histamine and heparin they 
contribute in allergic reactions following cross-linking of cell-bound IgE by 
allergens. They are also involved in defense against (mainly parasitic) pathogens and 
wound healing (Mair et al. 1988).  
Finally, neutrophils form an essential part of the innate immune response and are the 
hallmark of acute inflammation, being the first-responders to migrate from the blood 
towards the site of inflammation, attracted by chemokines (Nathan, 2006). 
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Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the major 
pathogens in swine industry, causing huge economic losses. Since the discovery of 
the virus and despite the efforts that have been made to control PRRS and understand 
the epidemiology and transmission of PRRSV, there are no adequate measures to 
prevent infection and eradicate the virus. All strains are able to cause reproductive 
disorders in pregnant sows. In fattening pigs, the outcome of an infection depends on 
the strain (genotype 1 subtype 1-low virulent versus genotype 1 subtype 2 and 3, and 
genotype 2-highly virulent), co-infections and pig genetics.  
PRRSV spreads by direct contact through saliva, nasal and mammary secretions, 
urine, feces and semen, and transplacental transmission in late gestation. In addition, 
an isolate-dependent aerosol transmission has also been reported. This aerosol 
transmission of the virus is mainly influenced by the pathogenicity of the isolate. The 
underlying mechanism of the difference in aerogenic spread is an enigma for PRRSV 
research.  
The last decade new highly virulent PRRSV type 1 and type 2 strains have emerged 
in Eastern Europe, Southern Asia and in the US, showing more severe clinical signs, 
a higher viremia, and an extensive replication in multiple organs. Due to the severe 
respiratory problems shown by infected pigs, it was hypothesized that new emerging 
PRRSV strains replicate better in the respiratory tract (primary replication site) 
leading to a higher viremia and entrance to replication sites and organs.  
The general aim of the present thesis was to examine the replication characteristics 
and the cell tropism of new emerging PRRSV strains in vitro, ex vivo and in vivo 
focusing on the nasal mucosa. A better understanding of the virus-host interactions in 
the nasal mucosa of young piglets at the early stages of infection may give directions 
for the development of novel vaccines and a better control of the respiratory disease 
caused by the virus.  
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The specific aims were: 
1. To compare the clinical, virological, serological and tissue tropism outcome 
of infection with two new isolated Belgian type 1 PRRSV strains (13V091 
and 13V117) with an older PRRSV strain (07V063). 
2. To design and evaluate a novel ex vivo explant system for the analysis of the 
replication characteristics of a low (subtype 1, Lelystad-LV) and a highly 
(subtype 3, Lena) virulent PRRSV type 1 strain in the nasal mucosa, and 
identify the macrophages that are infected. 
3. To compare the replication characteristics of different type 1 (LV, 07V063, 
08VA, Lena, 13V091), type 2 (VR2332, MN-184, VN) and two attenuated 
(MLV-DV, MLV-VR2332) PRRSV strains in nasal mucosa, and to examine 
whether an expanded cell tropism may contribute to virulence. 
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Chapter 3  
Different clinical, virological, serological and tissue tropism outcomes of two 
new and one old Belgian type 1 subtype 1 porcine reproductive and respiratory 
virus (PRRSV) isolates 
Ilias S. Frydas, Ivan Trus, Lise K. Kvisgaard, Caroline Bonckaert, Vishwanatha 
R.A.P. Reddy, Yewei Li, Lars E. Larsen and Hans J. Nauwynck 
Adapted from: Veterinary Research, 46(1):37, 2015 
In this study, the pathogenic behavior of PRRSV 13V091 and 13V117, isolated in 
2013 from two different Belgian farms with enzootic respiratory problems shortly 
after weaning in the nursery, were compared with the Belgian strain 07V063 isolated 
in 2007. Full-length genome sequencing was performed to identify their origin. 
Twelve weeks-old pigs were inoculated intranasally (IN) with 13V091, 13V117 or 
07V063 (9 pigs/group). At 10 days post inoculation (dpi), 4 animals from each group 
were euthanized and tissues were collected for pathology, virological and serological 
analysis. 13V091 infection resulted in the highest respiratory disease scores and 
longest period of fever. Gross lung lesions were more pronounced for 13V091 (13%), 
than for 13V117 (7%) and 07V063 (11%). The nasal shedding and viremia was also 
most extensive with 13V091. The 13V091 group showed the highest virus replication 
in conchae, tonsils and retropharyngeal lymph nodes. 13V117 infection resulted in 
the lowest virus replication in lymphoid tissues. 13V091 showed higher numbers of 
sialoadhesin- infected cells/mm2 in conchae, tonsils and spleen than 13V117 and 
07V063.  Neutralizing antibody response with 07V063 was stronger than with 
13V091 and 13V117. It can be concluded that (i) 13V091 is a highly pathogenic type 
1 subtype 1 PRRSV strain that replicates better than 07V063 and 13V117 and has a 
strong tropism for sialoadhesin- cells and (ii) despite the close genetic relationship 
between 13V117 and 07V063, 13V117 has an increased nasal replication and 
shedding, but a decreased replication in lymphoid tissues compared to 07V063.  
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Introduction 
Porcine reproductive and respiratory syndrome (PRRS) is a devastating disease that 
continuously hits swine industry all over the world (Nieuwenhuis et al. 2012). A 
recent economic analysis in the US demonstrated that the amount of total annual 
losses increased from $560 million in 2005 to $664 million in 2011 (Holtkamp et al. 
2013). The disease first appeared in the US in the late eighties and then a few years 
later in Europe and Asia (Yun et al. 2013). The causative agent is a positive single-
stranded enveloped RNA virus classified together with lactate dehydrogenase virus 
(LDV), simian hemorrhagic fever virus (SDHF) and equine arteritis virus (EAV) in 
the family of the Arteriviridae within the order of the Nidovirales (Stadejek et al. 
2013). PRRSV causes reproductive failure in late-term gestation sows with an 
increased number of stillborn, mummified and weak-born piglets. Respiratory 
disorders are characterized mainly by dyspnea and tachypnea in young animals 
(Terpstra et al. 1991, Mengeling et al. 1994). 
The PRRSV genome is approximately 15 kb in length and contains nine open reading 
frames (ORFs) (Yun et al. 2013). Open reading frames 1a and 1b constitute 75% of 
the viral genome and encode viral replicase polyproteins, which are processed by 
self-encoded proteases into 14 non-structural proteins (nsp) (Yun et al. 2013). Major 
(GP5, M, N) and minor (GP2, GP3, GP4, ORF5a-protein, E) structural proteins are 
being encoded at the 3’ end of the genome by ORFs 2a, 2b, 3, 4, 5, 5a, 6 and 7 
(Snijder et al. 2013). Like with other nidoviruses, transcription of the PRRSV 
genome is characterized by the formation of a 3’-co-terminal nested set of 
subgenomic messenger RNAs, each of them with a common 5’-leader sequence 
(Nelsen et al. 1999). 
Two distinct genotypes were identified, and designated as European type 1 (prototype 
LV-Lelystad, GenBank: M96262) and American type 2 (prototype VR2332, 
GenBank: AY150564), with 40% differences at the nucleotide level (Snijder et al. 
2013). A large genetic variability has been shown within both subtypes (Shi et al. 
2010). Genetic heterogeneity is one of the main reasons why current commercial 
attenuated and inactivated vaccines provide incomplete protection against 
heterologous strains and as a result there is an urgent need for a novel generation of 
vaccines (Labarque et al. 2000, Zuckermann et al. 2007). 
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Starting from 2006, new highly pathogenic strains emerged, causing large-scale 
outbreaks in Eastern Europe (type 1, prototype Lena, GenBank: JF802085), and 
Southeastern Asia (type 2, prototype JXA1, GenBank: EF112445). These isolates are 
characterized by high viral loads in blood and tissues, high fever, severe general 
clinical signs and increased mortality (Karniychuk et al. 2010, Tian et al. 2007, 
Weesendorp et al. 2012). A common genetic characteristic of highly pathogenic 
strains of both PRRSV type 1 and 2 is a discontinuous 30-amino acid deletion in the 
non-structural protein 2 (nsp2) (Lena: aa 710-739, JXA1: aa 534-563) [13,14]. 
However, this deletion is most probably not solely responsible for differences in 
virulence, as nsp2 is the most divergent one in PRRSV (Snijder et al. 2013). In 
Europe, highly virulent strains from Eastern Europe clearly differed from the 
circulating low virulent Western European strains and taxonomically they were 
designated as different type 1 subtypes (LV-like strains: subtype 1, Lena-like strains: 
subtype 3) (Stadejek et al. 2013). Subtype 3 strains are constrained in Eastern Europe 
and up till now, there were no reports of highly pathogenic strains emerging in 
Western Europe (Stadejek et al. 2013). 
In the present study, the virulence and pathogenicity of three PRRSV strains from 
Belgium were evaluated: two isolates (13V091 and 13V117) from 2013, originating 
from farms experiencing uncommon long-lasting anorexia, fever and respiratory 
problems within the first two weeks after weaning during an enzootic PRRSV 
infection, and the well-characterized Belgian strain 07V063 (GenBank: GU737264) 
from 2007 that was used as a reference (Karniychuk et al. 2012, Geldhof et al. 2012). 
Full-length genome sequencing was performed to characterize these PRRSV isolates.  
Materials and Methods  
Viruses  
PRRSV 13V091 and 13V117 were isolated from sera of pigs that showed severe 
respiratory problems in two Belgian farms. Virus isolation was performed as 
described before (Karniychuk et al. 2010). Briefly, porcine alveolar macrophages 
(PAM) were cultured in RPMI 1640 + GlutaMax modified medium (Gibco 
Invitrogen), supplemented with 10% fetal calf serum (FCS), 1% non-essential amino 
acids (Gibco Invitrogen), 1mM sodium pyruvate and a mixture of antibiotics. 
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Subsequently, cells were inoculated with ten-fold serial dilutions of sera and when 
cytopathic effect (CPE) was observed after three days, cells were fixed and stained 
with immunohistochemistry (IPMA) (Labarque et al. 2000). The monoclonal 
antibody (mAb) 13E2 against the nucleocapsid protein of PRRSV was used as 
primary antibody to identify PRRSV (Van Breedam et al. 2011). After isolation, 
13V091 and 13V117 were grown in PAM and used for sequencing and pathogenesis 
studies. The viral stocks were confirmed to be free from Mycoplasma, porcine 
parvovirus, porcine circoviruses and swine influenza viruses. The 07V063 strain was 
enclosed as a reference. A 2nd-3rd passage of 13V117, 13V091 and 07V063 was used 
for the animal inoculations.  
Experimental design 
Thirty-six twelve-week-old pigs, originating from a PRRSV-negative farm, were 
randomly divided in 4 groups of 9 animals. Relevant pathogens (PRRSV, SIV, 
PCV2) were not detected in the animals. Experiments were conducted in a biosafety 
level 2  (BSL-2) facility and were approved by the Ethical Committee of the 
University of Ghent (EC 2010/090). The pigs of groups 13V091, 13V117 and 
07V063 were inoculated intranasally (IN) with 2 ml containing 105 tissue culture 
infectious dose with 50% end point (TCID50) of the respective viruses (1 ml per 
nostril). Group CON consisted of animals mock-inoculated with PBS. Rectal 
temperature and clinical observations were monitored daily, starting from the third 
day before challenge until the 21st day post inoculation (dpi). Body temperature over 
40.0 °C was considered as fever. The scoring system was used before and is fully 
described in previous studies (Karniychuk et al. 2010, Weesendorp et al. 2012). 
Breathing, sneezing, coughing, nasal discharge, liveliness, ear discoloration, presence 
of peri-ocular oedema and diarrhea were taken into account. Detailed list and 
parameters of the clinical scores is shown in table 1 (see Additional file 1). In all 
groups, blood samples and nasal swabs were taken at 0, 3, 5, 7, 10, 14, 21, 28, 35 and 
42 dpi. Plasma and nasal secretions were collected and stored at -70 °C for virus 
titration. At 10 dpi, 4 pigs from each group were euthanized and two samples were 
collected from the following tissues: nasal mucosa (septum and conchae), pharynx, 
tonsils, lymph nodes (pharyngeal, bronchial, mediastinal, inguinal), lungs (apical, 
cardiac and diaphragmatic lobes from both sides) and spleen. Lungs were examined 
macroscopically. One sample was embedded in methocel and was snap frozen for 
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double immunofluorescense (IF) stainings, and the second sample was stored at -
70 °C for virus titration. 
Gross pathology and bacteriology 
After euthanasia, individual lungs were collected, and to all lung lobes macroscopic 
lesions were given a score to estimate the percentage of lungs affected by pneumonia 
using the evaluation system adapted from Halbur et al. (1995). Samples from lungs 
(cardiac left) and lymph nodes (bronchial) were collected after euthanasia and 
bacteriological analysis was performed. Each sample was inoculated on Columbia 
agar or Columbia CAN agar supplemented with 5% sheep blood (Oxoid, Hampshire, 
UK) with a Staphylococcus pseudintermedius streak for the growth support of NAD-
dependent bacteria (Actinobacillus, Haemophilus spp.). Plates were incubated for 48 
hours in a 5% CO2-enriched environment at 35 ± 2 °C and phenotypic identification 
of isolated bacteria was performed as earlier described (Quinn et al. 1994). 
Virus titration  
Nasal secretions and 20% suspensions of the collected tissues were titrated on PAM 
as previously described (Labarque et al. 2000). Nasal swabs were collected using 
Aluminium Rayon sterile plain swabs (160C, Copan Italia S.p.A., Italy). After 
swabbing, the swabs were brought into transportation medium consisting of 
phosphate buffer saline (PBS), 10% fetal calf serum (FCS) and a mixture of 
antibiotics. Afterwards, the swabs were vortexed, and the diluted secretions were 
titrated (Karniychuk et al. 2010). Tissue suspensions were titrated on PAM in 
quadruplicate and a final TCID50 was determined after subjecting the cells to a 
PRRSV-specific immunoperoxidase staining to analyse the presence of PRRSV-
positive cells. 
Serology  
Serum samples were examined for the presence of PRRSV-specific antibodies using 
IPMA plates as described before (Labarque et al. 2000). In these plates, LV-infected 
MARC-145 cells were used to detect PRRSV-specific antibodies. Virus neutralizing 
antibody titers were detected with a seroneutralization (SN) test on MARC-145 cells 
after propagation of PRRSV strains on this cell line. Two fold dilution series of sera 
were made and an equal volume containing 100 TCID50 PRRSV of the homologous 
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strains was added to each dilution and the mixture was further incubated for 1 h at 
37 °C. Afterwards, the serum-virus mixture was transferred to suspension cultures of 
MARC-145 cells and the cells were analyzed for cytopathic effect (CPE) at ten days 
post inoculation. The virus neutralizing antibody titers were determined as the 
reciprocal of the highest dilution that inhibited CPE in 50% of the wells (Geldhof et 
al. 2012). Samples that tested negative in IPMA were given a numerical value of 1.7 
and in SN test a numerical value of 0.5. 
 Quantification and identification of PRRSV-positive cells 
To quantify and identify viral antigen and sialoadhesin (Sn) positive cells in the 
different tissues, several 9 µm cryosections were made at a distance of 50 µm 
between each other and fixed in 100% methanol at -20 °C for 15 min. Mouse 
monoclonal antibodies were used against the PRRSV N protein (13E2, 1:25, IgG2a) 
and porcine sialoadhesin (41D3, 1:2, IgG1) (Van Breedam et al. 2011). Isotype-
specific secondary antibodies conjugated with FITC and Alexa Fluor 594 (1:500, 
Invitrogen) were used to reveal the different antigens. Cell nuclei were stained with 
Hoechst 33342 (Invitrogen) and to confirm the specificity of each antibody, negative 
isotype-specific control monoclonal antibodies were used: 13D12 against gD of PRV 
(IgG1), and 1C11 against gB of PrV (IgG2a) (Nauwynck et al. 1995). Countings were 
made in 5 sections with 5 fields per section measured in a blind way. Results were 
expressed per mm2, and analysis was performed using a Leica TCS SPE laser-
scanning confocal microscope (Leica Microsystems GmbH, Wetzlar, Germany). 
Sequencing 
Total RNA was extracted from 140 µl PAM culture supernatant of a 2nd passage of 
13V091 and a 3rd passage of 13V117 strain using the QIAcube 230 volt robot and the 
QIAamp® Viral RNA Mini kit (QIAGEN, cat. No. 52906). The QIAamp Viral RNA 
body fluid standard program was used as the extraction protocol with the elution 
volume of 60 µl. The RNA was screened for PRRSV using the previously published 
Kleiboeker modified type 1 assay (Wernike et al. 2012). PCR products covering the 
whole PRRSV genome in two fragments were produced from full genome cDNA as 
described elsewhere (Kvisgaard et al. 2013). The PCR fragments for each virus were 
pooled in equimolar concentration (165 ng in total) and sequenced by the Ion Torrent 
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PGM sequencer using the 318v2 chip (DMAC, Technical University of Denmark). 
After initial removal of adaptors and low quality sequences, the quality of the output 
data (FastQ) files was examined using the applicant FastQC (v. 0.10.1). The reads 
were trimmed accordingly to the FastQC report. De novo assembly was performed 
using the commercial software CLC Genomics v. 4.6.1 (CLCBIO, Aarhus, Denmark) 
and the genetic comparability of the obtained contigs was found using the NCBI’s 
Basic Local Alignment Search Tool (BLASTn). The most similar sequence to the 
newly sequenced virus found by NCBI BLASTn was used as reference sequence for 
mapping reads to a reference. The final consensus sequence was found by alignment 
of contigs derived from de novo assembly and the sequence obtained from mapping 
to a reference. The consensus sequence from each virus was aligned to other publicly 
available full genome PRRS type 1 viruses using MUSCLE (Multiple Sequence 
Comparison by Log-Expectation). Gaps were either confirmed or closed by 
specifically designed primers surrounding the gaps and sequenced by cycle 
sequencing (LGC Genomics GmbH, Germany). All alignments and phylogenetic 
analysis, were performed by the commercial software CLC DNA workbench v. 6.9 
(CLCBIO, Aarhus, Denmark). The phylogenetic trees were constructed using the 
Neighbor Joining algorithm, nucleotide/protein distance measure: Kimura80/Kimura 
Protein model, and Bootstrap analysis of 1000 replicates. 
Statistics 
All data were analyzed with GraphPad Prism 6 software (GraphPad Software Inc., 
San Diego, CA, USA). Serological titers (IPMA and SN) as well as viral loads were 
log-transformed prior to the analyses. Gross pathology scores and area under the 
curve (AUC) were analysed using the non-parametric Kruskal-Wallis test with 
Dunn’s post-test. Statistical analysis of continuous data was performed using two-
way analysis of variance (ANOVA) with Tukey’s post-test. All results shown 
represent means and standard deviation (SD). Results with P-values < 0.05 were 
considered significantly different. 
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Results 
Clinical signs and body temperature  
Clinical scores in respiratory functions, liveliness and presence of conjuctivitis are 
summarized in Figure 1. Daily registration of clinical scores for each individual 
animal is shown in additional file 2. Animals from the control group did not display 
clinical signs during the whole study. The 13V091 group exhibited significantly 
(P<0.05) higher mean scores from 3 till 10 and at 14 dpi compared to the 13V117 
group, and from 2 till 8 dpi compared to the 07V063 group. All 13V091-infected 
animals scored positive for clinical signs at least at one time point during the 
experiment. Respiratory symptoms were observed from the beginning of the 
experiment with a peak at 4 dpi (8 out of 9 animals) and lasted until 15 dpi (1 out of 4 
animals). The 13V117 group showed significantly (P<0.05) higher mean scores 
compared to the 07V063 group at 2 and 4 dpi. Animals scored positive from 2 till 6 
dpi but not all the animals showed respiratory disorders. A peak was observed at 4 
dpi (4 out of 9 animals). In the 07V063 group, 2 animals showed clinical scores from 
2 till 4 dpi and from 7 till 11 dpi. Loss of appetite was not observed in any group but 
visible growth retardation was marked in the 13V091 group compared to the other 
groups. Diarrhea was also apparent in the 13V091 group between 13 and 21 dpi. 
Nasal discharge, coughing or ear discoloration was never observed. 
Body temperature data are represented for each group in Figure 2. Detailed daily 
registration of body temperature for each individual animal is presented in additional 
file 2. The mean body temperature of group 13V091 was significantly higher 
(P<0.05) from 3 till 7 and at 13 dpi compared to the 13V117 group and from 3 till 5 
dpi compared to the 07V063 group. In the 13V091 group, 8 out of 9 animals showed 
fever at least at one day during the experiment, whereas in the 13V117 and the 
07V063 group, only 5 and 6 out of 9 animals showed fever, respectively. AUC values 
of individual pigs were calculated, and afterwards the AUC means per group were 
calculated and compared. The mean AUC value of increased body temperature with a 
threshold at 39.5 oC was significantly (P<0.05) higher in the 13V091 group (6.0 ± 
4.2) compared to the 13V117 (1.2 ± 1.3) and control groups (0.2 ± 1.3) but not to the 
07V063 group (3.5 ± 3.4). 13V091-infected animals showed the highest mean 
number of fever days (5.1 ± 4.2 days) which was significantly different (P<0.05) 
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from the 13V117 group (1.1 ± 1.1 days) but not from the 07V063 group (3.4 ± 3.3 
days).  
 
Figure 1 Clinical scores in pigs inoculated with PRRSV 13V091, 13V117 and 
07V063 are summarized. Lines represent the mean value in each group. Letters 
denote significant statistical differences (P<0.05) between viral strains (a: 13V091 
and 13V117, b: 13V091 and 07V063, c: 13V117 and 07V063). 
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Figure 2 Body temperature of pigs upon inoculation with PRRSV 13V091, 
13V117 and 07V063. Temperature ≥ 40 oC was considered as fever. Lines represent 
the mean value in each group.  
Gross pathology and bacteriology 
At 10 dpi, four pigs per group were euthanized and necropsied. Swollen pharyngeal, 
bronchial, mediastinal and inguinal lymph nodes were observed in the 13V091 and 
07V063 infected animals. 13V091 induced a pneumonia that was characterized by 
tissue consolidation, haemorrhagic spots and multifocal red tanned lesions in both 
sides (Figure 3A). 13V117-infected animals showed also tissue consolidation and 
single spotted lesions located mainly at the cardiac lobe. In 07V063-infected pigs, 
tissue consolidation and multifocal bilateral red-tanned lesions, concentrated mainly 
at the cranial and cardiac lobes, were observed. No gross pulmonary lesions were 
found in negative control pigs, and no pleuritis and no Mycoplasma-related lesions 
were observed in all animals of the experiment. 13V091-infected pigs showed the 
highest mean percentage of lungs with gross lesions (12.9 ± 3.6 %), which was 
significantly higher (P<0.05) than the 13V117 group (6.5 ± 1.4 %) and the control 
group (4.7 ± 2.4 %) but was not different from the 07V063 group (11.3 ± 9.4 %) 
(Figure 3B). Finally, samples from the cranial left part of the lungs and the bronchial 
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lymph nodes of euthanized pigs were sent for bacteriological analysis. No specific 
bacterial pathogens were isolated.  
 
Figure 3 Lung compartment analysis of animals infected with different PRRSV 
strains and euthanized at 10 dpi. Representative gross pulmonary lesions (A), mean 
macroscopic lesion scores (B) and virus titers in different lung compartments (C) are 
presented. CrL: Cranial Left, CrR: Cranial Right, CaL: Cardiac Left, CaR: Cardiac 
Right, DiL: Diaphragmatic Left, DiR: Diaphragmatic Right. Whiskers denote the 
standard deviation (SD) and P<0.05 values represent statistically significant 
comparisons.  
Virological analysis 
Titration of nasal swabs in the 13V091 group showed significantly higher mean titers 
(P<0.05) at 5 dpi compared to the 13V117 group and at 3 and 5 dpi compared to the 
07V063 group. Group 13V117 exhibited significantly higher mean titers than group 
07V063 at 3 and 5 dpi (Figure 4). The highest mean AUC value was observed in the 
13V091 group (16.9 ± 3.7), which was significantly higher (P<0.05) than the 13V117 
(13.3 ± 4.3) and the 07V063 group (8.2 ± 4.3). Virus was detected for the first time at 
$
% &
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3 dpi and two animals remained positive up till 14 dpi for the 13V091 and 07V063 
groups, whereas in the 13V117 group one animal remained positive until 21 dpi. The 
13V091 group showed the highest mean duration of nasal shedding (5.8 ± 2.4 days), 
which was not significantly different from the nasal shedding duration of the 13V117 
(5.4 ± 2.4 days) and 07V063 (3.3 ± 1.9 days) group.  
Viremia was first detected at 3 dpi and lasted until 14 dpi for the 13V091 group. Two 
pigs in the 13V117 and 07V063 groups remained positive until the 35th and 28th dpi, 
respectively. The 13V091 group showed significantly higher (P<0.05) mean virus 
titers at 5 dpi compared to the 13V117 group, and at 5 and 10 dpi compared to the 
07V063 group. The 13V117 group exhibited significantly higher mean titers at 5 and 
7 dpi compared to the 07V063 group (Figure 5). Control animals did not show 
viremia during the experiment. 13V091 showed the highest duration (8.8 ± 1.9 days) 
compared to 13V117 (8.1 ± 1.8 days) and 07V063 (6.9 ± 0.7 days). The average 
AUC value of the 13V091 (22.2 ± 9.3) and the 13V117 group (25.1 ± 8.4), were 
slightly higher than that of the 07V063 group (18.7 ± 10.5) (P>0.05).  
 
Figure 4 Virus titers in nasal secretions of pigs inoculated with PRRSV 13V091, 
13V117 and 07V063. Lines represent the mean value in each group. Whiskers denote 
the standard deviation (SD). The dotted line gives the detection limit for virus 
titration. Letters denote significant statistical differences (P<0.05) between viral 
strains (a: 13V091 and 13V117, b: 13V091 and 07V063, c: 13V117 and 07V063). 
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Figure 5 Viremia in pigs inoculated with PRRSV 13V091, 13V117 and 07V063. 
Patterns represent individual animals. Lines represent the mean value. Whiskers 
denote the standard deviation (SD). The dotted line gives the detection limit for the 
virus titration. Letters denote significant statistical differences (P<0.05) between viral 
strains (a: 13V091 and 13V117, b: 13V091 and 07V063, c: 13V117 and 07V063). 
Serology 
PRRSV-specific antibodies were first detected with IPMA in all PRRSV-infected 
groups as early as 7 dpi (Figure 6A). The highest mean antibody titers ranged from 
212.9 to 214.1 for all groups and were reached at 21-35 dpi. No significant difference 
was observed between the infected groups at any time point. Control animals 
remained seronegative during the whole experiment.  
In 07V063-infected animals, homologous SN titers appeared at 28 dpi in three out of 
five pigs, and reached a maximum mean titer at 49 dpi (23) when all animals were 
positive. In the 13V091 group, SN titers against the homologous strain could be 
detected in three pigs at 28 dpi (21) and the titers remained at a similar level until 49 
dpi when all the animals became positive and the group showed a mean titer of 21.4 ± 
20.4 (Figure 6B). 13V117-infected animals did not show any SN titer against the 
homologous strain until 42 dpi when one pig out of five was positive (21). At 49 dpi, 
one additional pig became positive (22).  
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PRRSV titers in different organs 
Respiratory tract. Tissues from animals euthanized at 10 dpi were collected for 
PRRSV titration. In the conchae, 13V091-infected animals showed higher (P>0.05) 
mean virus titers (5.1 ± 0.9 log10TCID50/g) than 13V117 (3.8 ± 2.1 log10TCID50/g) 
and 07V063 infected animals (3.7 ± 2.2 log10TCID50/g) (Figure 7A). In the 13V091-
infected animals, septum and pharynx displayed titers of 2.6 ± 1.2 and 3.5 ± 1.6 
log10TCID50/g respectively, which were slightly higher than the ones in the 13V117 
group (septum: 2.2 ± 1.3 log10TCID50/g, pharynx: 3.0 ± 1.4 log10TCID50/g) and the 
07V063 group (septum: 1.2 ± 0.1 log10TCID50/g, pharynx: 3.3 ± 1.1 log10TCID50/g), 
but not significantly different. Slightly higher titers for the 13V091 group were found 
after titration of lung compartments (Figure 3C), and values from all strains ranged 
from 4.8 to 6.2 log10TCID50/g. Samples from the pigs of the control group were 
negative for virus isolation.  
Lymphoid tissues. Average viral titers in tonsils (5.7 ± 0.5 log10TCID50/g) and 
retropharyngeal lymph nodes (RPLN) (5.2 ± 0.4 log10TCID50/g) in the 13V091 group, 
were significantly higher (P<0.05), than in the 13V117 group (tonsils: 4.0 ± 2.0 
log10TCID50/g, RPLN: 3.0 ± 1.8 log10TCID50/g), but not from the 07V063 group 
(tonsils: 4.8 ± 1.0 log10TCID50/g, RPLN: 4.5 ± 2.0 log10TCID50/g). Virus titration of 
bronchial (BLN), mediastinal (MLN) and inguinal (ILN) lymph nodes of the 13V091 
(BLN: 3.8 ± 0.4 log10TCID50/g, MLN: 4.4 ± 0.7 log10TCID50/g, ILN: 4.4 ± 0.8 
log10TCID50/g) and 07V063 groups (BLN: 4.5 ± 0.8 log10TCID50/g, MLN: 3.4 ± 0.8 
log10TCID50/g, ILN: 4.2 ± 0.1 log10TCID50/g), showed significantly (P<0.05) higher 
titers compared to the 13V117 group (BLN: 1.6 ± 0.5 log10TCID50/g, MLN: 1.7 ± 0.5 
log10TCID50/g, ILN: 2.5 ± 0.7 log10TCID50/g) (Figure 7C). Finally, in spleen, the 
13V091 group showed the highest titers (2.5 ± 0.6 log10 TCID50/g) of the PRRSV-
infected groups (P>0.05). 
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Figure 6 Antibody response, IPMA (A) and SN (B) in pigs inoculated with 
PRRSV 13V091, 13V117 and 07V063. Whiskers denote the standard deviation (SD). 
Dotted lines denote detection limits. Letters denote significant statistical differences 
(P<0.05) between viral strains (a: 13V091 and 13V117, b: 13V091 and 07V063, c: 
13V117 and 07V063). 
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Figure 7 Virus titers (A and C), and quantification and identification of PRRSV-
infected cells (B and D). Different parts of the respiratory system and lymphoid 
tissues from animals inoculated with PRRSV 13V091, 13V117 and 07V063, and 
euthanized at 10 dpi were analyzed.  Dark colors represent PRRSV+ cells, whereas 
lighter colors in the subcolumns represent PRRSV+Sn+ cells. CaL denotes the cardiac 
left part of the lungs. Whiskers denote the standard deviation (SD) and asteriscs (*) 
represent statistically significant comparisons (* P<0.05, ** P<0.01, *** P<0.001).  
Immunofluorescence  
Respiratory tract. Double IF stainings were performed for the quantification and 
identification of PRRSV cells. In conchae, 13V091 showed higher amounts of 
PRRSV+ cells/mm2 (8.0 ± 1.4) compared to 13V117 (2.5 ± 0.7) and 07V063 (4.3 ± 
0.7) (Figure 7B). Tissues from the septum displayed also a higher amount of PRRSV+ 
cells/mm2 in the 13V091 (2.2 ± 1.4) group, compared to the 13V117 (0.8 ± 0.9) and 
07V063 (0.6 ± 0.3) groups. In the pharynx, a higher (P<0.05) number of PRRSV+ 
cells/mm2 (6.0 ± 1.7) was found with 13V091 than with 13V117 (1.7 ± 1.2) but not 
from 07V063 (4.3 ± 1.2). Finally, immunofluorescence stainings from the left cardiac 
lobe of the lung showed higher amounts of PRRSV+cells/mm2 for 13V091 (25.5 ± 
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9.1) compared to 13V117 (20.3 ± 5.4) and 07V063 (16.5 ± 2.3). The number of 
infectious virus particles per infected cell in the left cardiac lung lobe was calculated 
according to the ratio: pfu per gram of tissue/cells per mm2 after converting TCID50/g 
to pfu/g (Flint et al. 2008). 07V063 showed the highest number (21200) of infectious 
virus particles per infected cell compared to 13V091 (15300) and 13V117 (8600). 
The Sn phenotype of PRRSV+ cells in the nasal mucosa, tonsils and lungs is shown in 
Figure 8. Identification of PRRSV+ cells in the nasal mucosa based on Sn, revealed 
that the 13V091 and 13V117 strains were able to replicate more efficiently in Sn- 
cells compared to the 07V063 strain. In conchae, 87.5% of 13V091-infected cells 
were Sn-, while that percentage was 80.0% with the 13V117 and only 17% with the 
07V063 strain  (Figure 7B). In the septum, half (48%) of the 13V091-infected cells 
and the few 13V117-infected cells (0.8 ± 0.9/mm2) were Sn-, whereas all 07V063-
infected cells were Sn+. In the pharynx and lungs, all isolates showed a restricted cell 
tropism, as the percentage of PRRSV+Sn+ cells ranged from 80.7% to 100% (Figure 
7B).  
Lymphoid tissues. In tonsils, a higher amount of PRRSV+ cells/mm2 was found in 
13V091-infected tissues (14.0 ± 5.6), compared to 13V117 (12.5 ± 2.1) and 07V063 
(9.0 ± 5.7) -infected tissues (Figure 7D). In BLN, a higher amount of PRRSV+ 
cells/mm2 was observed in the 07V063 group (5.5 ± 2.2) than in the 13V091 (2.6 ± 
0.8) and 13V117 (1.5 ± 0.7) groups, whereas in RPLN, 10.0 ± 2.8 (13V091), 2.5 ± 
0.6 (13V117) and 4.5 ± 3.5 (07V063) PRRSV+ cells/mm2 were found. Finally, in 
MLN, infection with the 13V091 and 07V063 strains resulted in 3.4 ± 1.5 and 3.3 ± 
2.3 PRRSV+ cells/mm2 respectively, while infection with the 13V117 strain gave 
only 1.1 ± 0.8 PRRSV+ cells/mm2. The amount of PRRSV+ cells in ILN was higher 
(P<0.05) with the 13V091 strain (10.3 ± 0.5) compared to the 13V117 (3.3 ± 2.1) and 
07V063 (5.3 ± 0.6) strains.  In spleen, the highest amount of PRRSV+ cells/mm2 was 
displayed by 13V091 (9.3 ± 6.7) while 13V117 showed 4.3 ± 3.5 and 07V063 4.0 ± 
2.8 PRRSV+ cells/mm2. The highest percentage of infected cells that were Sn-, ranged 
from 45% to 64% in tonsils, 20% to 68% in the different lymph nodes and 64% to 
71% in the spleen. 
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Figure 8 Confocal microscope double immunofluorescence images of 13V091-
infected nasal mucosa, tonsils and lungs are illustrated. Tissue samples were 
sectioned (9 µm) and co-immunostained for Sn (green) and PRRSV N-protein (red) 
at 10 dpi. White arrows show PRRSV+Sn+ and PRRSV+Sn- cells. Scale bar 50 µm. 
 
PRRSV genome sequencing and phylogenetic analysis 
The full genomes of 13V091 and 13V117 were 15020 and 15014 nucleotides (nt) 
long (excluding the polyA tail), respectively. A NCBI BLASTn search showed that 
the two viruses belong to the PRRSV type 1 genotype. Pairwise nucleotide 
comparisons of the complete genomes showed that 13V117 shared 91.55 % identity 
to Lelystad virus and 99.81 % identity to 07V063, whereas 13V091 only shared 
86.69 % identity to the Lelystad virus and 85.03 % to the 07V063 strain. The 
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nucleotide (nt) similarity between 13V091 and 13V117 was 84.38 %. 13V091, 
13V117 and 07V063 showed deletions in ORF1a, in the region encoding the non-
structural protein 2 (nsp2). 13V117 had a 84 nt deletion following the nucleotide 
position 2345 in LV. 13V091 had three discontinuous deletions of 3, 45, and 27 
nucleotides following the nt positions 1919, 2384, and 2492 in LV, respectively. The 
first deletion of 3 nt has also been found in five strains isolated in Asia (GenBank: 
FJ349261, KF287128-31). The deletions of 45 and 27 nucleotides were located in the 
highly variable region of nsp2 close to the deletion seen in 13V117. A partial amino 
acid alignment representing the highly variable region of nsp2 is shown in additional 
file 3. The 13V091 strain, also harbored a 3 nt deletion in the region of the genome 
encoding the structural proteins. This deletion affected both ORF3 and ORF4 as the 
coding regions of these two genes overlap, but did not disturb the open reading 
frame.  
Phylogenetic analysis of the complete genomes of the two viruses to 33 published 
PRRSV type 1 sequences showed that 13V091 grouped alone, and 13V117 grouped 
with 07V063 (Figure 9). Phylogenetic analysis of 171 complete PRRSV type 1 ORF5 
sequences showed that 13V117 grouped with 07V063 and viruses isolated in 
Denmark, China, Korea, and Spain, whereas 13V091 grouped with viruses isolated in 
Romania. The phylogenetic analysis of ORF5 is presented in additional file 4. The 
phylogenetic tree of ORF7 was constructed from 154 sequences and showed 13V117 
to group with 07V063 and viruses from Hong Kong, Korea, and Thailand. 13V091 
grouped with an Italian isolated virus.  
To investigate the impact of the high genetic diversity of 13V091 and 13V117, a 
pairwise amino acid comparison of the case viruses to three other type 1 viruses was 
performed and is shown in table 2 (see Additional file 5). From the comparison, it 
was clear that both 13V091 and 13V117 showed a high level of diversity on the 
protein level to the LV virus, the subtype 1 prototype and to Lena, the subtype 3 
prototype virus. 13V091 was also different from 13V117 and 07V063, where the 
percentage identity for nsp2, GP3, GP4 and GP5 ranged from 77% to 88%. Finally, 
full-genome analysis revealed that 13V117 and 07V063 only differed by 8 amino 
acids located in nsp1, nsp2, nsp7 nsp9, GP3 and GP4, respectively. 
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Figure 9 Phylogenetic analysis of complete genome nucleotide sequences of 
PRRSV type 1 is presented. The tree was constructed by the Neighbor Joining 
algorithm with Bootstrap 1,000 replicates. Bootstrap values are shown in percent. 
13V091 and 13V117 are highlighted in red.  
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Discussion 
PRRSV is one of the most economically important pathogens in swine industry 
worldwide (Holtkamp et al. 2013). The virus continues to evolve genetically and 
antigenically despite the efforts for control and eradication (Snijder et al. 2013). 
Genetically, PRRSV strains are divided into European type 1 and North-American 
type 2 strains (Nelsen et al. 1999). Type 1 strains are subdivided in four subtypes (1, 
2, 3 and 4). In the recent past, highly pathogenic type 1 subtype 3 strains emerged in 
Eastern Europe but there was no indication of an invasion of these strains in Western 
Europe, a region that is dominated by type 1 subtype 1 isolates (Stadejek et al. 2013). 
Up till now, no highly pathogenic type 1 subtype 1 strains have been isolated. 
Continuous monitoring of emerging PRRSV isolates is of great importance in order 
to prevent new outbreaks and provide novel insights for vaccine development. In the 
current study, the pathogenicity and the virulence of two new Belgian PRRSV 
isolates designated 13V091 and 13V117 originating from animals experiencing 
severe respiratory disorders were compared clinically, virologically and genetically 
with the mild-pathogenic PRRSV strain 07V063.  
PRRSV 13V091 appeared to be more pathogenic than the 13V117 and 07V063 
strains.  Animals infected with 13V091 showed the longest duration of fever (5.1 ± 
4.2) and the highest clinical scores (1.6 ± 0.3) due to dyspnea, tachypnea and 
respiratory distress. Macroscopic analysis of lungs of pigs euthanized at 10 dpi 
showed that 13V091 strain caused the most severe multifocal gross lesions compared 
to the 13V117 and 07V063 isolates. Percentage of lung lesions of 13V091 was also 
higher than that of the type 1 strains that were used in a recent study from Spain 
(Martinez-Lobo et al. 2011). In another Korean study, three new subtype 1 strains 
were compared with the prototype LV, and it was found that at 10 dpi only one of 
them (SNUVR100744, GenBank: JX988618) showed a higher percentage (> 25%) of 
affected lung surface than 13V091 (12.9 ± 3.6) (Han et al. 2013). The clinical and 
pathological outcome of 13V091 showed some similarities with the highly 
pathogenic subtype 3 strain (Lena, GenBank: JF802085) (Karniychuk et al. 2010, 
Weesendorp et al. 2012). In the latter study, Lena showed clinical score values 
ranging from 0.5 to 2 from 3 to 14 dpi, whereas in our results 13V091 showed a 
clinical score from 0.6 to 1.6 during the same timeframe. Previous in vivo studies 
with the Lena strain, induced fever from 2 till 13 dpi [14], and from 2 till 28 dpi 
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(Karniychuk et al. 2010). In the current study, 13V091 induced fever from 2 till 14 
dpi.  
The clinical outcome can be fully attributed to PRRSV and not to PRRSV-related 
pathogens (SIV, PCV2). Experiments were performed in BSL-2 facilities and 
pathogenic bacteria were not isolated from all the euthanized pigs. Furthermore, no 
Mycoplasma-related lung lesions were observed in all animals. Co-infections are 
important because they enhance the impact of PRRSV leading to porcine respiratory 
disease complex (PRDC) (Choi et al. 2003). In a previous study with highly 
pathogenic PRRSV strains that showed mortality, bacteria like Arcanobacterium 
pyogenes and Streptococcus suis were isolated from the lungs (Karniychuk et al. 
2010).  
Transmission of PRRSV via airborne route is an important characteristic after the 
appearance of highly pathogenic viral strains (Otake et al. 2010). In a previous study, 
virus titers in nasal secretions of a highly pathogenic strain (Lena) showed a titer of 
2.5 to 5.6 log10TCID50/100mg from 3 to 14 dpi (Karniychuk et al. 2010). In the 
current study, during the same timeframe, viral titers of 2.0 to 4.8 and 1.8 to 4.3 
log10TCID50/100mg were detected for 13V091 and 13V117 respectively. These 
results indicate that both new strains although not as pathogenic as Lena, have the 
potential to be transmitted via airborne route in the early stages of infection based on 
the high virus titers in the nasal secretions. It has been speculated, that recent 
outbreaks in the USA and China were due to virus isolates that can replicate and 
spread more efficiently (Murtaugh et al. 2010). The location of virus replication and 
an expanded cell tropism may strongly support this hypothesis. In typical swine herds, 
animals are in close nose-to-nose contact with each other, and during the last years 
several studies were performed evaluating the efficiency of different isolates to 
spread via airborne route (Cutler et al. 2011). A PRRSV strain that is able to replicate 
in the nasal mucosa and produce progeny virus, will be more likely to spread to 
another pig via airborne route compared to a virus strain that mainly replicates the 
lungs such as typical LV-like strains. In addition, presence of other nose pathogens 
such as Bordetella bronchiseptica and Chlamydia suis may cause intensive sneezing, 
which may facilitate virus spread (Thanawongnuwech et al. 2003). 
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In this study, different PRRSV strains showed a different tissue tropism. Animals 
infected with the 13V091 strain, showed the highest replication efficiency based on 
virus titration and PRRSV-positive cell counting. Furthermore, 13V091 showed 
significantly higher numbers of PRRSV+ cells compared to 13V117 and 07V063 in 
the upper respiratory tract, tonsils and draining lymph nodes (conchae, septum, 
pharynx, RPLN). Respective virus titers of 13V091 were 10 to 1000 times higher 
than 13V117, and 10 times higher than 07V063. In the upper respiratory tract, 
13V091 and 13V117 showed an expanded cell tropism as they were shown to 
replicate in Sn- macrophages with a different degree of efficiency. It is important to 
mention that in the nasal mucosa (conchae, septum), the same distribution pattern of 
PRRSV+Sn- cells was observed for 13V091 and 13V117, with cells being located 
within the epithelium, and just underneath the basement membrane. Large round cells 
with large cytoplasm was the morphology of PRRSV+Sn- and PRRSV+Sn+ cells 
located in the lamina propria, whereas PRRSV+Sn- cells located within the epithelium 
and just underneath the basement membrane were smaller with large elongated 
filopodia. Together with the disability of Lelystad virus to grow in Sn- cells and the 
strong ability of a highly pathogenic PRRSV strain (Lena) to replicate extremely 
efficiently in Sn- cells of the nasal mucosa, this indicates that in Western Europe 
there is an increase of PRRSV tropism for Sn- nasal macrophages in time, which 
reaches the level of virulent/pathogenic subtype 3 strains (Frydas et al. 2013).  
In our study, 13V091 showed a higher replication rate and produced more progeny 
virus in the lungs compared to 13V117 and 07V063. Viral loads of type 1 subtype 1 
strains of our study in lungs, are in agreement with the results of Labarque et al., 
where LV reached a mean titer of 106.2 TCID50/g in lung tissues at 9 dpi (Labarque et 
al. 2000). It was shown before, that PRRSV replication in the lungs is correlated with 
the number of the susceptible Sn+ macrophages that are present at the time of 
infection and that only 2% of susceptible macrophages are infected (Labarque et al. 
2000). In the present study, 13V117 and 07V063 showed a similar number of viral 
antigen positive cells and virus titers in the left cardiac lung lobe (13V117: 20.3 
cells/mm2 and 105.4 TCID50/g, 07V063: 16.5 cells/mm2 and 105.7 TCID50/g). Analysis 
of the virus production per infected cell showed that 13V091 and 07V063 were able 
to produce more infectious virus particles per infected cell than 13V117 in a ratio of 
1:2 and 1:2.4 respectively. Thus, not only the number of susceptible cells, but also the 
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strain-dependent replication efficiency is important for PRRSV lung pathogenesis. 
Differences in replication level within distinct lung lobes were not observed with all 
the tested strains, which correlate with two other studies with the Lelystad (LV) virus, 
where no difference in replication levels of distinct lung lobes was observed at 10 dpi 
(Labarque et al. 2000, Halbur et al. 1995).  
Virus replication in BLN and MLN showed that 13V091 and 07V063 produced 
similar amounts of virus, which were up to 1000 times higher than 13V117. High 
viral loads of 13V091 and 07V063 in the lungs and the draining lymph nodes (BLN, 
MLN) can be explained by the mobilization of Sn+ cells from lungs to LN. In 
addition, strains with an expanded cell tropism like 13V091, may use the Sn- 
monocytic cells that are infiltrating after 9 dpi to increase their transportation and 
replication efficiency in the correspondent tissues (Labarque et al. 2000).  
In the spleen, 13V091 showed the highest replication level compared to the other 
tested isolates and the virus production reached 102.8 TCID50/g at 10 dpi, which was 
similar to LV (103 TCID50/g) at 8 dpi (Pol et al. 1991). More than 60% of PRRSV-
infected cells were of Sn- phenotype. The lower replication level observed in spleen 
compared to lungs and lymph nodes might be explained by the low expression of Sn 
and presence of other receptor(s). In rats, it was shown that Sn expression on splenic 
macrophages is reduced 25-fold compared to lymph node macrophages mainly due to 
masking of Sn by endogenous ligands (Nakamura et al. 2002).  
In our study, PRRSV-specific antibodies for all strains appeared at 7 dpi and reached 
a plateau at 14 dpi, which is in agreement with previous studies using other PRRSV 
strains (Labarque et al. 2000, Xiao et al. 2004). The late induction and the low titers 
of neutralizing antibodies observed in the current study is in agreement with other 
studies that used the LV and the 07V063 strains, where only low titers of Nabs were 
observed after 25 dpi for LV (21-3.6), and after 35 dpi for 07V063 (21-2.2) (Labarque et 
al. 2000, Geldhof et al. 2012). A correlation between the appearance of neutralizing 
antibodies (Nabs) and the virus elimination from blood was mentioned before, but the 
exact degree of Nabs contribution in viral clearance is still questionable (Xiao et al. 
2004, Diaz et al. 2005, Mateu et al. 2008). Only in the 07V063 group Nabs appeared 
at the same time with the elimination of viremia, an observation that was reported 
before for the 07V063 strain (Geldhof et al. 2012). In 13V091 and 13V117, Nabs 
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appeared later and at lower titers, and at that time the virus was already eliminated 
from blood. Based on these observations, it is obvious that neutralizing antibodies are 
not the sole immunological tool to eliminate PRRSV, and their role in clearance of 
primary viremia and prevention of reinfection is not clear (Van Gorp et al. 2011). The 
presence of additional glycosylation sites at the neutralizing epitopes, and the 
sensitivity of the SN test, might contribute for the late development of Nabs observed 
in 13V091 and 13V117 compared to 07V063. Analysis of glycosylation sites on 
PRRSV structural proteins based on Lelystad virus, revealed one additional 
glycosylation site for 13V091 into GP3 protein at the amino acid position 253 
(Vanhee et al. 2011). No additional or different glycosylation sites were observed 
within 13V117 and 07V063. Addition of newly acquired sugar moieties to the sugar 
tree of 13V117 may make the virus unrecognizable and mask the neutralizing 
epitopes that reduce or eliminate the binding affinity of the antibodies. This 
mechanism of immune evasion has been well described for HIV-1 (Kwong et al. 
2002). MARC-145 cells and PRRSV strains adapted on this cell line are generally 
used in SN tests. This cell type is not the natural cell-target for PPRSV and does not 
express Sn, and CD163 is not present at detectable levels. Both Sn and CD163 are 
main factors for PRRSV entry and replicaton, and are major targets for viral entry 
mediators (GP5-M for Sn and GP2-GP3-GP4 for CD163) (Van Breedam et al. 2010, 
Das et al. 2010). Therefore, primary target cells like alveolar macrophages or cell 
lines that express Sn and CD163 like PK15Sn-CD163 cells should be preferably used for 
all the contemporary PRRSV strains that have a main tropism for PAM (Delrue et al. 
2010). Newly emerging isolates with a tropism for additional receptors might need 
another SN test based on primary monocytic cells from nasal mucosa or lymph nodes 
that express the new receptors to search for neutralizing antibodies. New SN tests 
might help to better understand the function of virus Nabs, with regard to the degree 
of viral clearance. 
To study the evolutionary relationship of 13V091 and 13V117 with other PRRSV 
strains, the complete genome sequence was compared with other type 1 European 
strains and the prototype type 2 strain VR-2332. 13V091 showed a high genetic 
diversity to all, currently, publicly available complete genomes of type 1 viruses and 
was located ‘alone’ in the phylogenetic tree between 13V117 and 07V063, and the 
highly pathogenic subtype 3 strain Lena. The phylogenetic analysis of ORF5 and 
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ORF7 showed that 13V091 and 13V117 grouped with other type 1 subtype 1 
sequences, thus, it can be concluded that both isolates belong to PRRSV type 1 
subtype 1.  
By coincidence, 13V117 showed an extremely high genetic similarity to 07V063. 
Despite the fact that genome comparison revealed only eight different amino acids, 
the virological, clinical and pathological changes induced by these two viruses were 
quite different. 13V117 replicated efficiently in the nasal mucosa, induced a high 
viremia but had problems to replicate in lymphoid tissues. In addition, 13V117-
infected animals showed breathing problems between 2 and 7 dpi. On the other hand, 
animals from the 07V063 group, showed a restricted replication in the nasal mucosa, 
a ten-fold lower viremia but an extensive replication in the lymphoid tissues. Only 
two pigs had mild breathing problems. Pairwise alignments revealed that the 
following eight amino acid differences were observed between 07V063 and 13V117: 
V140M in nsp1, H786L and G1300S in nsp2, S2192N in nsp7a, M72I and M266V in 
nsp9, N253H in GP3 and Q72P in GP4. Nsp1 is a cysteine protease that plays an 
important role in the cleavage of ORF1 proteins and for virion biogenesis 
(Nedialkova et al. 2009). Nsp2 is the papain-like proteinase 2 (PLP2) that is encoded 
from ORF1a and is responsible for the cleavage of the nsp2-3 junction (Snijder et al. 
2013). It is the most variable non-structural protein between PRRSV subtypes, and it 
contains a hypervariable region (HVR) in which deletions are commonly found 
among PPRSV isolates; a cluster of immunodominant B- and T-cell epitopes was 
also identified (Snijder et al. 2013). Deletions in nsp2 have also been found for 
13V091 and 13V117. Recent data support the hypothesis that these deletions are not 
necessarily related to virulence, but other studies support that changes in the nsp2 
region might be related with plaque appearance and the cytolytic activity of the 
isolate (Zhou et al. 2009, Brockmeier et al. 2012). Nsp7a is a 149 aa protein that 
plays an important role in the induction of host humoral immune response and has 
been found to induce specific antibodies as early as 14 dpi till 202 dpi (Brown et al. 
2009).  Nsp9 is the RNA-dependent RNA polymerase (RdRp) encoded by ORF1b. It 
mediates the genome replication and the synthesis of subgenomic mRNAs, and is one 
of the most conserved proteins within nidoviruses (Snijder et al. 2013). GP3 is a 
heavily glycosylated membrane protein with a hydrophobic C-terminal domain 
(Vanhee et al. 2011). The single amino-acid change in GP3 between 07V063 and 
13V117 is located within the neutralizing antigenic region in the C-terminal domain, 
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that has been found to be recognised by neutralizing antibodies against LV (Vanhee 
et al. 2011). GP4 is a membrane protein with an N-glycosylated ectodomain that 
forms a heterotrimer with GP2 and GP3, and interacts with GP5 (Das et al. 2010). 
The single amino acid difference between 07V063 and 13V117 is located at the 
ectodomain of GP4 within the most immunogenic region that was identified, in all 
envelope proteins, but is also part of a neutralizing antibody region (NAR) named 
ES12 found to induce high virus neutralizing antibody titers at 42 dpi in all the 6 
tested animals of the study  (Das et al. 2010, Oleksiewicz et al. 2001). In our results, 
only one animal in the 13V117 group showed low virus neutralizing antibody titers at 
42 dpi, whereas at the same timepoint all animals in the 07V063 group developed 
virus neutralizing antibody titers (mean titer: 22.16). Whether these single amino acid 
substitutions have an effect on virus pathogenesis and immune response by changing 
the glycan shielding, or the possible immune decoy epitopes remains to be clarified. 
A distinct PRRSV population was reported that emerged by one single amino acid 
change in the GP5 ectodomain after infection in pigs (Rowland et al. 1999). 
Furthermore, it was reported for lactate dehydrogenase virus (LDV) in mice that a 
small number of mutations in ORF5 can alter the tropism and the interaction of virus 
with neutralizing antibodies favoring viral persistence (Chen et al. 1997). Viral 
persistence may also be favored by a single amino acid change in the C-terminus 
region of a viral protein if this modification, creates a novel motif selecting the 
retainment of virions to the endoplasmatic reticulum (ER) (Rowland et al. 1999). 
Production of viral infectious clones of the 07V063 and 13V117 isolates and site-
directed mutations will shed new light in this field. 
In summary: (1) two new PRRSV strains designated 13V091 and 13V117 were 
isolated from pigs showing respiratory distress. Pathogenic and genetic studies 
showed that 13V091 is the most pathogenic type 1 subtype 1 strain isolated up till 
now showing fever, breathing problems, high virus titers in nasal secretions, an 
increased percentage of lung lesions in young animals and an expanded cell tropism 
to Sn- cells in nasal mucosa and other lymphoid tissues. (2) Despite the fact that 
13V117 and 07V063 have only eight amino acid differences in their genomes, they 
showed contrasting clinical and virological outcomes. 13V117 was able to induce 
fever, high viremia, and respiratory problems at the early stages of infection and it 
was able to replicate in the nasal mucosa but not in the lymph nodes, whereas 
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07V063 showed only fever, a 10-fold lower viremia, low virus titers in nasal 
excretions, but higher virus titers in lymphoid tissues.  
These are important findings in order to evaluate the virulence and the pathogenesis 
caused by different type 1 subtype 1 PRRSV strains, to control the respiratory disease 
caused by PRRSV in young animals, and to develop novel vaccines for the newly 
emerged PRRSV isolates.  
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4.1 
Replication characteristics of porcine reproductive and respiratory syndrome 
virus (PRRSV) European subtype 1 (Lelystad) and subtype 3 (Lena) strains in 
nasal mucosa and cells of the monocytic lineage: indications for the use of new 
receptors of PRRSV (Lena) 
Ilias S. Frydas, Mieke Verbeeck, Jun Cao and Hans J. Nauwynck 
Adapted from Veterinary Research, 44:73, 2013 
Recently, it has been demonstrated that subtype 3 strains of European type porcine 
reproductive and respiratory syndrome virus (PRRSV) are more virulent/pathogenic 
than subtype 1 strains. This points to differences in the pathogenesis. In the present 
study, a new polarized nasal mucosa explant system was used to study the invasion of 
the low virulent subtype 1 PRRSV strain Lelystad (LV) and the highly virulent 
subtype 3 PRRSV strain Lena at the portal of entry. Different cell types of the 
monocytic lineage (alveolar macrophages (PAM), cultured blood monocytes and 
monocyte-derived dendritic cells (moDC)) were enclosed to examine replication 
kinetics of both strains in their putative target cells. At 0, 12, 24, 48 and 72 hours post 
inoculation (hpi), virus production was analyzed and the infected cells were 
quantified and identified. Lena replicated much more efficiently than LV in the nasal 
mucosa explants and to a lesser extent in PAM. Differences in replication were not 
found in monocytes and moDC. Confocal microscopy demonstrated that for LV, 
almost all viral antigen positive cells were CD163+Sialoadhesin (Sn)+, which were 
mainly located in the lamina propria of the respiratory mucosa. In Lena-infected 
nasal mucosa, CD163+Sn+, CD163+Sn- and to a lesser extent CD163-Sn- monocytic 
subtypes were involved in infection. CD163+Sn- cells were mostly located within or 
in the proximity of the epithelium. Our results show that, whereas LV replicates in a 
restricted subpopulation of CD163+Sn+ monocytic cells in the upper respiratory tract, 
Lena hijacks a broader range of subpopulations to spread within the mucosa. 
Replication in CD163+Sn- cells suggests that an alternative entry receptor may 
contribute to the wider tropism of Lena. 
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Introduction 
Porcine reproductive and respiratory syndrome (PRRS) is the most devastating 
disease in swine-producing countries all over the world with huge annual economic 
losses (Nieuwenhuis et al. 2012). PRRSV causes reproductive failure in late gestation 
sows and is associated with respiratory disorders in growing pigs. It is a positive 
single stranded enveloped RNA virus classified together with lactate dehydrogenase 
virus, simian hemorrhagic fever virus and equine arteritis virus in the family of the 
Arteriviridae within the order Nidovirales (Meulenberg et al. 1993). The syndrome 
was first detected in the United States in the late eighties and the virus was isolated in 
Europe, America and Asia in the early nineties (Keffaber et al. 1989, Shimizu et al. 
1994). Genetic analysis of PRRSV isolates from all over the world showed the 
existence of two major types with clear genetic and antigenic differences: European 
type 1 (prototype Lelystad - LV) and American type 2 (prototype VR2332) 
(Wensvoort et al. 1991, Collins et al. 1992). During the last decade new highly 
virulent strains emerged in Eastern Europe, China and Vietnam, showing more severe 
clinical signs (Tian et al. 2007, Karniychuk et al. 2010). Previous in vivo studies 
showed for LV a narrow cell tropism limited to cells of the monocytic lineage that 
are present in lungs, lymphoid tissues, placenta and other organs (Duan et al. 1997, 
Zimmerman et al. 2006). In vitro studies showed that freshly isolated blood 
monocytes, red bone marrow cells and peritoneal macrophages were resistant to 
infection with LV, whereas cultured blood monocytes, monocyte-derived dendritic 
cells (moDC), red bone marrow-derived dendritic cells (BmDC) and primary alveolar 
macrophages (PAM) were susceptible to type I and II PRRSV (Duan et al. 1997, 
Loving et al. 2007, Park et al. 2008, Chang et al. 2008, Silva-Campa et al. 2010). The 
host cell receptors of PRRSV were identified in PAM as sialoadhesin (Sn) and 
CD163, responsible for virus attachment, internalization and disassembly, both of 
which are exclusively expressed by different types of monocytic cells (Vanderheijden 
et al. 2003, Calvert et al. 2007, Van Breedam et al. 2011, Van Gorp et al. 2008). 
Airway mucosal surface is a common entry site for many viruses. In evolution, these 
pathogens have developed several different mechanisms to penetrate through the 
epithelial cell layer, degrade the basement membrane and spread in the underlying 
connective tissue (Steukers et al. 2012). The epithelial cell layer forms a strong 
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barrier against pathogens primarily due to cell-cell junctions and desmosomes 
(Vareille et al. 2011). Due to the complex nature of the mucosal surfaces, tissue 
cultures are preferred to study pathogen replication and invasion. Tissue cultures of 
mucosa of different species have already provided new insights in the pathogenesis of 
early stages of infection with alphaherpesviruses (PrV, EHV, BoHV, HSV) and 
retroviruses (HIV) (Glorieux et al. 2007, Steukers et al. 2011, Tugizov et al. 2012, 
Vanderkerckhove et al. 2011, Vairo et al. 2013). 
PRRSV spreads by direct contact through saliva, nasal and mammary secretions, 
urine, feces and semen and transplacental transmission in late gestation (Zimmerman 
et al. 2006). In addition, an aerogenic spread over a distance of 4 km has also been 
reported. This aerosol transmission of the virus is mainly influenced by the 
pathogenicity of the isolate (Otake et al. 2010). Despite the increasing knowledge of 
the pathogenesis of PRRSV, the pathways that the virus follows to invade at mucosal 
surfaces at the early stage of infection remain unknown. 
In the present study, the mechanism to penetrate the nasal mucosa was examined for 
PRRSV. To this end, polarized nasal mucosa explants, which were embedded in 
agarose in order to represent the natural condition of the respiratory epithelial barrier, 
were used. Replication characteristics and cell tropism of a low virulent European 
subtype 1 strain (LV) and a new highly virulent European subtype 3 strain (Lena) 
were compared. Lena, was isolated by Karniychuk et al. (2010), and alignment with 
LV showed 84%identity and 89%similarity at the amino acid level, with the greatest 
variation in Orf1a (Nsp2) where a deletion of 29 amino acids was found (Van 
Doorselaere et al. 2012). In addition, viral replication of both strains was compared in 
different types of monocytic cells. 
Materials and methods 
Animals and collection of tissue and cells 
Three 5 to 8-week-old conventional Belgian Landrace pigs originating from a 
PRRSV-negative, PCV2-positive farm were used. Using tissues of euthanized 
animals is in agreement with the statement of the Local Ethical and Animal Welfare 
Committee of the Faculty of Veterinary Medicine of Ghent University. Collection 
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and culture of the nasal mucosa explants were performed as described before 
(Glorieux et al. 2007). Nasal mucosa was stripped from the nasal septum and conchae 
and then immediately placed in transport medium containing phosphate buffer saline 
(PBS), 0.1 mg/mL gentamicin (Invitrogen, Gent, Belgium), 0.1 mg/mL streptomycin 
(Certa, Eigenbrakel, Belgium), and 100 U/mL penicillin (Continental Pharma, Puurs, 
Belgium). Afterwards, the tissues were cut in small square pieces (10 mm2), placed in 
six-well plates with the epithelial side facing up on a fine-meshed gauze and cultured 
for 24 h (37°C, 5% CO2) at an air-liquid interface with serum-free medium 
containing 50% DMEM (Invitrogen), 50% Ham’s F-12 GlutaMAX (Invitrogen) and 
supplemented with 0.1 mg/mL gentamicin (Invitrogen), 0.1 mg/mL streptomycin 
(Certa), 100 U/mL penicillin (Continental Pharma) and 0.01 mg/mL fungizone 
(Bristol-Myers Squibb, USA). In order to inoculate only at the epithelial side, a 
polarized culture model was set up as illustrated in Figure 1, using a technology 
described by others (Vairo et al. 2013). PAM were seeded in a six-well plate and 
after 24 h of culture (37°C, 5% CO2) the cells were overlaid with 3 mL of an agarose 
solution consisting of a 1:1 mix of 50% of sterile 6% agarose (low gelling agarose, 
Sigma, Diegem, Belgium) and 50%of 2X Ham’s F-12 GlutaMAX medium 
supplemented with 0.2 mg/mL streptomycin (Certa), 200 U/mL penicillin 
(Continental Pharma) and 0.2 mg/mL gentamicin (Invitrogen). Subsequently, the 
tissue explants were transferred from the gauzes on the solidified agarose solution 
and the exposed lateral edges were sealed with additional 4% agarose solution. 
Finally, the explants were incubated in the presence of 500 µL of culture medium at 
37°C, 5% CO2. 
PAM were collected by lung lavage (Wensvoort et al. 1991) and seeded (1 × 106/mL 
per well) into 24-well plates for 24 h in RPMI-1640 supplemented with 10%fetal calf 
serum (FCS), 2 mM L-glutamine, 0.1 mM non-essential amino acids, 1 mM sodium 
pyruvate and a mixture of antibiotics. Monocytes were isolated from porcine 
peripheral blood mononuclear cells (PBMC) by Ficoll-paque gradient centrifugation 
as described by the manufacturer (Pharmacia Biotech). Afterwards, cells were seeded 
into 24-well plates in the same medium that was used for PAM for 2 h at 37°C in a 
5% CO2 atmosphere. Non-adherent cells were gently removed and the adherent 
monocytes were cultured in the same conditions for 24 h. Finally, for the generation 
of moDC an existing method was adapted (Silva-Campa et al. 2010). Monocytes 
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were cultured at 37°C and 5% CO2 for 4 days in the presence of 20 U/mL 
recombinant porcine granulocyte-macrophage colony-stimulating factor (GM-CSF) 
and 100 U/mL IL-4. Viability and morphology of cells were monitored each day 
under a light microscope (Leica, Germany) and all experiments were performed in 
triplicate. 
 
Figure 1 - An illustration of the polarized tissue explant model for studying 
PRRSV replication kinetics. Nasal mucosa explants were placed over a 3% agarose 
layer with the mucosal side facing up in a 6-well plate. The lateral edges of the 
explants were sealed with 4% agarose and cell-free PRRSV particles were added to 
the apical surfaces. PRRSV susceptible cells (PAM) were seeded on the bottom of 
the plate to examine virus particle penetration through the agarose layer. PAM: 
Porcine alveolar macrophages. 
Evaluation of tissue viability and morphometry in polarized explants 
Cilia beating and explant morphology were observed every day under a light 
microscope. To evaluate the viability of the polarized explants, an In Situ Cell Death 
Detection Kit was used (Roche Diagnostics, Switzerland) based on terminal 
deoxynucleotidyl transferase dUTP nick end-labeling (TUNEL). The effect of in 
vitro culture on the epithelial morphology and the basement membrane thickness and 
continuity was evaluated by immunofluorescence staining using mouse monoclonal 
antibodies against cytokeratin (1:50, IgG1, DAKO) and collagen VII (1:50, IgG1, 
Sigma). Samples were collected at 0, 24, 48 and 72 h for analysis of viability and 
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morphology using a confocal fluorescence microscope (Leica TCS SP2, Germany). 
TUNEL-positive cells were counted within the epithelium and the lamina propria in 3 
sections per sample and 5 fields of 100 cells per section. Epithelial and basement 
membrane thickness was measured at various time points after random selection of 
five fields per sample. 
Viruses 
A 13th passage of PRRSV European subtype 1 Lelystad virus (LV), kindly provided 
by G. Wensvoort (Institute of Animal Science and Health, The Netherlands), and a 
3rd passage of PRRSV European subtype 3 (Lena) were used in these studies. All 
viral stocks were propagated in PAM and the culture medium was stored at −70°C. 
Cell-free viral strains were used after centrifugation at 13000 rpm for 10 min, 
filtration through a 0.45 µm filter and dilution in serum-free medium to a final titer of 
105.5 tissue culture infectious dose 50% endpoint (TCID50)/mL (Reed and Muench, 
1938). 
Virus inoculation and sample collection of nasal explants and monocytic cells 
Explants were inoculated with 500 µL of PRRSV strains at a titer of 105.5 TCID50/mL 
for 1 h at 37°C in the presence of 5%CO2. Afterwards, they were washed three times 
with medium and further incubated with 500 µL of medium. Samples were collected 
at 0, 24, 48 and 72 hpi and medium was collected for virus titration. The explants 
were cut in two equal parts. The first part was used for immunofluorescence analysis 
and the second part for virus titration. To exclude virus transmission through the 
agarose layer, alveolar macrophages from the bottom of each well were subjected to 
PRRSV-specific immunoperoxidase staining (Wensvoort et al. 1991). No PRRSV-
positive cells were found at any time-point. 
PAM, monocytes and moDC were inoculated with PRRSV at a multiplicity of 
infection (MOI) of 0.1 virions/cell. After 1 h of incubation at 37°C and 5% CO2, the 
inoculum was removed and the cells were washed three times with RPMI-1640 
before further culture. Cells and medium were collected at different time points for 
viral antigen quantification and virus titration. 
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Culture medium, tissue suspensions and monocytic cells were titrated on PAM in 
quadruplicate and a final TCID50 was determined after subjecting the cells to a 
PRRSV-specific immunoperoxidase staining to analyse the presence of PRRSV 
positive cells. 
Immunofluorescence microscopy 
To quantify PRRSV-positive cells in the nasal mucosa, several 9 µm cryosections 
were made at a distance of 30 µm between each other and fixed in 100% methanol at 
−20°C for 15 min. Samples were subsequently incubated with the PRRSV N-specific 
monoclonal antibody 13E2 (1:25, IgG2a) and a secondary goat anti-mouse IgG2a 
antibody (1:500, Invitrogen) (Van Breedam et al. 2011). To reduce the background 
signal, 10%negative goat serum was included for blocking during each step. Cell 
nuclei were stained with Hoechst (10 µg/mL, Hoechst 33342, Invitrogen) for 10 min 
at RT. A mouse monoclonal antibody against gB of PRV (1C11, IgG2a) (Nauwynck 
et al. 1995) was used as negative control at the same dilution as the monoclonal 
antibody 13E2. Analysis was performed in a minimum of 25 sections with 5 fields 
per section. PRRSV-positive cells were counted within regions of interest (ROIs) 
including the epithelium and the lamina propria. 
To identify, localize and quantify the different cell types that were infected by 
PRRSV, double or triple immunofluorescence (IF) stainings were performed. Mouse 
monoclonal antibodies were used against CD163 (2A10/11, 1:500, IgG1, AbD 
Serotec, Dusseldorf, Germany) and porcine sialoadhesin (41D3, 1:2, IgG1 and 262B, 
1:2, IgG2b) (Duan et al. 1998). To detect viral proteins, a biotinylated form of the N-
protein specific monoclonal antibody 13E2 was used. Isotype-specific secondary 
antibodies and streptavidin conjugated with FITC, Alexa Fluor 594 or Alexa Fluor 
350 (Invitrogen) were used to reveal the different markers. Cell nuclei were stained 
with Hoechst and to confirm the specificity of each antibody, negative isotype-
specific control antibodies were used: 13D12 against gD of PRV (IgG1) (Nauwynck 
et al. 1995), 1C11 against gB of PrV (IgG2a) and F190 against the capsid protein of 
PCV2 (IgG2b) (McNeilly et al. 2001). Countings were made in a minimum of 3 
sections and three microscopic fields (300×) per section for each marker with the 
sections being located 100 µm from each other. 
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PAM, monocytes and moDC were fixed in ice-cold methanol at −20°C for 15 min 
and PRRSV-positive cells were visualized using the same technique as for the 
cryosections. The percentage of PRRSV-positive cells was determined for the 
different monocytic cell types. For each condition two independent researchers 
analyzed a total of 600 cells at a magnification of 400×. Analysis for all the samples 
was performed using a Leica TCS SP2 laser-scanning confocal microscope (Leica 
Microsystems GmbH, Wetzlar, Germany). 
Statistical analysis 
Data were analyzed with GraphPad Prism5 software (GraphPad Software Inc., San 
Diego, CA, USA). Analyzed data for statistical significance were first subjected to a 
Shapiro-Wilk test and then a multiparameter t-test was performed. All results shown 
represent means and standard deviation (SD) of three independent experiments. 
Results with P-values ≤ 0.05 were considered statistically significant. 
Results 
Evaluation of tissue viability and morphometry in polarized explants 
To evaluate the effect of in vitro cultivation on the viability of nasal mucosa explants, 
the percentage of TUNEL-positive cells was calculated at 0, 24, 48 and 72 h after 
incubation (Table 1). Differences in number of apoptotic cells were not observed 
within the epithelium and only a small increase, not statistically significant, was 
observed in the lamina propria at 72 h of cultivation. The thickness of the epithelium 
and the lamina reticularis did not change during the time of cultivation. 
Representative images and evaluation of morphology are illustrated in Figure 2. 
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Table 1 Evaluation of the effect of in vitro culture on the viability of nasal mucosa 
explants by TUNEL staining at different hours of cultivation. 
Percentage (%) of TUNEL-positive cells at…h of cultivation 
 
0 h 24 h 48 h 72 h 
Epithelial cells 0.2 ± 0.1 0.5 ± 0.1 0.9 ± 0.6 0.6 ± 0.3 
Lamina propria 2.1 ± 0.6 3.4 ± 0.5 2.0 ± 0.4 5.3 ± 0.9 
Data are represented as means ± SD. 
 
 
Figure 2 - Evaluation of the thickness of the epithelium and lamina reticularis 
by immunofluorescence stainings. Average and representative confocal 
microscopic images of epithelium immunofluorescence staining using antibodies 
against cytokeratin (indicated by arrow) (A) and lamina reticularis 
immunofluorescence staining using antibodies against collagen VII (indicated by 
arrows) (B) are presented. Data are represented as means ± SD of three independent 
experiments. Scale bar = 50 µm. 
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Virus production and quantification of PRRSV-positive cells in nasal mucosa 
explants  
The presence of PRRSV infected cells was determined by indirect 
immunofluorescence of cryosections from nasal explants collected at 0, 24, 48 and 72 
hpi (Figure 3). In order to study the pattern of infection, regions of interest (ROIs) 
were set including the epithelium and lamina propria. At 24 hpi, single Lena-positive 
cells (1 to 2 cells/mm2) appeared in the lamina propria while no LV-positive cells 
were detected. At 48 hpi, the number of Lena-positive cells gradually increased with 
cells being located in the epithelium and in the lamina propria. Besides single 
positive cells, clusters of 2 to 5 cells were also observed in these areas. Only a few 
single positive cells (1 or 2 cells per mm2) were detected in LV-infected tissue, all of 
them located in the lamina propria. The largest number of Lena-positive cells was 
observed at 72 hpi (52 cells/mm2), while the number of LV-positive cells remained 
low (2 to 4 cells/mm2).  Immunostainings of Lena-infected explants showed that 
expanded large clusters had accumulated within or close to the epithelium and lamina 
propria.  
Virus titration of the 20% tissue homogenates revealed a 100-fold higher virus 
production rate for Lena (104 TCID50/g) compared to LV (102 TCID50/g) at 72 hpi. 
The virus titer remained stable for LV while it increased in Lena-infected explants 
over time (Figure 3B). In addition, virus titration of the medium, showed for Lena a 
100-fold higher replication titer at 24 hpi. At 48 hpi, both strains reached the same 
titer of 105 TCID50/ml and at 72 hpi, viral titers for Lena and LV were 106.5 
TCID50/ml and 105 TCID50/ml, respectively. 
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Figure 3 - PRRSV replication characteristics in porcine nasal mucosa explants 
at different hours post inoculation. (A) Fluorescence microscopical images of nasal 
mucosa tissues inoculated with PRRSV strains LV and Lena at 72 hpi. PRRSV 
inoculated explants were immunostained with mouse anti-nucleocapsid and goat anti-
mouse IgG2a (green). Nuclei are visualized with Hoechst staining (blue). EP: 
epithelium, LP: lamina propria. White lines indicate the border between the lamina 
propria and the mucosal epithelium. Scale bar = 50 µm. (B) PRRSV-positive cells 
were counted in 25 sections. Tissues and medium were collected to study viral 
production. Error bars show ± SD and a Student’s t-test was performed to evaluate 
significant differences between samples, * denotes a P value ≤ 0.05. 
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Identification of PRRSV-susceptible cells in nasal mucosae  
Double IF stainings were performed for identification of PRRSV-susceptible cells. 
The number of cells expressing CD163 remained stable for both LV and Lena 
infected explants at around 150 cells/mm2 (Figure 4B, D). In LV-inoculated explants, 
all the detected LV-positive cells during cultivation were CD163+ and were located at 
the lamina propria area (Figure 4B). In Lena-inoculated tissues, viral antigen positive 
cells were first detected at 24 hpi and all of them were positive for CD163 (Figure 
4D). At 48 hpi, 79% of the Lena-positive cells were CD163+. The Lena-positive cells 
that were CD163- were located within or close to the epithelium and this distribution 
remained the same at 72 hpi (Figure 5A). The number of positive cells increased at 
72 hpi, but the percentage of viral antigen positive cells that were CD163+ remained 
stable at 76%. Clusters of infected cells in Lena-infected tissues consisted of central 
CD163+ cells and CD163- cells at the periphery. Within the epithelium, single 
CD163+ cells with long dendrites were observed, resembling DC. The 75% of Lena-
positive cells located in the lamina propria were CD163+ and were found in the 
proximity of secretory glands and veins.  
The number of Sn expressing cells was stable for both strains during cultivation 
(approximately 95 cells/mm2) and no de novo upregulation was observed (Figure 4-A, 
C). The Sn+ cells were located in the lamina propria and only a small number of Sn+ 
cells (4.8/mm2) were detected within or close to the epithelium (Figure 5B). In all 
LV-infected explants tested, 99% of the antigen positive cells were found positive for 
Sn (Figure 4A). At 48 hpi, the number of Lena-positive cells was 23 cells/mm2 and 
only 43% of the cells were Sn+ (Figure 4C). All the Sn- cells were located close to or 
within the epithelium (Figure 5B). At 72 hpi, the number of Lena-positive cells raised 
slightly but the percentage of positive cells that were Sn+ remained constant at 43%. 
Triple IF stainings were performed with antibodies against CD163, Sn and PRRSV 
N-protein. In Lena-infected tissues, both CD163+Sn-PRRSV+ and CD163-Sn-
PRRSV+ cells were observed within or close to the epithelium, whereas 
CD163+Sn+PRRSV+ cells were found only in the lamina propria. At 48 hpi, the 
number of CD163+Sn-PRRSV+ cells was 7/field and the number of 
CD163+Sn+PRRSV+ cells was 4/field. At 72 hpi this proportion changed and the 
number of CD163+Sn+PRRSV+ cells was 8/field and the number of CD163+Sn-
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PRRSV+ cells was 4/field. Finally, CD163-Sn-PRRSV+ cells were detected at the 
periphery of clusters at 48 hpi. The number of these cells was 1.6/field and increased 
to 2.6/field at 72 hpi. In LV-infected explants, all infected cells had a phenotype of 
CD163+Sn+. At 72 hpi, the number of CD163+Sn+PRRSV+ was 2/field. All of these 
cells were located in the lamina propria.  
 
 
Figure 4 - Identification of PRRSV LV and Lena infected cells. Nasal mucosa 
explants were inoculated with PRRSV strains and cultivated for 0, 24, 48 and 72 h. 
Cryosections were made, fixed, and co-immunostained with antibodies against 
PRRSV N-protein and Sn (A, C) or CD163 (B, D). Cells were quantified within ROIs 
including the epithelium and lamina propria. Data are represented as means ± SD. 
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Figure 5 - Double immunofluorescence stainings of nasal mucosa explants. 
Tissue samples were sectioned (9 µm) and co-immunostained for PRRSV N-protein 
(red) and markers for (A) CD163 or (B) Sn (green) at 72 hpi. EP: epithelium, LP: 
lamina propria. White lines indicate the border between the lamina propria and the 
mucosal epithelium. White arrows show CD163+PRRSV+, Sn+PRRSV+ or Sn-
PRRSV+ cells. Scale bar = 50 µm. 
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PRRSV infection kinetics in PAM, monocytes and moDC 
Infection kinetics of LV and Lena in PAM showed a different pattern in the three 
pigs (Figure 6). For pig 1, both strains followed the same replication kinetics 
reaching infection in 100% of cells after 72 hpi. Lena showed a 100-fold higher virus 
titer than LV at 24 hpi but at 72 hpi both strains reached a titer of 104 TCID50/ml. For 
pig 2, LV-positive cells were found only at 72 hpi (5%). Lena-positive cells were 
already found at 24 hpi (6%) and increased at 72 hpi (80%). LV virus titers remained 
low (101.5-102 TCID50/ml) while Lena virus titers were over 104 TCID50/ml.  Finally 
in pig 3, Lena already infected 100% of the PAM at 24 hpi whereas LV reached that 
level only at 48 hpi. Lena showed a 2 to 10-fold higher viral titers at 24 hpi compared 
to LV. Both strains reached the same titer of 104 TCID50/ml after 72 hpi.  
In cultured monocytes and moDC, replication kinetics was similar for both LV and 
Lena. At 72 hpi, the average percentage of infection was 60% in monocytes and 100% 
in moDC for both strains. Virus production in monocytes showed for Lena a 10-fold 
higher titer than LV at 48 hpi but at 72 hpi, both strains showed similar titers. 
Titrations in moDC showed no differences for LV and Lena  (Figure 7).  
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Figure 6 - Replication of PRRSV in PAM. Quantification of viral antigen positive 
cells is expressed as percentage (%). Intracellular and extracellular titers are 
expressed in a log10 scale. Experiments were performed with cells from three 
different pigs.  
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Figure 7 - Quantification of PRRSV-positive cells and virus titers, in cultured 
monocytes and monocyte-derived dendritic cells (moDC). Cells were inoculated 
with PRRSV strains LV and Lena at a MOI of 0.1 for 1 h. Experiments were 
performed with cells from three different pigs and data are represented as means ± 
SD.   
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Discussion 
In the present study it was shown that European PRRSV strains subtype 1 (LV) and 
subtype 3 (Lena) differ in their capacity to enter the body at the nasal mucosa: (1) the 
epithelial cell barrier of the nasal mucosa seems to be rather resistant to LV infection as 
only a few infected cells were observed at 72 hpi, all of them located in the lamina 
propria; (2) Lena was able to replicate much more efficiently than LV in the nasal 
mucosa and formed clusters of cells in the epithelial cell layer and the lamina propria; 
(3) LV was able to infect only CD163+Sn+ cells whereas Lena showed a wider cell 
tropism as it also replicated in CD163+Sn- and to a lesser extent in CD163-Sn- cells; (4) 
an alternative co-receptor might be involved in the spreading of this highly virulent 
PRRSV strain to other monocytic subtypes.  
Studies with similar explant systems have been performed with different tissues of the 
respiratory tract in different animal species to investigate virus transmission and cell 
tropism (Glorieux et al. 2007, Steukers et al. 2011, Tugizov et al. 2012, 
Vanderkerckhove et al. 2011, Vairo et al. 2013). To examine the behavior of PRRSV in 
nasal mucosa, a polarized nasal mucosa explant system was generated. Agarose was 
used to cover the bottom and the lateral edges of the explant, having only the apical 
surface free for inoculation. The epithelial thickness and the basement membrane 
integrity were preserved after three days of culture, in serum-free conditions. In this 
way, the natural route of infection was mimicked. This polarized nasal mucosa explant 
system allowed us to study the local PRRSV transmission and primary events during 
the early stages of PRRSV infection.  
At 72 hpi, Lena was found to infect twenty times more cells than LV in the nasal 
mucosa (Lena: 51 positive cells/mm2, LV: 2.5 cells/mm2). In LV-infected tissues, 
mainly single infected cells were detected in the lamina propria, whereas in Lena-
infected explants cell foci were also observed after 48 hpi. The small number of LV-
infected cells in our experiments was in agreement with previous work, where no viral 
antigen positive cells were detected in the nasal mucosa after intranasal inoculation of 
specific-pathogen-free pigs with LV (Pol et al. 1991). In the present study, virus 
titrations showed a 100-fold higher titer for Lena at the end of the experiment (72 hpi). 
The higher replication level that was observed with Lena correlates with previous in 
vivo studies where this strain was found to be more virulent than LV. Lena was secreted 
Chapter 4.1	  
 
 116 
at high virus titers in nasal swabs (mean peak titer: 105.6 TCID50/100mg) and 100-fold 
higher titers were detected in serum (mean peak titer: 106.1 TCID50/ml) compared to a 
recent European subtype 1 strain (mean peak titer: 104 TCID50/ml) (Karniychuk et al. 
2010). This higher virus replication coincided with severe clinical signs such as 
anorexia, listlessness and high fever lasting two to three weeks (Karniychuk et al. 2010). 
In another in vivo study, higher viral titers seven days after inoculation were also found 
for Lena in serum (105.4 TCID50/ml) compared to LV (103.8 TCID50/ml) and fever was 
observed only in Lena infected pigs (Weesendorp et al. 2012). 
In general, PRRSV shows a narrow cell tropism for cells of the monocytic lineage. 
Infection is primarily found in specific subtypes of macrophages located in lungs, 
lymph nodes, tonsils, spleen, liver, Peyer’s patches, thymus, myometrium, 
endometrium and placenta (Duan et al. 1997, Karniychuk et al. 2009, Karniychuk et al. 
2011, Labarque et al. 2000, Rossow et al. 1996, Haynes et al. 1997). CD163 and Sn are 
two identified entry mediators for PRRSV in macrophages (Van Gorp et al. 2008). 
Sialoadhesin is a macrophage-restricted siglec that has been identified as PRRSV 
receptor responsible for binding and internalization (Vanderheijden et al. 2003). CD163 
is a type 1 transmembrane glycoprotein present in specific subtypes of monocytes, 
macrophages and DC (Piriou-Guzylack et al. 2008). It plays a role in viral uncoating 
and genome release (Calvert et al. 2007). It is already known that monocytic cells lying 
within the mucosal surfaces form a network in order to capture antigens, communicate 
with each other and process the antigens to T-cells (Steinman et al. 2007). 
Immunofluorescence microscopy in non-infected nasal mucosa explants revealed that 
CD163+ cells are in close proximity to each other and equally distributed within the 
epithelium, the lamina propria and the submucosa. Cells that are located within the 
epithelium showed extended dendrites displaying dendritic cell morphology. 
Conversely, Sn+ cells, were found to be equally distributed in the lamina propria and the 
submucosa. Only a small number of cells with this phenotype was present in the 
epithelial cell layer (5.2 cells/mm2). Cell identification experiments revealed a different 
cell tropism for LV and Lena. Our data suggest that the nasal mucosa is not one of the 
main entry portals for LV. It was shown that this strain has a restricted cell tropism for 
CD163+Sn+ macrophages, which are present in the lamina propria. It is thought that LV 
is sporadically taken up by a CD163+Sn+ macrophage and afterwards migrates to the 
lamina propria of the mucosa. On the contrary, Lena showed a wider cell tropism and 
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productively infected CD163+Sn- cells that form a dense network within the epithelium 
and under the basement membrane, and used them as a “trojan horse” in order to get 
free access to the deeper parts of the mucosa.   
The single layer of columnar epithelial cells makes it easier for the nasal mucosa 
antigen presenting cells (APC) to extend protrusions into the airway lumen, capture 
antigens and migrate, compared to oral and vaginal mucosal surfaces that consist of 
five to seven cell layers (Vareille et al. 2011, Tugizov et al. 2012). After the antigen 
uptake, the APC regulate the degradation of the basement membrane in order to 
facilitate the dissemination of the pathogen to the blood circulation and other organs 
(Steukers et al. 2012). Unfortunately, none of the previous studies in human or other 
nasal mucosa tissues has included CD163 and Sn as a phenotype marker (Till et al. 
2001, Jahnsen et al. 2000, 2004). We believe that the CD163+Sn- cells that are present 
in the porcine nasal mucosa have a specific function in antigen capturing and 
presentation.  Additional studies are needed to further characterize these different cell 
types and test their properties in functional assays. 
In this work, it was shown that LV-positive cells, were single infected cells located in 
the lamina propria and that 97% of them were CD163+Sn+. Remarkably, in Lena 
infected tissues large clusters of cells were formed after 48 hpi. More than 50% of these 
cells were CD163+Sn- and that was the phenotype of the majority of the cells in clusters 
within or close to the epithelium. CD163-Sn- cells were also found at the periphery of 
the clusters indicating that Lena is capable of spreading to bystander cells. It was 
shown that PRRSV induces apoptosis at the early stages of infection and that in vivo 
apoptotic cells, are engulfed by phagocytes (Labarque et al. 2003, Costers et al. 2008). 
Therefore, it is possible that bystander cells are infected by the uptake of apoptotic 
bodies that contain infectious viral particles. However, viral spreading to other cell 
types through phagocytosis of apoptotic remains should occur with LV as well. In the 
results, it was shown that infection seems to start from CD163+Sn+ cells and in Lena 
strain it spreads later to other cell types. This fact could be another indication that Lena 
uses an alternative receptor for viral entry or up-regulates specific adhesion molecules, 
which promote extensive viral spreading. 
The dense network of monocytic cells is ideal to protect the host against invasion of 
pathogens into the lamina propria. The effective replication of PRRSV strain Lena may 
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alter the function of the immune cells in the local microenvironment and change the 
mucosal homeostasis. A big drawback of the clustering of CD163+ cells is that the 
migrating monocytic cells may leave “open doors” for other upper respiratory 
pathogens to invade through the mucosa, establish a secondary infection and enhance 
the severity of the disease (Johnson et al. 2004, Thanawongnuwech et al. 2000). 
Previous studies have shown that PRRSV (Lena)-infected pigs allow bacteria to enter, 
causing sepsis and leading to death (Karniychuk et al. 2010).  
In order to compare nasal mucosa monocytic cells with primary target cells from the 
lungs and the blood compartment, PAM, cultured circulating monocytes and moDC 
were enclosed. No changes were observed in replication rates between LV and Lena in 
isolated monocytes from PBMC and in moDC. The replication of PRRSV strains to 
these cell types correlates with previous studies, but since there are functional and 
phenotypic differences between subpopulations of monocytic cells in different tissues, 
further studies with primary cells need to be done to evaluate better these results (Duan 
et al. 1997, Loving et al. 2007, Park et al. 2008, Chang et al. 2008, Silva-Campa et al. 
2010). In PAM, the susceptibility of the two strains seemed to be pig-dependent and 
three patterns of infection were observed. In pig one both strains showed a similar 
pattern of infection whereas in pig two, LV did not replicate while Lena could replicate 
efficiently. Finally, in pig three Lena was able to reach higher levels of replication at 
early timepoints (12 and at 24 hpi). A possible explanation for the different patterns of 
replication observed in PAM could be the genetic background of the viral isolate and 
the host, which was shown before to affect the outcome of PRRSV infection (Wills et 
al. 2003). Furthermore, the pigs that were used in this study were seropositive for 
PCV2. Therefore, a possible M1/M2 macrophage polarization that had affected the 
lung environment it cannot be excluded, but even then, Lena was able to replicate to all 
the three pigs efficiently. To the end, in this study a 13th passage of LV and a 3rd 
passage of Lena was used. All viral stocks were grown on PAM, which is the primary 
cell target of the virus. Since the virus is naturally designed to infect this cell type, it is 
unlikely that the passage history would have influenced the receptor preference and the 
outcome of the results. 
In summary, different mechanisms of invasion were observed between the two PRRSV 
strains in nasal mucosa (Figure 8). On the one hand, LV susceptibility was mainly 
restricted to CD163+Sn+ cells, which were located in the lamina propria. The small 
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number of Sn+ cells (5.2/mm2) that are present within the epithelial cell layer does not 
allow LV to reach high levels of infection. Only 2.5 LV-infected cells/mm2 were 
observed at 72 hpi, all of them located in the lamina propria and the 97% of them had a 
CD163+Sn+ phenotype. On the other hand, Lena was found to hijack CD163+Sn+ and 
CD163+Sn- cells lying within or close to the epithelium in order to gain access to 
deeper parts of the mucosa. After 48 hpi, clusters of mainly CD163+Sn- Lena-infected 
cells were observed within or close to the epithelium and clusters of CD163+Sn+ cells 
were observed in the lamina propria. These clusters expanded at 72 hpi, and to a lesser 
extent than the other phenotypes, CD163-Sn- cells were detected at the periphery of 
them. 
Finally, we conclude that Lena is a highly virulent PRRSV strain that can replicate 
more efficiently and faster than LV, in nasal mucosa and alveolar macrophages 
respectively. The ability of Lena to replicate in Sn negative cells suggests the use of an 
additional receptor for this strain. No significant differences between LV and Lena 
were observed in PBMC isolated monocytes and in moDC.  
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Figure 8 - Model of PRRSV invasion and spread in porcine nasal mucosa. The 
porcine nasal mucosa consists of a ciliated pseudostratified columnar epithelium, an 
underlying basement membrane and the lamina propria [22]. Different mechanisms 
of invasion were observed between PRRSV strains LV and Lena. LV mainly infects 
CD163+Sn+ cells. The small number of Sn+ cells (5.2 cells/mm2) that are present 
within the epithelial cell layer does not allow LV to reach high levels of replication. 
Only 2.5 LV infected cells/mm2 were observed at 72 hpi, all of them located in the 
lamina propria. 97% of the LV-infected cells had a phenotype of CD163+Sn+ (1).  
Lena showed a wider cell tropism. This strain infects both CD163+Sn+ and 
CD163+Sn- cells in order to migrate into the depth (2). Lena was found to spread 
easily from one cell to another, forming after 48 hpi, clusters of mainly CD163+Sn- 
infected cells within the epithelial cell layer and CD163+Sn+ in the lamina propria. 
These clusters expanded at 72 hpi and CD163-Sn- cells were detected at the periphery 
of them (3). 
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4.2 
Replication characteristics of eight virulent and two attenuated genotype 1 and 2 
porcine reproductive and respiratory syndrome virus (PRRSV) strains in nasal 
mucosa explants 
Ilias S. Frydas and Hans J. Nauwynck 
Submitted to Veterinary Microbiology, 2015 
Porcine reproductive and respiratory syndrome virus (PRRSV) can spread in between 
pigs via contact and airborne route. It was shown before that the highly pathogenic 
PRRSV strain Lena was able to replicate 10 to 100 times more efficiently in the nasal 
mucosa compared to the low pathogenic PRRSV strain LV. In this work, the 
replication characteristics of four type 1 (LV, 07V063, 08VA, 13V091), three type 2 
(VR2332, MN-184, VN) and two attenuated (MLV-DV, MLV-VR2332) PRRSV 
strains were studied in nasal mucosa explants. After 72 hpi, mean virus titers reached 
104.5 to 4.8 TCID50/ml for LV and 08VA, 105.2 to 5.4 TCID50/ml for VR2332 and Lena, 
and 105.8 to 6.3 TCID50/ml for 07V063, 13V091, MN-184 and VN strains, whereas 
attenuated strains remained below detection limit. The mean number of PRRSV-
positive cells/mm2 at 72 hpi was 1.1 and 1.3 for the attenuated strains and LV, 13.3 
for 08VA, 23.5 and 29.3 for VR2332 and 07063, 31.1 and 33.8 for 13V091 and Lena, 
and, 39.1 and 59.2 for MN-184 and VN respectively. All the LV and MLV-LV 
infected cells were Sn+, whereas all other strains also infected Sn- macrophages. In 
conclusion, (i) based on the virus shedding in the respiratory explants, PRRSV strains 
can be categorized as poor (MLV-DV, MLV-VR2332, LV, 08VA), moderate (Lena, 
VR2332) and strong (07V063, 13V091, MN-184, VN) secretors, and (ii) based on the 
number of infected cells isolates can be categorized as low (MLV-DV, MLV-
VR2332, LV), moderately (08VA, VR2332), highly (07V063, Lena, 13V091) and 
hyper (MN-184, VN) virulent in the nasal mucosa. 
Introduction 
Porcine reproductive and respiratory syndrome (PRRS) is the most devastating 
porcine infectious disease with massive economic losses in swine producing 
countries (Nieuwenhuis et al. 2012). The etiological agent is an arterivirus (PRRSV), 
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which is a 15 kb positive-sense single-stranded enveloped RNA virus. It is classified 
together with lactate dehydrogenase virus, simian hemorrhagic fever virus and equine 
arteritis virus in the family Arteriviridae within the order Nidovirales (Snijder et al. 
2013). PRRSV infection causes reproductive failure in sows, and is associated with 
the porcine respiratory disease complex (PRDC) in young animals (Choi et al. 2003). 
The virus is classified into a European genotype (type 1) and a North America 
genotype (type 2), which show a difference of 40% at the nucleotide level 
(Wensvoort et al. 1991, Nelsen et al. 1999). Despite the strong progress in 
pathogenesis and vaccination research, it is still difficult to control PRRS and 
eliminate the virus. This problem is mainly due to its fast mutation rate, which is one 
of the highest among all RNA viruses (Hanada et al. 2005).  
Previous in vivo studies showed that PRRSV primarily infects macrophages in the 
respiratory tract. Following a cell-free viremia, the virus replicates in monocytic cells 
all over the body with a strong tropism for lymphoid and placental residential 
macrophages (Duan et al. 1997b, Karniychuk et al. 2013). The host cell receptors for 
PRRSV Lelystad (LV) were identified in PAM as sialoadhesin (Sn, binding and 
internalization receptor) and CD163 (disassembly molecule) (Vanderheijden et al. 
2003, Calvert et al. 2007). Both molecules are exclusively expressed by different 
subsets of monocytic cells.  
 The virological and clinical outcome of a PRRSV infection is highly variable as it 
depends on the virulence of the isolate, environmental factors and presence of other 
pathogens (Brockmeier et al. 2002). It has been shown that the virus spreads by direct 
contact through nasal discharge, saliva, mammary secretions, urine, feces, and by 
transplacental spread during late gestation (Zimmerman et al. 2006, Karniychuk et al. 
2013). Airborne transmission is isolate-dependent and has been reported for a 
distance of 4 to 9 km, which represents a real danger in areas with a high density of 
swine farms (Otake et al. 2010). During the last decade, new highly virulent strains 
emerged in Eastern and Western Europe, and in South-East Asia, characterized by 
high viral loads in blood and tissues, more severe clinical signs with increased 
respiratory problems, and increased mortality (Tian et al. 2007, Karniychuk et al. 
2010, Frydas et al. 2015). 
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In a previous study, it was shown that a highly pathogenic type 1 PRRSV strain 
(Lena) is able to replicate 10 to 100 times more efficiently than a low pathogenic 
strain (LV) in nasal mucosa explants (Frydas et al. 2013). Furthermore, Lena 
displayed a different pattern of infection, as it was able to replicate in intra- and sub-
epithelial CD163+Sn- cells, whereas LV could only replicate in lamina propria 
CD163+Sn+ cells (Frydas et al. 2013). 
The purpose of this study was to evaluate the replication characteristics in the nasal 
mucosa of four type 1 (LV, 07V063, 08VA, 13V091) and three type 2 (VR2332, 
MN-184, VN) virulent PRRSV strains and of two attenuated PRRSV vaccine strains 
(MLV-DV (type 1) and MLV-VR2332 (type 2). The type 1 07V063 strain was 
isolated in 2007 from fetal tissues from a Belgian farm experiencing a severe 
PRRSV-outbreak (Geldhof et al. 2013). PRRSV 08VA was isolated from serum of a 
4-week old piglet in a subclinically infected herd. The 13V091 type 1 strain was 
isolated in 2013 from the serum of a young piglet from a Belgian farm experiencing 
severe respiratory problems (Frydas et al. 2015). VR2332 is the prototype type 2 
PRRSV strain isolated in the US in the late eighties (Benfield et al. 1992). The MN-
184 type 2 strain was isolated in 2001 from a commercial swine herd in Minnesota, 
USA, experiencing a severe outbreak of abortion and pre-weaning, nursery and 
finisher mortality (Cho et al. 2006). The VN strain was isolated in 2013 from a farm 
located in an area of South-East Asia experiencing severe problems after the 
emergence of new highly pathogenic PRRSV (HP-PRRSV) strains with a mortality 
in piglets reaching up to 91% (Ni et al. 2012). The current study provides new 
information on the replication power of different PRRSV-1 and PRRSV-2 strains in 
the nasal mucosa and the particular target cells (sialoadhesin positive/negative status). 
This work may help to better understand why some PRRSV strains are more 
virulent/pathogenic than others. 
Materials and Methods 
Animals and collection of tissues 
Twenty weeks-old conventional Belgian Landrace pigs originating from a PRRSV-
negative farm were used. The use of tissues from euthanized animals is in agreement 
with the laws of the Local Ethical and Animal Welfare Committee of the Faculty of 
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Veterinary Medicine of Ghent University. All pigs were negative for relevant 
pathogens (SIV, PCV2, PPV). Nasal mucosa was stripped from the septum and 
conchae, and then immediately placed in transport medium containing phosphate 
buffer saline (PBS), 0.1 mg/ml gentamicin (Invitrogen), 0.1 mg/ml streptomycin 
(Certa), and 100 U/ml penicillin (Continental Pharma). Afterwards, the tissues were 
cut in small square pieces (1 cm2), placed in six-well plates with the epithelial side 
facing up on a fine-meshed gauze and cultured for 24 h (37oC, 5% CO2) at an air-
liquid interface with serum-free medium containing 50% DMEM (Invitrogen), 50% 
Ham’s F-12 GlutaMAX (Invitrogen) and supplemented with 0.1 mg/ml gentamicin 
(Invitrogen), 0.1 mg/ml streptomycin (Certa), 100 U/ml penicillin (Continental 
Pharma) and 0.01 mg/ml fungizone (Bristol-Myers Squibb, USA). Six-well plates 
were overlaid with 3 ml of an agarose solution consisting of a 1:1 mix of 50% of 
sterile 6% agarose (low temperature gelling agarose, Sigma) and 50% of 2X Ham’s 
F-12 GlutaMAX medium supplemented with 0.2 mg/ml streptomycin (Certa), 200 
U/ml penicillin (Continental Pharma) and 0.2 mg/ml gentamicin (Invitrogen). Before 
inoculation, the tissue explants were transferred from the gauzes on solidified agarose 
and the exposed lateral edges were sealed with additional 3% agarose. Finally, the 
explants were incubated in the presence of 1 ml of culture medium at 37oC, 5% CO2.  
Viruses 
 A 4th passage of American type 2 virus VR2332, a 2nd passage of the European type 
1 Lelystad virus (LV) and the type 1 subtype 3 Lena, a 3rd passage of the PRRSV 
vaccine strain MLV-DV, a 1st passage of the vaccine strain MLV-VR2332, a 3rd 
passage of 07V063, 08VA, 13V091, MN-184 and a 2nd passage of VN was used. All 
viral stocks were propagated on MARC-145 cells in order to be able to use a high 
virus titer for virus inoculation and to make a comparison between the different 
strains. The macrophage grown and the MARC-145 cell grown viruses grew in 
alveolar macrophages with the same kinetics. Cell-free viral strains were used after 
centrifugation at 13000 rpm for 10 min, filtration through a 0.45 µm filter and 
dilution in serum-free medium to a final titer of 105.8 tissue culture infectious dose 
50% endpoint (TCID50)/ml. 
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Virus inoculation and sample collection of nasal explants  
Explants were inoculated with 500 µl of PRRSV at a titer of 105.8 TCID50/ml for 1 h 
at 37oC in the presence of 5% CO2.  Afterwards, they were washed two times with 
warm medium and further incubated with 1 ml of medium. At 0, 24, 48 and 72 hpi, 
medium was collected for virus titration. Culture medium was titrated on 24 h 
cultured PAM and on 3 days cultured MARC-145 cells in quadruplicate and a final 
TCID50 was determined after subjecting the cells to a PRRSV-specific 
immunoperoxidase staining with monoclonal antibody 13E2 against the PRRSV 
nucleocapsid protein to analyze the presence of PRRSV positive cells (Van Breedam 
et al. 2011) 
Immunofluorescence microscopy 
To quantify, localize and identify PRRSV-positive cells in the nasal mucosa, double 
immunofluorescence (IF) stainings were performed. Several 9 µm cryosections were 
made at a distance of 50 µm between each other and fixed in 100% methanol at -20oC 
for 15 min. The presence of PRRSV-infected cells was determined by indirect 
immunofluorescence of cryosections from nasal explants collected at 0, 24, 48 and 72 
hpi. In order to study the pattern of infection, regions of interest (ROIs) were 
randomly selected including the epithelium and lamina propria. Samples were 
incubated with a cocktail of primary antibodies including a PRRSV N-specific 
monoclonal antibody 13E2 (1:25, IgG2a), and a mouse monoclonal antibody against 
porcine sialoadhesin (Sn) (41D3, 1:2, IgG1) (Duan et al. 1998, van Breedam et al. 
2011). Subsequently, a mixture of secondary antibodies was used to reveal the 
different markers, including a goat anti-mouse IgG2a Alexa Fluor 594 antibody (1:500, 
Invitrogen) and a goat anti-mouse IgG1 Alexa Fluor 488 antibody (1:500, Invitrogen). 
To reduce the background signal, 10% negative goat serum was included for 
blocking during each step. Cell nuclei were stained with Hoechst (10 µg/ml, Hoechst 
33342, Invitrogen) for 5 min at room temperature (RT). To confirm the specificity of 
each antibody, negative isotype-specific control antibodies were used: 13D12 against 
gD of PRV (IgG1), 1C11 against gB of PrV (IgG2a), at the same dilution as the 
primary antibodies (Nauwynck et al. 1995). Analysis was performed on a minimum 
of 20 sections with 5 fields per section. PRRSV-positive cells were counted within 
regions of interest (ROIs) including the epithelium and the lamina propria.  
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Statistical analysis 
Data were evaluated with GraphPad Prism6 software (GraphPad Software Inc., San 
Diego, CA, USA). For statistical significance, analyzed data were first subjected to a 
Shapiro-Wilk test and then a multiparameter t-test was performed. All results shown 
represent means and standard deviation (SD) of three independent experiments. 
Results with P-values ≤ 0.05 were considered statistically significant. 
Results 
Virus production in nasal mucosa explants 
Field PRRSV strains - Virus titers after titration of the culture medium on PAM 
increased gradually starting from 24 hpi, and at 72 hpi, 07V063, 13V091, MN-184 
and VN PRRSV reached the highest mean virus titers ranging from 105.8 to 106.3 
TCID50/ml. At 72 hpi, VR2332 and Lena were released at a mean titer of 105.2 and 
105.4 TCID50/ml respectively, and the LV and 08VA strains showed the lowest mean 
titers of 104.5 and 104.8 TCID50/ml, respectively (Figure 1).  
Attenuated PRRSV strains - Virus titers in medium from explants infected with the 
attenuated strains remained below detection limit (0.97 TCID50/ml) after titration on 
PAM, except for the MLV-VR2332 in pig 9, which had a titer of 101.3 TCID50/ml at 
24 hpi. Titration of the medium on MARC-145 cells showed that for both MLV-DV 
and MLV-VR2332 all explants were positive at 24 hpi, displaying a mean titer of 
101.5 TCID50/ml (Figure 2). No detectable vaccine virus titers were observed after 24 
hpi. 
Quantification of PRRSV-positive cells in nasal mucosa explants  
Field PRRSV strains - The quantification of the viral antigen positive cells of the 
wild type strains is summarized in Figure 1 and 3. The two type 1 and type 2 
prototypes (LV, VR2332), four recently isolated type 1 (07V063, 08VA, Lena, 
13V091), and two highly pathogenic type 2 (MN-184, VN) PRRSV strains were 
examined, and showed different replication kinetics. The number of PRRSV-infected 
cells gradually increased starting from 24 hpi and the highest level of replication was 
shown for VN-infected explants, which reached a mean number of 59.2 PRRSV-
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positive cells/mm2 at 72 hpi. At the same time point, MN-184 showed also a high 
replication level reaching 39.1 PRRSV-positive cells/mm2. The type 1 07V063, Lena, 
13V091 and the type 2 VR2332 strains displayed a significantly (P<0.05) lower level 
of infection compared to MN-184 and VN with a mean number of 29.3, 33.8, 31.1 
and 23.5 PRRSV-positive cells/mm2 respectively. 08VA reached a mean number of 
13.3 PRRSV-positive cells/mm2 at 72 hpi, and at the same timepoint LV showed the 
lowest replication level with a mean of 1.3 PRRSV-positive cells/mm2. Two different 
infection patterns were observed between the two genotypes. Type 1 strains showed 
single-infected cells and infected cell clusters at 48 hpi, which increased at 72 hpi (3 
to 8 cells). The largest clusters were located in the lamina propria, just underneath the 
epithelium. Smaller clusters were also located in the epithelium. In explants infected 
with type 2 strains mainly single-infected cells were observed till the end of the 
experiment, and only a few small clusters (< 3 cells) were observed in the lamina 
propria at 72 hpi.  
Attenuated PRRSV strains - The quantification of the viral antigen-positive cells of 
the attenuated (MLV-DV and MLV-VR2332) and the closely related prototype (LV 
and VR2332) PRRSV strains is summarized in Figures 2 and 3. At 24 hpi, single 
PRRSV-positive cells (1 to 2 cells/mm2) appeared in the lamina propria of explants 
infected with wild type and vaccine PRRSV strains, except in LV-infected explants 
of pig 8, where no infected cells were observed. Explants inoculated with MLV-DV 
strain showed only 0.51 cells/mm2 at 24 hpi, and only in pig 9 infected cells were 
observed at 48 hpi (1.1 positive cells/mm2). In MLV-VR2332 explants, infected cells 
reached a mean number of 2.1 cells/mm2 at 48 hpi. Infected cells were no longer 
observed at 72 hpi in vaccine strain-infected explants. 
Sialoadhesin status of PRRSV-infected cells in nasal mucosa 
Sialoadhesin immunofluorescence stainings showed that in all pigs, the number of the 
Sn-expressing cells was stable for all the tested strains compared to the uninfected 
control tissues, and no de novo upregulation of Sn occurred during the 72 h 
cultivation period. Sialoadhesin-positive cells were located mainly in the lamina 
propria and only few cells were visible within the epithelium.  
In explants infected with type 1 PRRSV strains, the single-infected cells that 
appeared in the lamina propria at 24 hpi were mainly of Sn+ phenotype and the 
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percentage of Sn- infected cells ranged from 22% to 31%. Only in LV-infected 
explants all the infected cells were of Sn+ phenotype. At the same timepoint, the 
percentage of Sn- cells infected with type 2 strains, ranged from 44% to 65% of 
PRRSV+ cells. All the tested strains showed a similar absolute number of 
PRRSV+Sn+ cells at 72 hpi, ranging from 3.6 to 10.1 PRRSV+Sn+ cells/mm2, but the 
number of PRRSV+Sn- cells was different between strains. At 72 hpi, the 07V063, 
08VA and VR2332 isolates showed 9.2 to 18.6 PRRSV+Sn- cells/mm2 and the Lena, 
13V091, MN-184 and VN isolates showed 24.5 to 52.2 PRRSV+Sn- cells/mm2. The 
percentage of PRRSV+Sn- cells for the latter four PRRSV strains ranged from 72.8% 
to 89.8% of PRRSV+ cells. Finally, two different patterns of infection between type 1 
and type 2 strains were observed. Type 1 strains formed large clusters of cells (4 to 
10 cells) in the area of lamina propria at 48 hpi, whereas type 2 strains showed 
mainly single-infected cells till the end of the experiment at 72 hpi (Figure 3). Finally, 
the phenotypic analysis after double immunofluorescence stainings using antibodies 
against virus N-capsid protein and sialoadhesin, revealed that at 24 hpi, all MLV-DV 
infected cells were located in the lamina propria and were of Sn+ phenotype. On the 
other hand, in MLV-VR2332 infected tissues, more than half of the infected cells at 
24 and 48 hpi were Sn-.  
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Figure 1 - Quantification of PRRSV replication (number of viral antigen 
positive cells and virus titers) in explants infected with different type 1 (LV, 
Lena, 07V063, 08VA, 13V091) and type 2 (VR2332, MN-184, VN) PRRSV 
strains. Nasal mucosa explants from different pigs were inoculated with PRRSV 
strains and cultivated for 0, 24, 48 and 72 h. Cryosections were made, fixed, and co-
immunostained with antibodies against PRRSV N-protein and Sn. Cells were 
quantified within ROIs including the epithelium and lamina propria. Culture medium 
was titrated on alveolar macrophages. Data are represented as means ± SD. Type 2 
PRRSV strains are coloured red. 
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Figure 2 - Quantification of PRRSV replication (number of viral antigen 
positive cells and virus titers) in explants infected with different PRRSV wild 
(LV, VR2332) and vaccine (MLV-DV, MLV-VR2332) type 1 and type 2 strains. 
Nasal mucosa explants from different pigs were inoculated with PRRSV strains and 
cultivated for 0, 24, 48 and 72 h. Cells were quantified within ROIs including the 
epithelium and lamina propria. Culture medium was titrated on alveolar macrophages. 
Data are represented as means ± SD. Type 2 PRRSV strains are coloured red. 
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Figure 3 - PRRSV-positive cells in explants inoculated with different type 1 and 
type 2 PRRSV strains. Tissue samples from type 1- and type 2 PRRSV-infected 
explants were sectioned (9 µm) and co-immunostained for PRRSV N-protein (red) at 
72 hpi. EP: epithelium, LP: lamina propria. White lines indicate the border between 
the mucosal epithelium and the lamina propria. White arrows indicate large cell 
clusters (>4 cells). White arrowheads denote small cell clusters (2-3 cells). Scale bar 
= 50 µm. 
Discussion 
Recently, in order to study PRRSV replication and invasion mechanisms in the nasal 
mucosa, a novel explant culture system was developed in our laboratory. A low (LV) 
and a highly pathogenic (Lena) PAM-grown PRRSV type 1 strain were compared. 
Lena replicated 10 to 100 times more efficiently than LV. Whereas LV infected a low 
number of Sn+ macrophages, Lena was able to replicate in a large number of Sn- 
intra- and sub-epithelial nasal macrophages (Frydas et al. 2013). The goal of the 
present study was to further expand our knowledge on PRRSV replication in the 
nasal mucosa with other field and attenuated strains. The replication kinetics and cell 
tropism of different historical type 1 and type 2 strains, and two attenuated vaccine 
strains (MLV-DV and MLV-VR2332) were compared in nasal mucosa explants.  
Our results showed that in the nasal mucosa the vaccine strains MLV-DV and MLV-
VR2332 showed a very restricted replication, which fully fits with their attenuated 
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nature. Based on the production of progeny virus and the subsequent viral shedding 
attenuated, LV and 08VA PRRSV strains can be considered as poor secretors, 
whereas PRRSV Lena and VR2332 are moderate, and PRRSV 07V063, 13V091, 
MN-184 and VN are strong disseminators. Concerning the number of virus-infected 
cells PRRSV isolates can be classified as low (MLV-DV, MLV-VR2332, LV, 08VA), 
moderately (VR2332), highly (07V063, Lena, 13V091) and hyper (MN-184, VN) 
virulent in nasal mucosa. At 72 hpi, the number of PRRSV-infected cells of recently 
isolated type 1 strains 07V063, 08VA and 13V091 were 5 to 50 times higher than the 
classical LV type 1 strain.  Efficient replication of 07V063 and 13V091 in the nasal 
mucosa in contrast with LV is in agreement with in vivo studies where 13V091 and 
07V063 showed high titers in nasal secretions, whereas LV was difficult to isolate 
(Duan et al. 1997b, Frydas et al. 2015). Results obtained from 08VA-infected 
explants correlate with current in vivo experiments with 08VA, where it reached 
similar titers (104.6 TCID50/ml) in nasal secretions at the early stages of infection (3 
dpi) (unpublished data). The prototype type 2 PRRSV VR2332 strain was able to 
replicate efficiently in the nasal mucosa, as it reached a similar replication level as the 
highly virulent type 1 strain Lena, which was shown to reach high virus titers in nasal 
explants and in nasal secretions in in vivo experiments (Karniychuk et al. 2010, 
Frydas et al. 2013). In our study, highly virulent PRRSV type 2 strains MN-184 and 
VN showed a 2 to 3 times higher level of replication compared to VR2332. The 
biodynamics of the MN-184 isolate was studied before. It was shown to have a 
higher frequency in aerosol shedding compared to another isolate (MN-30100) that 
displayed the same concentration in nasal swabs and respiratory samples (Cho et al. 
2006). Another comparative study has shown that infectivity of PRRSV in aerosols 
differs among isolates and depends on the isolate (Cho et al. 2007). In the present 
study, MN-184 and VR2332 reached 106.3 TCID50/ml and 105.4 TCID50/ml 
respectively, at 72 hpi. The importance of virus strain and titer in nasal secretions for 
transmission in between pigs was demonstrated in a previous study, where 103.1 
TCID50 was necessary for VR2332 strain to infect sentinel pigs via aerosol exposure 
(Hermann et al. 2009), while another work following exactly the same protocol 
showed that MN-184 was by far more efficient in transmission to sentinel animals via 
aerosol as only 100.24 TCID50 was sufficient to infect sentinel pigs (Cutler et al. 2012). 
A recent study using both MLV-DV and MLV-VR2332 vaccines showed that MLV-
VR2332 was 2 times more efficient than MLV-DV in its transmission to contact pigs 
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(Martinez-Lobo et al. 2013). The power of MLV-VR2332 to spread in between pigs 
is in agreement with the results of the present ex vivo work, where MLV-VR2332 
reached higher virus titers in the supernatant of infected explants compared to MLV-
DV. 
Vaccine strains showed a restricted replication power (low number of virus-positive 
cells and low virus titers). Attenuation of PRRSV strains did not affect viral cell 
tropism as both isolates followed the same tropism as the closely related prototype 
PRRSV strains (LV and VR2332) with MLV-DV infecting Sn+ macrophages and 
MLV-VR2332 being able to infect also Sn- macrophages. Vaccine viruses completed 
a restricted number of replication cycles showing a maximum replication level of 3.3 
PRRSV+ cells/mm2 (MLV-VR2332) at 48 hpi, and no vaccine virus positive cells and 
no detectable viral titers at 72 hpi. In the future, nasal mucosa explants will be a great 
help to screen new candidate vaccine viruses. This will speed up the development and 
is in agreement with the 3R principle. 
In general, modified-live PRRSV vaccines appeared to be protective against 
homologous reinfection and are able to reduce significantly viral shedding through 
nasal secretions (Hu et al. 2012). Therefore, they are the vaccines of choice for 
primo-vaccination in pigs. Nonetheless, an important issue of MLV vaccination is the 
risk of reversion to virulence under farm conditions as it was shown before, that 
vaccine-derived PRRSV strains could be isolated and cause disease in pigs (Bøtner et 
al. 1997, Opriessnig et al. 2002). The results received from the explants infected with 
vaccine virus strains showed that only low vaccine virus titers were observed at 24 
hpi, and no titers were detected at 48 and 72 hpi. From our results, we can conclude 
that the vaccine viruses did not switch into a virulent mutant. However, in order to 
come to sound conclusions, experiments with more and larger explants, more 
passages and evaluation of co-infections should be performed. 
Two different patterns of infection were observed for type 1 and type 2 PRRSV 
strains. On the one hand, type 1 strains formed after 48 hpi small cluster of cells (2 to 
3 cells) within the epithelium and larger cluster of cells (4 to 10 cells) within the area 
of the lamina propria. On the other hand, type 2 strains showed mainly single-cell 
infection in both areas and only few clusters of cells were observed in the lamina 
propria. In a previous study with a low (LV) and a highly (Lena) virulent type 1 
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PRRSV strain, it was shown that in the lamina propria, infection with both strains 
started in Sn+ cells but only PRRSV Lena spread later to Sn- cells (Frydas et al. 2013). 
In the current study, it was shown that except for the prototype VR2332, which seems 
to infect mainly Sn+ cells at 24 hpi, the other type 2 PRRSV isolates are able to infect 
Sn- cells in the lamina propria from the very beginning of the infection at 24 hpi. 
After 24 hpi, the prototype VR2332 follows the same single-cell infection pattern as 
the other type 2 strains. It can be hypothesized, that type 1 strains have the ability to 
upregulate monocytic cell chemotactic factors enhancing the clustering of monocytic 
cells, and cell-to-cell spread of the virus. This may allow type 1 viruses to spread 
from Sn+ to Sn- cells. It has been already shown before that, in contrast with LV, 
Lena is upregulating chemotactic factors (Badaoui et al. 2014). Type 2 PRRSV 
strains may directly infect Sn- cells. These viruses most probably use besides Sn 
another receptor to enter monocytic cells. This is in agreement with the findings of 
Prather et al. 2009, who showed that a type 2 isolate was able to replicate in 
sialoadhesin-deficient pigs. A recent analysis on the N-glycans of the GP5 protein of 
VR2332 showed that in addition to sialic acids, there is an abundance of N-
acetylglucosamine (GlcNAc) and N-acetyllactosamine (LacNAc) oligomers, which 
gives the ability to bind with ligands that are different from sialoadhesin (Li et al. 
2015). Whether there are different N-glycan patterns on PRRSV structural proteins 
that enable different PRRSV isolates to bind and use additional receptors remains to 
be elucidated. 
Due to the explant model that was used in our study, influx of sialoadhesin positive 
monocytic cells from blood could be excluded. Further, there was no de novo 
upregulation of sialoadhesin expression during the experiment. Experiments were 
performed with a standardized protocol and an inoculum of the same virus titer was 
used for all the strains and therefore, the differences in the number of infected cells 
cannot be attributed to differences in multiplicity of infection.  As a consequence, it 
can be concluded that the main difference between PRRSV isolates is their efficacy 
to infect Sn- cells. A comparative study between the US isolates VR2385, VR2431 
and the European Lelystad virus has concluded that despite the differences in 
virulence, the distribution of viral antigen within specific tissues and organs was 
quite similar for the different isolates (Halbur et al. 1996). In the present study, cell 
identification of PRRSV-positive cells showed no differences in between isolates in 
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their efficiency of infecting Sn+ cells, as the numbers of PRRSV+Sn+ cells ranged 
from 3.6 to 10.1 cells/mm2. The main difference between the moderately (VR2332), 
and the highly virulent (07V063, Lena, 13V091, MN-184, VN) strains is detected in 
the fact that the highly virulent isolates are able to infect a higher number of Sn- cells 
(mean number: 37.2 cells/mm2), and produce and shed more virus (105.9 TCID50/ml), 
than the low or moderately virulent strains (mean number: 12.6 cells/mm2, 105 
TCID50/ml). Immunofluorescence stainings of nasal explants using antibodies against 
the pan-myeloid CD172 marker have revealed that almost all the Sn- cells are 
CD172+ and have a myeloid origin. A widespread damage of other subtypes of 
antigen-presenting cells may worsen the ineffective immune response against 
PRRSV, resulting in a prolonged viremia and persistent infection, and may damage 
the defense against other pathogens leading to co-infections and PRDC. 
Finally, it can be concluded that (i) the tested PRRSV strains may be categorized ex 
vivo, based on their viral shedding in the supernatant of the nasal mucosa explants in 
poor (MLV-DV, MLV-VR2332, LV, 08VA), moderate (Lena, VR2332) and strong 
(07V063, 13V091, MN-184, VN) secretors, (ii) based on the number of infected cells, 
isolates can be categorized as low (MLV-DV, MLV-VR2332, LV, 08VA), 
moderately (VR2332), highly (07V063, Lena, 13V091) and hyper (MN-184, VN) 
virulent in nasal mucosa, (iii) vaccine strains show a limited number of replication 
cycles, low production of progeny virus and the same cell tropism as the homologous 
virulent field viruses, (iv) the tested PRRSV strains have a different ability to infect 
intra- and sub-epithelial Sn- nasal macrophages, which was correlated with their 
virulence and (v) two different replication patterns were observed as the tested type 1 
PRRSV isolates were able to form large clusters of cells after 48 hpi, whereas type 2  
PRRSV strains mainly showed a gradually increasing single-cell infection. 
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 General discussion 
Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most 
economically important pathogens in swine industry worldwide, causing huge 
economic losses (Holtkamp et al. 2013). PRRSV is an RNA virus showing a high 
mutation rate that results in genetical and antigenical changes despite the efforts for 
control and eradication (Snijder et al. 2013). Genetically, PRRSV strains are divided 
into European type 1 and North-American type 2 strains (Nelsen et al. 1999). Type 1 
strains are subdivided in four subtypes (1, 2, 3 and 4). The virus causes reproductive 
failure in late-term gestation sows, characterized by an increased number of 
mummified, and still- and weak-born piglets, and respiratory disorders characterized 
mainly by dyspnea and tachypnea in young animals (Terpstra et al. 1991, Mengeling 
et al. 1994). In the nineties, highly pathogenic type 1 subtype 3 strains emerged in 
Eastern Europe but there was no indication of an invasion of these strains in Western 
Europe, a region that is dominated by type 1 subtype 1 isolates (Stadejek et al. 2008). 
Up till now, no highly pathogenic type 1 subtype 1 strains have been isolated.  
In the first study (Chapter 3) of this thesis, twelve-week-old pigs were inoculated 
intranasally with two Belgian isolates designated 13V091 and 13V117 from 2013, 
originating from farms experiencing uncommon respiratory disorders within the first 
two weeks after weaning during an enzootic PRRSV infection. They were compared 
clinically, virologically and genetically with the mild-pathogenic PRRSV strain 
07V063. The outcome of the first study confirmed the reports that circulating PRRSV 
type 1 isolates in Belgium showed more severe respiratory disorders and an increase 
in virulence and pathogenicity compared to contemporary isolates.  
Results from this in vivo study with different type 1 subtype 1 PRRSV strains 
revealed differences in clinical signs and virulence, tissue and cell tropism, and 
stimulation of humoral immune response 
 PRRSV 13V091 was more pathogenic than the 13V117 and 07V063 strains, and the 
most pathogenic type 1 subtype 1 strain isolated up till now, inducing fever, 
breathing problems, high virus titers in nasal secretions, an increased percentage of 
lung lesions in young animals and an expanded cell tropism to Sn- cells in nasal 
mucosa and other lymphoid tissues. Thus far, no other contemporary PRRSV subtype 
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1 type 1 strain has shown these clinical and virological signs. Animals infected with 
13V091 showed the longest duration of fever (5.1 ± 4.2) and the highest clinical 
scores (1.6 ± 0.3) due to dyspnea, tachypnea and respiratory distress. The clinical and 
pathological outcome of 13V091 showed some similarities with the highly 
pathogenic subtype 3 strain Lena (Karniychuk et al. 2010, Weesendorp et al. 2012). 
In the study of Karniychuk et al., Lena showed clinical score values ranging from 0.5 
to 2 from 3 to 14 dpi, whereas in our results 13V091 showed a clinical score from 0.6 
to 1.6 during the same timeframe. In previous in vivo studies, Lena induced fever 
from 2 till 13 dpi (Weesendorp et al. 2012), and from 2 till 28 dpi (Karniychuk et al. 
2010), whereas in the current study, 13V091 induced fever from 2 till 14 dpi. It 
seems that the outcome of the infection with the 13V091 strain is correlated with the 
highly virulent subtype 3 PRRSV strain Lena. Whether there is an evolution drift for 
more virulent subtype 1 type 1 strains remains to be elucidated. 
The primary target cells of PRRSV are lung macrophages and the impact on the lungs 
is crucial for the progress of the disease. Macroscopic analysis of lungs of pigs 
euthanized at 10 dpi showed that 13V091 strain caused the most severe multifocal 
gross lesions compared to the 13V117 and 07V063 isolates. The percentage of lung 
lesions of 13V091 was also higher than that observed with the type 1 strains used in a 
recent study from Spain (Martinez-Lobo et al. 2011). In another Korean study, three 
new subtype 1 strains were compared with the prototype LV, and it was found that at 
10 dpi only one of them (SNUVR100744) showed a higher percentage (> 25%) of 
affected lung surface than 13V091 (12.9 ± 3.6) (Han et al. 2013). Furthermore, it was 
shown that 13V091 displayed a higher replication rate and produced more progeny 
virus in the lungs compared to 13V117 and 07V063. Viral loads of type 1 subtype 1 
strains of our study in lungs, are in agreement with the results of Labarque et al., 
where LV reached a mean titer of 106.2 TCID50/g in lung tissues at 9 dpi (Labarque et 
al. 2000). Strain-dependent replication efficiency is also determined by the virus 
production per infected cell. 13V091 and 07V063 were able to produce more 
infectious virus particles per infected cell than 13V117 in a ratio of 1:2 and 1:2.4, 
respectively. The latter results show that different factors might contribute for the 
increased virulence of specific isolates. It might be the case that some PRRSV strains 
are able to produce more infectious virus particles and a faster damage to the host via 
cell lysis. Further research need to be done in order to identify the factors involved in 
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these mechanisms. At this point, it should be mentioned that infectious clones of 
either the 07V063 or the 13V117 strain could be very useful, since these strains differ 
genetically in only 8 amino acids. It was shown that even one amino acid mutation at 
the structural or non-structural viral protein level can change the virulence and the 
shedding of an isolate (White and Fenner, 1994). In influenza A virus (IAV), a single 
amino acid substitution (R638A) of the polymerase protein subunit (PA) of the 
A/WSN/33 RNA polymerase can result in severe attenuation in the viral growth in 
cell culture by promoting the synthesis of defective interfering RNAs (Fodor et al. 
2003). Furthermore, it was demonstrated that in vitro inoculation of myeloid cells 
with the same MOI of different Dengue virus type 2 (DV2) isolates resulted in 
different degrees of productive infection between isolates. The latter event was 
correlated with the accumulation of viral RNA, meaning that viral strains with high 
levels of viral RNA produced greater levels of viral antigen and secreted more 
infectious virus (Diamond et al. 2000). The hypothesis that accumulation of viral 
RNA in the cell could be advantageous should be investigated for the PRRSV type 1 
subtype 1 strains. A crucial amino acid substitution at the non-structural protein level 
could lead either to a faster endosome membrane fusion or faster virus packaging and 
virion exocytosis. 
Virus shedding from the nasal mucosa is an important feature for PRRSV 
pathogenesis and has gained much attention the last years. Transmission of PRRSV 
via airborne route is an important characteristic after the appearance of highly 
pathogenic viral strains (Otake et al. 2010). It has already been shown that virus titers 
in nasal secretions of a highly pathogenic strain (Lena) reached a titer of 2.5 to 5.6 
log10TCID50/100mg from 3 to 14 dpi (Karniychuk et al. 2010). In the current study, 
during the same timeframe, viral titers of 2.0 to 4.8 and 1.8 to 4.3 
log10TCID50/100mg were detected for 13V091 and 13V117 respectively. These 
results indicate that both new strains although not as pathogenic as Lena, have the 
potential to be transmitted via airborne route in the early stages of infection based on 
the high virus titers in the nasal secretions. It has been speculated that recent 
outbreaks in the USA and China were due to virus isolates that can replicate and 
spread more efficiently (Murtaugh et al. 2010). The localization of virus replication 
and an expanded cell tropism may strongly support this hypothesis.  
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In this work, different PRRSV strains showed a different tissue tropism. In general, 
PRRSV infects macrophages that are localized in multiple tissues like the nasal 
turbinates, tonsils, lymph nodes, lungs, thymus, spleen, endometrium and testes 
(Kang et al. 2010, Karniychuk et al. 2010). Animals infected with the 13V091 strain, 
showed a higher replication efficiency based on virus titration and PRRSV-positive 
cell counting compared to the 07V063 and 13V117 strains. In addition, 13V091 
showed significantly higher numbers of PRRSV+ cells and 10 to 1000 times higher 
titers compared to 13V117 and 07V063 in the upper respiratory tract, tonsils and 
draining lymph nodes (conchae, septum, pharynx, RPLN). In the upper respiratory 
tract, 13V091 and 13V117 showed an expanded cell tropism as they were shown to 
replicate in Sn- macrophages with a different degree of efficiency, which correlates 
with the higher nasal virus titers observed for 13V091 compared to the other strains. 
It is important to mention that in the nasal mucosa (conchae, septum), the same 
distribution pattern of PRRSV+Sn- cells was observed for 13V091 and 13V117, with 
cells being located within the epithelium, and just underneath the basement 
membrane, which makes tempting to speculate that in the area of the nasal mucosa a 
different cell tropism may be the reason for the high titers in nasal secretions. The 
different tissue tropisms between virus isolates have been reported before for 
different HIV isolates, giving an explanation for the AIDS dementia complex (ADC) 
(Smit et al. 2001). The complex was attributed to neuropathogenic viral isolates using 
the CCR5 protein as a co-receptor in the brain and not showing the syncytium-
inducing phenotype. Similarly, the increased respiratory disorders in newly emerged 
type 1 PRRSV strains may be attributed to the use of an additional receptor in nasal 
macrophages. 
In general, virus-neutralizing antibodies in serum cannot be detected earlier than two 
to four weeks upon PRRSV infection in very low amounts, and maximum titers are 
only reached after several months. The late induction and the low titers of 
neutralizing antibodies observed in our results is in agreement with other studies that 
used the LV and the 07V063 strains, where only low titers of neutralizing antibodies 
(Nabs) were observed after 25 dpi for LV (21-3.6), and after 35 dpi for 07V063 (21-2.2) 
(Labarque et al. 2000, Geldhof et al. 2012). A correlation between the appearance of 
Nabs and the virus elimination from blood was mentioned before, but the exact 
degree of Nabs contribution to viral clearance is still questionable (Xiao et, al. 2004, 
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Diaz et al. 2005, Mateu et al. 2008). In 13V091 and 13V117-infected animals, Nabs 
appeared later and at lower titers compared to 07V063, and at that time the virus was 
already eliminated from the blood. Analysis of glycosylation sites on PRRSV 
structural proteins based on Lelystad virus, revealed one additional glycosylation site 
for 13V091 into GP3 protein at amino acid position 253 (Vanhee et. al 2011). It can 
be hypothesized that the presence of additional glycosylation sites at the neutralizing 
epitopes, and the sensitivity of the SN test, might contribute for the late development 
of Nabs observed in 13V091 and 13V117 compared to 07V063. As no additional or 
different glycosylation sites were observed within 13V117 and 07V063, it is tempting 
to speculate that addition of newly acquired sugar moieties to the already known 
neutralizing epitopes of 13V117 may make the virus unrecognizable and mask the 
neutralizing epitopes that reduce or eliminate the binding affinity of the antibodies.  
The complete genome sequence of 13V091 and 13V117 revealed that both isolates 
can be categorized as PRRSV type 1 subtype 1. Remarkably, 13V117 showed only 
eight different amino acids compared to 07V063. Despite the latter fact, the 
virological, clinical and pathological changes induced by these two viruses were quite 
different. On the one hand, 13V117 replicated efficiently in the nasal mucosa, 
induced a high viremia, with infected animals showing breathing problems between 2 
and 7 dpi, but the virus had problems to replicate in lymphoid tissues. On the other 
hand, 07V063-infected animals showed a restricted replication in the nasal mucosa, a 
10-fold lower viremia but an extensive replication in the lymphoid tissues. Only two 
pigs had mild breathing problems. Pairwise alignments revealed single amino acid 
changes in different crucial areas of structural and non-structural viral proteins. Some 
of these single amino acid changes are located in important areas in structural 
proteins like GP3 and GP4. The single amino-acid change in GP3 between 07V063 
and 13V117 is located within the neutralizing antigenic region in the C-terminal 
domain, that has been found to be recognised by neutralizing antibodies against LV 
(Vanhee et al. 2011). The single amino acid difference between 07V063 and 13V117 
in GP4 is located at the ectodomain of GP4 within the most immunogenic region that 
was identified in all envelope proteins, but is also part of a neutralizing antibody 
region (NAR) named ES12 found to induce high virus neutralizing antibody titers at 
42 dpi (Vanhee et al. 2011, Oleksiewicz et al. 2009). Neutralization can be done 
either by alteration of the structure of the virus structural proteins or by interference 
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of antibodies with virus-host cell interactions. Whether these single amino acid 
substitutions have an effect on these procedures by changing the glycan shielding, or 
by reforming the possible immune decoy epitopes remains to be clarified. In fast 
evolving RNA viruses like PRRSV, addition or deletion of glycosylation sites 
happens frequently, in order for the virus to gain access in target cells or evade the 
immune mechanism via glycan shielding (Murtaugh et al. 2010). It has been reported 
that type 2 PRRSV is able to evade the immune system via glycan shielding that 
involves the GP3 and the GP5 protein (Vu et al. 2011). The importance of a single 
amino acid substitution is already known since 1983, where a single amino acid 
substitution in the HA protein of the influenza A, subtype H5 led to a devastating 
outbreak of fowl plaque on poultry farms around Pennsylvania US (White and Fenner, 
1994). In that case, the point mutation abolished a glycosylation site, exposing the 
cleavage site previously concealed by an oligosaccharide chain to proteolysis. 
The reports of Belgian farms experiencing more severe respiratory problems in pigs 
triggered us to study extensively the replication kinetics of PRRSV in nasal mucosa 
in order to identify the factors that lead to an increase in nasal replication and 
airborne transmission between different isolates. An already successful explant 
culture system that has been extensively used to study the replication kinetics of 
herpesviruses in our lab was adapted.  Studies with similar explant systems have been 
performed with different tissues of the respiratory tract in different animal species to 
investigate virus transmission and cell tropism (Glorieux et al. 2007, Steukers et al. 
2011, Tugizov et al. 2012, Vairo et al. 2013). To examine the behavior of PRRSV in 
nasal mucosa, a polarized nasal mucosa explant system that mimics the natural 
condition and prevents infection from the lateral and the bottom sides was generated. 
This polarized nasal mucosa explant system allowed us to study the local PRRSV 
transmission and primary events during the early stages of PRRSV infection. The 
replication kinetics and cell tropism of different type 1 strains (LV, 07V063, 08VA, 
Lena, 13V091), type 2 strains (VR2332, MN-184, VN), and two attenuated vaccine 
strains (MLV-DV and MLV-VR2332) were compared in these explants. 
Some notable differences in the number of infected cells and cell tropism, the amount 
of shedded virus (secretors) in the culture supernatant, and the pattern of infection 
were observed between the PRRSV strains in nasal mucosa explants. Concerning the 
number of virus-infected cells, PRRSV isolates could be classified as low (MLV-DV, 
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MLV-VR2332, LV, 08VA), moderately (VR2332), highly (07V063, Lena, 13V091) 
and hyper (MN-184, VN) virulent in nasal mucosa. At 72 hpi, Lena was found to 
infect twenty times more cells than LV in the nasal mucosa. In LV-infected tissues, 
mainly single infected cells were detected in the lamina propria, whereas in Lena-
infected explants cell foci were also observed after 48 hpi. The small number of LV-
infected cells in our experiments was in agreement with previous work, where no 
viral antigen positive cells were detected in the nasal mucosa after intranasal 
inoculation of specific-pathogen-free pigs with LV (Pol et al. 1991). The forming of 
cell clusters in Lena strain shows a plaquewise spread of infection, which is different 
from the usual single-cell infection that is observed in PRRSV infection. This event 
might help the virus to infect more local antigen-presenting cells and and leave an 
“open” door for secondary infections. Vaccine viruses completed a restricted number 
of replication cycles showing a maximum replication level of 3.3 PRRSV+ cells/mm2 
(MLV-VR2332) at 48 hpi, and no vaccine virus positive cells and no detectable viral 
titers at 72 hpi. At the same time point, the numbers of PRRSV-infected cells of 
recently isolated type 1 strains 07V063, 08VA and 13V091 were 5 to 50 times higher 
than the classical LV type 1 strain. In contrast with LV, efficient replication of 
07V063 and 13V091 in the nasal mucosa is in agreement with the in vivo studies of 
the first work (Chapter 3), where 13V091 and 07V063 showed high titers in nasal 
secretions (Frydas et al. 2015). Type 2 PRRSV (VR2332, MN-184, VN) strains 
appeared to replicate extremely efficiently in the nasal mucosa showing an up to 60 
times higher replication level compared to low pathogenic strains. This fact may aid 
to explain why in general type 2 strains cause more respiratory disorders in pigs, than 
contemporary type 1 strains (Martinez-Lobo et al. 2011) 
Based on the production of progeny virus and the subsequent viral shedding 
attenuated (MLV-DV, MLV-VR2332), LV and 08VA PRRSV strains can be 
considered as poor secretors, whereas PRRSV Lena and VR2332 are moderate, and 
PRRSV 07V063, 13V091, MN-184 and VN are strong secretors. In our results, virus 
titrations showed a 10 to 100-fold higher titer for moderate and strong compared to 
poor secretors at the end of the experiment (72 hpi). The higher replication level that 
was observed with Lena correlates with previous in vivo studies where this strain was 
found to be more virulent than LV (Karniychuk et al. 2010). 13V091 was also 
confirmed as a strong secretor in nasal mucosa as it reached similar titers as observed 
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in the in vivo work (Chapter 3). The prototype type 2 PRRSV VR2332 strain was 
able to strongly produce progeny virus in the nasal mucosa, as it reached similar titers 
with the in vivo studies with Lena (Karniychuk et al. 2010). In our results, highly 
virulent PRRSV type 2 strains MN-184 and VN showed a 2 to 3 times higher level of 
replication compared to VR2332. The biodynamics of the MN-184 isolate are studied 
before. It was shown to have a higher frequency in aerosol shedding compared to 
another isolate (MN-30100) that displayed the same concentration in nasal swabs and 
respiratory samples (Cho et al. 2006). Other comparative studies have shown that 
transmissibility of PRRSV in aerosols differs among isolates and depends on the 
isolate (Murtaugh et al. 2002, Cho et al. 2007). In this study, MN-184 and VR2332 
reached 106.3 TCID50/ml and 105.4 TCID50/ml respectively, at 72 hpi. The importance 
of virus titer in nasal secretions for transmission in between pigs is demonstrated in a 
previous study where 103.1 TCID50 was necessary for VR2332 strain to infect sentinel 
pigs via aerosol exposure (Hermann et al. 2009).  
Monocytic cells lying within the mucosal surfaces communicate with each other and 
form a network in order to capture antigens, and process the antigens to T-cells 
(Steinman et al. 2007). Immunofluorescence microscopy in non-infected nasal 
mucosa explants revealed that Sn+ cells were found to be equally distributed in the 
lamina propria and the submucosa, and only a small number of cells with this 
phenotype was present in the epithelial cell layer (5.2 cells/mm2). Two different 
patterns of infection were observed for type 1 and type 2 PRRSV strains. On the one 
hand, type 1 strains seemed to form after 48 hpi, small clusters of cells (2 to 3 cells) 
within the epithelium and larger clusters of cells (4 to 10 cells) within the area of the 
lamina propria. On the other hand, type 2 strains showed mainly single-cell infection 
in both areas and only few clusters of cells were observed in the lamina propria. The 
different strategies of spreading the infection followed by the highly pathogenic type 
1 and type 2 strains highlights the need for further research on this matter. The future 
research will show whether the different type 1 or type 2 strains may use different 
receptors or whether other factors that affect plaque-wise spread may be involved. 
Attenuation of parental vaccine strains did not affect viral cell tropism as both 
isolates followed the same tropism as the closely related prototype PRRSV strains 
(LV and VR2332) with MLV-DV infecting Sn+ macrophages and MLV-VR2332 
being able to infect also Sn- macrophages. It was shown that LV- and MLV-DV 
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positive cells, were single infected cells located in the lamina propria and that 97% of 
them were Sn+. Remarkably, in highly pathogenic type 1 (07V063, Lena, 13V091) 
infected tissues large clusters of cells were formed after 48 hpi. More than 50% of 
these cells were CD163+Sn- and that was the phenotype of the majority of the cells in 
clusters within or close to the epithelium. CD163-Sn- cells were also found at the 
periphery of the clusters indicating that highly pathogenic type 1 strains are capable 
of spreading to bystander cells. Additional immunofluorescence stainings with the 
pan-myeloid CD172 marker revealed that almost all the Sn- infected cells are CD172-
positive and are of myeloid origin. The prototype type 2 VR2332, seems to infect 
mainly Sn+ cells at 24 hpi, whereas the other type 2 PRRSV isolates are able to infect 
Sn- cells in the lamina propria from the very beginning of the infection at 24 hpi. The 
latter event helps the highly virulent strains to reach faster a higher level of 
replication and produce more progeny virus. After 24 hpi, the prototype VR2332 
follows the same single-cell infection pattern as the other type 2 strains. Cell 
identification of PRRSV-positive cells showed no differences in between isolates in 
their efficiency of infecting Sn+ cells, as the numbers of PRRSV+Sn+ cells ranged 
from 3.6 to 10.1 cells/mm2. The main difference between the moderately (VR2332), 
and the highly virulent (07V063, Lena, 13V091, MN-184, VN) strains relate to the 
fact that the highly virulent isolates are able to infect a higher number of Sn- cells and 
produce more virus than the low or moderately virulent strains, as the total number of 
infected cells is also higher. The isolation of Sn- cells from the nasal mucosa and the 
study of the replication kinetics in vitro will shed light in this matter. 
Several hypotheses can be discussed for the different patterns of infection and the 
different cell tropisms of the PRRSV strains. First, the cell-cell spread observed in 
highly pathogenic type 1 strains may be the result of engulfed apoptotic bodies that 
contain infectious viral particles by bystander cells, as it was shown before (Labarque 
et al. 2003, Costers et al. 2008). However, viral spread to other cell types through 
phagocytosis of apoptotic bodies should also occur with low pathogenic strains as 
well. Secondly, the observation of single or cell clusters of Sn-negative infected cells 
leads to the hypothesis that an additional cell entry receptor is possibly used by the 
highly pathogenic strains, which may allow the spread to Sn-negative cells. Highly 
pathogenic type 1 strains might have the ability to upregulate monocytic cell 
chemotaxis enhancing the clustering of monocytic cells, and cell-to-cell spreading of 
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the viruses. This may allow type 1 viruses to spread from Sn+ to Sn- cells. It has 
already been shown before that in contrast with LV, an infection of alveolar 
macrophages with Lena is activating signaling pathways, which results in chemotaxis 
(Badaoui et al. 2014). Type 2 PRRSV strains may directly infect Sn- cells through the 
use of an additional receptor besides Sn to enter monocytic cells. This is in agreement 
with the findings of Prather et al. 2009, which showed that a type 2 isolate was able 
to replicate in sialoadhesin-deficient pigs. A recent analysis on the N-glycans of the 
GP5 protein of VR2332 showed that in addition to sialic acids, there is an abundance 
of N-acetylglucosamine (GlcNAc) and N-acetyllactosamine (LacNAc) oligomers, 
which may provide the virus the ability to bind with ligands that are different from 
sialoadhesin (Li et al. 2015). The lectin-sialic acid binding capacity has been reported 
to determine the tissue and cellular tropism in other viruses (Van Breedam et al. 
2014). In avian influenza viruses, one or few amino acid mutations in the viral 
surface protein hemagglutinin can determine the preference for either a2,3- or a2,6-
linked sialic acids and subsequently the cell tropism of the virus (Wan et al. 2007). In 
addition, sialic acid binding capacity is crucial for many coronaviruses in order to 
penetrate the mucus layer of the respiratory or gut mucosa (Schwegmann-Wessels et 
al. 2006). It was reported that dependence on the sialic acid binding activity for an 
efficient infection differs in different transmissible gastroenteritis virus strains 
(Schwegmann-Wessels et al. 2011). In PRRSV, the condition of lectin-sialic acid 
binding is reversed since the sialylated glycans on the virion surface bind to a lectin 
cell receptor of the Siglec family (Sn; CD169; Siglec-1) (Van Breedam et al. 2010). 
In humans it is already known that except for Sn, other Siglecs are expressed on the 
surface of cells of the monocytic lineage, like Siglec-3, 5, 7, 10, 11, 15 and 16 
(O’Reilly and Paulson, 2009). Just as in sialoadhesin, the sialic acid binding capacity 
of the other siglecs is due to a conserved arginine residue in the N-terminal domain 
(O’Reilly and Paulson, 2009). It is possible that another member of the Siglec family 
present on the nasal macrophages can serve as a candidate receptor for the highly 
pathogenic type 1 and type 2 PRRSV isolates. A small “jump” concerning the 
binding capacity of PRRSV for another protein of the same family is an evolutionary 
advantage for the highly pathogenic PRRSV strains as they can infect additional cells 
of the monocytic lineage. Furthermore, the existence of a novel receptor might 
change the adaptive immune response and have an impact on the available vaccines 
against PRRSV. Neutralizing antibodies block the interaction of PRRSV with its 
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internalization receptor (Sn) via anti-GP5 specific antibodies (Delputte et al. 2004, 
Van Breedam et al. 2010). Thus, vaccination of animals with isolates that use Sn as a 
receptor might not work against an infection with highly pathogenic PRRSV isolates, 
which use a new receptor that subsequently interacts with another structural virus 
glycoprotein. Whether there are different N-glycan patterns on PRRSV structural 
proteins that enable different PRRSV isolates to bind and use additional receptors 
remains to be elucidated.  
The results obtained in this thesis, have advanced our understanding on the factors 
that contribute to the virulence of new highly pathogenic PRRSV strains. Moreover, 
new insights were gained on the pathogenesis and the respiratory disorders that can 
be caused with type 1 PRRSV strains. The high replication level in Sn-negative cells 
in nasal mucosa may increase the airborne transmission of the virus, and the change 
in cell tropism can possibly alter the host immune response and virus pathogenesis. 
Further research still needs to be done to answer questions that are raised during this 
thesis. Although new highly pathogenic strains have emerged during the last decade, 
there is limited information on the pathogenesis and the expanded cell tropism they 
display. On the one hand, the isolation of myeloid Sn-negative cells from the nasal 
mucosa and the identification of new receptor(s) will give new insights concerning 
the viral attachment and internalization. On the other hand, the identification of new 
receptors(s) will lead to the development of novel vaccines for the control of the 
highly pathogenic PRRSV strains, and improve our knowledge concerning PRRSV 
immune evasion and the priming of neutralizing antibodies. Finally, further research 
on the structural and non-structural proteins of PRRSV will shed light on the 
regulation of the chemotaxis and on the different strategies followed by the two 
genotypes to spread the infection. 
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Summary 
Porcine reproductive and respiratory syndrome (PRRS) is one of the most devastating 
diseases causing huge economic losses in swine industry. Only in the US the losses 
reached $664 million in the year 2013. The disease is caused by the PRRS virus 
(PRRSV), which is a single-stranded positive RNA virus, classified in the 
Arteriviridae family. The virus affects pigs of all ages, resulting in reproductive 
failures in sows and gilts and respiratory disorders in piglets. A high genetic 
heterogeneity divided PRRSV into the European type 1 and the American type 2. The 
virus shows a high mutation rate and evolves rapidly, resulting in the appearance of 
new highly pathogenic variants of both genotypes in Europe, North America and 
Asia over the last decade. Specifically in Europe, highly pathogenic PRRSV strains 
with increased respiratory disorders and more severe clinical signs have emerged 
recently. Therefore, the main goal of the present thesis was to examine the 
pathogenesis of the newly emerged isolates and identify the factors that contribute to 
the increased virulence.  
In the first part of chapter 1, an introduction is given based on the current literature 
on virus history, taxonomy, heterogeneity, pathogenesis, immune response and 
vaccination. In the second part, a brief introduction on the history and the 
applications of explant culture systems is presented, and the histology and immune 
system of the respiratory mucosae.  
In chapter 2 the general aim of the thesis is stated, and the specific goals are 
presented. 
In chapter 3, the different clinical, virological, serological and tissue tropism 
outcome of two new PRRSV strains (13V091 and 13V117), isolated in 2013 from 
two different Belgian farms with enzootic respiratory problems shortly after weaning 
in the nursery, were compared with the Belgian strain 07V063 isolated in 2007. Full 
genome sequencing was performed to identify the origin of the new isolates. Twelve 
weeks-old pigs were inoculated intranasally (IN) with 13V091, 13V117 or 07V063 (9 
pigs/group). At 10 days post inoculation (dpi), 4 animals from each group were 
euthanized and tissues were collected for pathology, virological and serological 
analysis. 13V091 infection resulted in the highest respiratory disease scores and 
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longest period of fever. Gross lung lesions were more pronounced for 13V091 (13%) 
than for 13V117 (7%) and 07V063 (11%). The nasal shedding and viremia was also 
most extensive with 13V091. The 13V091-inoculated group showed the highest virus 
replication in conchae, tonsils and retropharyngeal lymph nodes. 13V117 infection 
resulted in the lowest virus replication in lymphoid tissues. 13V091 showed higher 
numbers of sialoadhesin- infected cells/mm2 in conchae, tonsils and spleen than 
13V117 and 07V063.  Neutralizing antibody response with 07V063 was stronger 
than with 13V091 and 13V117. In summary: (1) two new PRRSV strains designated 
13V091 and 13V117 were isolated from pigs showing respiratory distress. 
Pathogenic and genetic studies showed that 13V091 is the most pathogenic type 1 
subtype 1 strain isolated up till now inducing fever, breathing problems, high virus 
titers in nasal secretions, an increased percentage of lung lesions in young animals 
and an expanded cell tropism to Sn- cells in nasal mucosa and other lymphoid tissues. 
(2) Despite the fact that 13V117 and 07V063 show only eight amino acid differences, 
they showed contrasting clinical and virological outcomes. 13V117 was able to 
induce fever, high viremia, and respiratory problems at the early stages of infection 
and it was able to replicate in the nasal mucosa but not in the lymph nodes, whereas 
07V063 showed only fever, a 10-fold lower viremia, low virus titers in nasal 
excretions, but higher virus titers in lymphoid tissues.  
The increased respiratory disorders compared to contemporary PRRSV isolates and 
the expanded cell tropism observed in the results of chapter 3 triggered us to study 
the virus replication kinetics in the nasal mucosa more extensively. Thus, in chapter 
4.1, a new polarized nasal mucosa explant system was used to study the invasion of 
the low virulent subtype 1 PRRSV strain Lelystad (LV) and the highly virulent 
subtype 3 PRRSV strain Lena at the portal of entry. Different cell types of the 
monocytic lineage (alveolar macrophages (PAM), cultured blood monocytes and 
monocyte-derived dendritic cells (moDC)) were enclosed to examine replication 
kinetics of both strains in their putative target cells. At 0, 12, 24, 48 and 72 hours post 
inoculation (hpi), virus production was analyzed and the infected cells were 
quantified and identified. Differences in replication were not found in monocytes and 
moDC. Confocal microscopy demonstrated that for LV, almost all viral antigen 
positive cells were CD163+Sialoadhesin (Sn)+, which were mainly located in the 
lamina propria of the respiratory mucosa. In Lena-infected nasal mucosa, 
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CD163+Sn+, CD163+Sn- and to a lesser extent CD163-Sn- monocytic subtypes were 
involved in infection. CD163+Sn- cells were mostly located within or in the proximity 
of the epithelium. In summary, we proposed a model for the different mechanisms of 
invasion that were observed between these two PRRSV strains in nasal mucosa. On 
the one hand, LV susceptibility was mainly restricted to CD163+Sn+ cells, which 
were located in the lamina propria. The small number of Sn+ cells (5.2/mm2) that are 
present within the epithelial cell layer likely does not allow LV to reach high levels 
of infection. Only 2.5 LV-infected cells/mm2 were observed at 72 hpi, all of them 
located in the lamina propria and the 97% of them had a CD163+Sn+ phenotype. On 
the other hand, Lena was found to replicate 10 to 100 times more efficiently than LV 
and appears to hijack both CD163+Sn+ and CD163+Sn- cells lying within or close to 
the epithelium in order to gain access to deeper parts of the mucosa. After 48 hpi, 
clusters of mainly CD163+Sn- Lena-infected cells were observed within or close to 
the epithelium and clusters of CD163+Sn+ cells were observed in the lamina propria. 
These clusters expanded at 72 hpi, and to a lesser extent than the other phenotypes, 
CD163-Sn- cells were also detected at the periphery of them. 
In chapter 4.2, the explant system was used to expand our research and study the 
replication characteristics in the nasal mucosa of four type 1 (LV, 07V063, 08VA, 
13V091), three type 2 (VR2332, MN-184, VN) and two attenuated (MLV-DV, 
MLV-VR2332) PRRSV strains. After 72 hpi mean virus titers reached 104.5 to 4.8 
TCID50/ml for LV and 08V204, 105.2 to 5.4 TCID50/ml for Lena and VR2332, and 105.8 
to 6.3 TCID50/ml for 07V063, 13V091, MN-184 and VN strains, whereas attenuated 
strains remained around the detection limit (0.9 TCID50/ml). The mean number of 
PRRSV-positive cells/mm2 at 72 hpi was 1.1 and 1.3 for the attenuated strains and 
LV, 13.3 for 08VA, 23.5 and 29.3 for VR2332 and 07V063, 31.1 and 33.8 for 
13V091 and Lena, and, 39.1 and 59.2 for MN-184 and VN respectively. All the LV 
and MLV-DV infected cells were Sn+, whereas all other strains also infected Sn- 
macrophages. In conclusion, (i) based on virus shedding in the respiratory explants, 
PRRSV strains can be categorized as poor (MLV-DV, MLV-VR2332, LV, 08VA), 
moderate (Lena, VR2332) and strong (07V063, 13V091, MN-184, VN) secretors, 
and (ii) based on the number of infected cells isolates can be categorized as low 
(MLV-DV, MLV-VR2332, LV), moderately (08VA, VR2332), highly (07V063, 
Lena, 13V091) and hyper (MN-184, VN) virulent in the nasal mucosa. 
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Finally, a general discussion of the main findings of this thesis and the future 
perspectives are presented in chapter 5.  
 Samenvatting 
Porcien reproductief en respiratoir syndroom (PRRS) is een van de meest ingrijpende 
ziekten met enorme economische verliezen in de varkenshouderij. In 2013 was er in 
de VS alleen al voor $664 miljoen schade. De ziekte wordt veroorzaakt door het 
PRRS virus (PRRSV), een enkelstrengig positief RNA virus dat behoort tot de 
familie Arteriviridae. Het virus tast varkens aan van alle leeftijden, wat enerzijds leidt 
tot reproductiestoornissen bij biggen en vleesvarkens en anderzijds 
ademhalingsstoornissen bij biggen. PRRSV kan door de hoge genetische 
heterogeniciteit worden onderverdeeld in het Europees type 1 en het Amerikaans type 
2. Het is een snel evoluerend virus dat een hoge mutatiegraad vertoont, wat leidt tot 
nieuwe en hoog pathogene varianten van beide genotypen. Deze werden gedurende 
het laatste decennium waargenomen in Europa, Noord-Amerika en Azië. 
Hoogpathogene PRRSV stammen die erge respiratoire stoornissen en meer algemene 
ziektesymptomen veroorzaken, worden recent meer waargenomen in Europa. Dit 
leidde tot het doel van deze thesis, namelijk de pathogenese van de nieuw opkomende 
isolaten bestuderen en de factoren die bijdragen tot de toegenomen virulentie 
identificeren.  
In het eerste deel van hoofdstuk 1 wordt een inleiding gegeven over het virus, de 
taxonomie, heterogeniciteit, pathogenese, immuniteit en vaccinatie gebaseerd op de 
huidige literatuur. In het tweede deel wordt er een korte inleiding gegeven over de 
achtergrond en toepassingen van explantcultuursystemen, en de histologie en het  
immunsysteem van de respiratoire mucosa. 
In hoofdstuk 2 wordt het algemene doel van deze thesis vermeld en worden alle 
specifieke doelstellingen voorgesteld. 
In hoofdstuk 3 worden twee nieuwe PRRSV stammen (13V091 en 13V117), die een 
verschillende kliniek, virologie, serologie en weefseltropisme hebben, vergeleken 
met de Belgische stam 07V063, geïsoleerd in 2007.  De 13V091 en 13V117 stammen 
werden in 2013 geïsoleerd op twee verschillende Belgische bedrijven met enzoötisch 
respiratoire problemen bij pasgespeende biggen.  Een volledige genoomsequenering 
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werd uitgevoerd om de oorsprong van deze nieuwe isolaten te identificeren. Twaalf-
weken-oude varkens werden intranasaal (IN) geïnoculeerd met 13V091, 13V117 of 
07V063 (9 varkens/groep). Tien dagen na inoculatie (dpi) werden vier dieren per 
groep geëuthanaseerd en weefsels werden verzameld voor een pathologische, 
virologische en serologische analyse. Een infectie met 13V091 veroorzaakte de 
meeste respiratoire stoornissen en de langste periode van koorts. Het merendeel van 
de longlesies waren meer uitgesproken voor 13V091 (13%), in vergelijking met  
13V117 (7%) en 07V063 (11%). De nasale uitscheiding en viremie waren eveneens 
uitgebreider voor 13V091. De 13V091-geïnoculeerde groep vertoonde de hoogste 
virusreplicatie in de conchae, tonsillen en retrofaryngeale lymfeknopen.  Een infectie 
met 13V117 leidde tot de minste virusreplicatie ter hoogte van de lymfoïde weefsels. 
13V091 vertoonde een hoger aantal sialoadhesin- (Sn-) geïnfecteerde cellen/mm2 in 
de conchae, tonsillen en milt dan 13V117 en 07V063. Een sterkere neutraliserende 
antistoffenrespons werd waargenomen bij 07V063 dan bij 13V091 en 13V117.  
Samengevat: (1) twee nieuwe PRRSV stammen (13V091 en 13V117) werden 
geïsoleerd uit varkens met ademnood. Pathologische en genetische studies toonden 
aan dat 13V091 de meest pathogene type 1 subtype 1 stam is die tot nog toe werd 
geïsoleerd. Deze stam leidde tot koorts, ademhalingsproblemen, hoge virustiters in de 
nasale secreten, een verhoogd percentage van longletsels bij jonge dieren en een 
verhoogd celtropisme voor Sn- cellen in de nasale mucosa en andere lymfoïde 
weefsels. (2) Ondanks het feit dat 13V117 en 07V063 slechts acht aminozuren 
verschillen in hun genoom, vertoonden ze zowel klinisch als economisch een 
verschillende resultaat. 13V117 kon koorts, een hoge viremie en respiratoire 
problemen induceren in een vroeg stadium van infectie en was in staat om in de 
nasale mucosa maar niet in de lymfeknopen te vermeerderen. 07V063 daarentegen, 
veroorzaakte enkel koorts, een 10-voudig lagere viremie, lagere virustiters in de 
nasale secreten maar hogere virustiters in de lymfoïde weefsels. 
De toegenomen ademhalingsstoornissen en het uitgebreid celtropisme die werden 
waargenomen in de resultaten van hoofdstuk 3, stimuleerden ons om de 
vermeerdering in de nasale mucosa uitgebreider te bestuderen. 
Bijgevolg is er in hoofdstuk 4.1 een nieuw gepolariseerd neusmucosa-
explantsysteem gebruikt om de invasie van de laag virulente subtype 1 PRRSV-stam 
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Lelystad (LV) en van de hoog virulente subtype 3-PRRSV stam Lena t.h.v. hun 
intredepoort te bestuderen. Verschillende cellen van de monocytaire lijn (alveolaire 
macrofagen (PAM), in cultuur gebrachte bloed monocyten en monocyt-afgeleide 
dendritische cellen (moDC)) werden gebruikt om de replicatiekinetiek van beide 
stammen in hun vermoedelijke doelwitcellen te onderzoeken. De virusproductie werd 
bepaald  op 0, 12, 24, 48 en 72 uur post-infectie (hpi) en er werd nagegaan hoeveel en 
welke cellen geïnfecteerd werden. Er was geen verschil tussen de replicatie in 
monocyten en moDC. Confocale microscopie toonde aan dat bij LV bijna alle virale 
antigeen positieve cellen ook CD163+Sialoadhesine (Sn)+ waren en zich vooral in de 
lamina propria van de respiratoire mucosa bevonden. Bij Lena-geïnfecteerde 
neusmucosa waren vooral de CD163+Sn+, CD163+Sn- en in iets mindere mate 
CD163+Sn- monocytensubtypes aangetast. CD163+Sn+ cellen waren vooral 
gelokaliseerd in of nabij het epitheel. We stellen hier dus een model voor over de 
invasiemechanismen van de twee PRRSV stammen in de nasale mucosa. De 
gevoeligheid voor LV beperkt zich tot CD163+Sn+ cellen, die zich in de lamina 
propria bevinden. Omdat er slechts een klein aantal Sn+ cellen (5.2/mm2) voorkomen 
in het epitheel kan LV geen hoge infectiegraad bereiken. Op 72 hpi konden slechts 
2.5 LV-geïnfecteerde cellen/mm2 geteld worden, deze bevonden zich allemaal in de 
lamina propria en 97% van hen was CD163+Sn+. Lena daarentegen, kon 10 tot 100 
keer meer repliceren dan LV en kon ook CD163+Sn+ en CD163+Sn- cellen, die 
dichtbij het epitheel lagen, ‘kidnappen’ om zo toegang  te krijgen tot het diepere deel 
van de neusmucosa. Na 48 u infectie werden er enerzijds clusters CD163+Sn- Lena-
geïnfecteerde cellen waargenomen in of nabij het epitheel en anderzijds clusters 
CD163+Sn+ cellen in de lamina propria. Deze clusters vergrootten op 72 hpi en aan 
de periferie werden minder CD163-Sn-cellen waargenomen dan andere fenotypes.  
In hoofdstuk 4.2 werd het explantsysteem gebruikt om de replicatiekarakteristieken 
van vier type 1 (LV, 07V063, 08VA, Lena, 13V091), drie type 2 (VR2332, MN-184, 
VN) en twee geattenueerde (MLV-DV, MLV-VR2332) PRRSV stammen in de 
neusmucosa te bestuderen. Op 72 hpi bereikten de gemiddelde virustiters 104.5 tot 4.8 
TCID50/ml voor LV en 08V204, 105.2 tot 5.4 TCID50/ml voor Lena en VR2332, en 105.8 
tot 6.3 TCID50/ml voor 07V063, 13V091, MN-184 en VN stammen, terwijl de titers 
van de geattenueerde stammen rond de detectielimiet schommelden (0.9 TCID50/ml). 
Het gemiddeld aantal PRRSV-positieve cellen/mm2 op 72 hpi was respectievelijk 1.1 
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en 1.3 voor de geattenueerde stammen en LV, 13.3 voor 08VA, 23.5 en 29.3 voor 
VR2332 en 07V063, 31.1 en 33.8 voor 13V091 en Lena, en tenslotte 39.1 en 59.2 
voor MN-184 en VN. LV en MLV-DV infecteerden enkel Sn+ cellen, terwijl alle 
andere stammen ook Sn- macrofagen infecteerden. Er kan dus besloten worden dat (i) 
de onderzochte PRRSV stammen op basis van virusuitscheiding gecategoriseerd 
kunnen worden in zwakke (MLV-DV, MLV-VR2332, LV, 08VA), gemiddelde 
(Lena, VR2332) en sterke (07V063, 13V091, MN-184, VN) uitscheiders, en (ii) 
gebaseerd op het aantal geïnfecteerde cellen, de isolaten verdeeld kunnen worden in 
laag (MLV-DV, MLV-VR2332, LV), gemiddeld (08VA, VR2332), hoog (07V063, 
Lena, 13V091) en hyper (MN-184, VN) virulent in de neusmucosa.  
De algemene discussie en toekomstige perspectieven worden weergegeven in 
hoofdstuk 5. 
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